Sentence,class,file
References  Journal of Pharmacopuncture 2013;16(4):022-029 http://www.journal.ac,Non-OADS,/arxiv_data1/oa_pdf/72/5a/2093-6966-v16-n04-022.PMC4331978.pdf
"Bee venom pharma - copuncture can have severe side effects in humans,  Original article Received:  Oct 22, 2013     Accepted:  Oct 30, 2013ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2013;16[4]:043-048 DOI:    http://dx.doi.org/10.3831/KPI.2013.16.023    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/e0/2093-6966-v16-n04-043.PMC4331979.pdf
Tel: +82-33-741-9257 FAX: +82- 33-732-2124 E-mail: redphilips@hanmail.net ⓒ 2013 Korean Pharmacopuncture Institute                      http://www.journal.ac,Non-OADS,/arxiv_data1/oa_pdf/7a/e0/2093-6966-v16-n04-043.PMC4331979.pdf
044  http://www.journal.ac Journal of Pharmacopuncture 2013;16(4):043-048 and several reports have been published about these side  effects [2-5].,Non-OADS,/arxiv_data1/oa_pdf/7a/e0/2093-6966-v16-n04-043.PMC4331979.pdf
http://www.journal.ac045 4.,Non-OADS,/arxiv_data1/oa_pdf/7a/e0/2093-6966-v16-n04-043.PMC4331979.pdf
"Removal of the allergens inhibits the hypersensitive re -Journal of Pharmacopuncture 2013;16(4):043-048 http://www.journal.ac Table 2  Distribution of skin test reactions among Sasang Constitution TE§ SY|| SE¶ TotalGroup A* 9 3 0 12Group B† 30 8 14 52Group C‡ 7 2 3 12Total 46 13 17 76 Fisher’s Exact Test; P > 0.05 ( P = 0.300) * Who showed positive response of SBV skin test † Who showed positive response of bee venom pharmacopuncture 25% skin test ‡ Who showed negative response in all bee venom pharmacopuncture skin test § Tai-eum person || So-yang person ¶ So-eum personTable 1  Patients characteristics and skin test reactions between males and females Group A Group B Group C Total Age* Males Females Total8 4 1219 33 524 8 1231 45 7657.68 ± 15.94 62.18 ± 18.17 60.34 ± 17.33 Fisher’s Exact Test; P > 0.05 ( P = 0.163, Distribution of all groups; P = 0.060, Group A only)  *Mean ± SD",Non-OADS,/arxiv_data1/oa_pdf/7a/e0/2093-6966-v16-n04-043.PMC4331979.pdf
"046  http://www.journal.ac Journal of Pharmacopuncture 2013;16(4):043-048 action to bee venom pharmacopuncture significantly, so  local allergic reactions for SBV are remarkably lower than  those for bee venom pharmacopuncture.",Non-OADS,/arxiv_data1/oa_pdf/7a/e0/2093-6966-v16-n04-043.PMC4331979.pdf
http://www.journal.ac047 the diagnostic accuracy of the Sasang constitution may be  a factor that need further consideration.,Non-OADS,/arxiv_data1/oa_pdf/7a/e0/2093-6966-v16-n04-043.PMC4331979.pdf
References  Journal of Pharmacopuncture 2013;16(4):043-048 http://www.journal.ac Korean Pharmacopuncture Institute.,Non-OADS,/arxiv_data1/oa_pdf/7a/e0/2093-6966-v16-n04-043.PMC4331979.pdf
048  http://www.journal.ac Journal of Pharmacopuncture 2013;16(4):043-048 Oh SK.,Non-OADS,/arxiv_data1/oa_pdf/7a/e0/2093-6966-v16-n04-043.PMC4331979.pdf
"Also, SMS can  protect against heat stroke-induced arterial hypoten - sion and cerebral ischemia by the inhibition of induc - Original article Received:  Sep 10, 2013     Accepted:  Nov 03, 2013ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2013;16[4]:036-042 DOI:    http://dx.doi.org/10.3831/KPI.2013.16.025    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/a6/2093-6966-v16-n04-036.PMC4331980.pdf
Tel: +82-51-510-8469 Fax: +82-51-510-8420  E-mail: vision@pusan.ac.kr ⓒ 2013 Korean Pharmacopuncture Institute                      http://www.journal.ac,Non-OADS,/arxiv_data1/oa_pdf/0d/a6/2093-6966-v16-n04-036.PMC4331980.pdf
http://www.journal.ac 037 Journal of Pharmacopuncture 2013;16(4):036-042 http://www.journal.ac ible nitric oxide synthase (iNOS)-dependent NO overpro - duction in the brain and excessive accumulation of several  inflammatory cytokines in the peripheral blood stream [4].,Non-OADS,/arxiv_data1/oa_pdf/0d/a6/2093-6966-v16-n04-036.PMC4331980.pdf
More information about SMS  can be found on I-WORLD Pharmaceuticals Homepage  (http://i-pharm.koreasme.com).,Non-OADS,/arxiv_data1/oa_pdf/0d/a6/2093-6966-v16-n04-036.PMC4331980.pdf
038  http://www.journal.ac Journal of Pharmacopuncture 2013;16(4):036-042 The lactose and corn starch can affect the ICCs and the GI  motility.,Non-OADS,/arxiv_data1/oa_pdf/0d/a6/2093-6966-v16-n04-036.PMC4331980.pdf
http://www.journal.ac039  Journal of Pharmacopuncture 2013;16(4):036-042 http://www.journal.ac 3.2.,Non-OADS,/arxiv_data1/oa_pdf/0d/a6/2093-6966-v16-n04-036.PMC4331980.pdf
040  http://www.journal.ac Journal of Pharmacopuncture 2013;16(4):036-042 Figure 3  Effects of SMS on PLC inhibitors in cultured ICCs.,Non-OADS,/arxiv_data1/oa_pdf/0d/a6/2093-6966-v16-n04-036.PMC4331980.pdf
http://www.journal.ac041  Journal of Pharmacopuncture 2013;16(4):036-042 http://www.journal.ac erate the rhythmic oscillations in the membrane potential  known as slow waves [5-8].,Non-OADS,/arxiv_data1/oa_pdf/0d/a6/2093-6966-v16-n04-036.PMC4331980.pdf
042  http://www.journal.ac Journal of Pharmacopuncture 2013;16(4):036-042 HPLC/MS/MS for quantification of two types of neu - rotransmitters in rat brain and application: myocardial  ischemia and protection of Sheng-Mai-San.,Non-OADS,/arxiv_data1/oa_pdf/0d/a6/2093-6966-v16-n04-036.PMC4331980.pdf
"Since ancient times, the  medicinal properties of plants have been investigated,  Original article Received:  Jul 18, 2013     Accepted:  Dec 03, 2013ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[1]:013-019 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.002    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/19/2093-6966-v17-n01-013.PMC4331981.pdf
"Tel: +91-94-3309-8372 Fax: +91-33-2837-1078 Email: subhashmandal@yahoo.com ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.ac1 Pharmacognosy and Phytotherapy Research Laboratory, Division of Pharmacognosy, Department of Pharmaceutical Technology,     Jadavpur University, Kolkata, India 2 Institute of Pharmacy, Guru Ghasidas Central University, Bilaspur, India 3 Department of Botany, Rajiv Gandhi University, Itanagar, India",Non-OADS,/arxiv_data1/oa_pdf/90/19/2093-6966-v17-n01-013.PMC4331981.pdf
"014  http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):013-019 and recently, new scientific developments  have involved   traditional practitioners in the development of modern  medicine throughout the world.",Non-OADS,/arxiv_data1/oa_pdf/90/19/2093-6966-v17-n01-013.PMC4331981.pdf
http://www.journal.ac015 ANOVA.,Non-OADS,/arxiv_data1/oa_pdf/90/19/2093-6966-v17-n01-013.PMC4331981.pdf
Significant reductions in the se -Journal of Pharmacopuncture 2014;17(1):013-019 http://www.journal.ac Figure 1  Influence of PEME of W.volubilis  on fasting blood glucose  level in hyperglycemic and non-hyperglycemic rats.,Non-OADS,/arxiv_data1/oa_pdf/90/19/2093-6966-v17-n01-013.PMC4331981.pdf
016  http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):013-019 rum protein levels within the group treated with metform - in were also seen after 21 days of treatment.,Non-OADS,/arxiv_data1/oa_pdf/90/19/2093-6966-v17-n01-013.PMC4331981.pdf
"http://www.journal.ac017  Journal of Pharmacopuncture 2014;17(1):013-019 http://www.journal.ac STZ is a nitrosurea, a naturally-oc curring, broad-spec - trum antibiotic, from Streptomyces achromogenes  and a  cytotoxic chemical that is particularly toxic to the pancre - atic, insulin-producing beta cells in mammals.",Non-OADS,/arxiv_data1/oa_pdf/90/19/2093-6966-v17-n01-013.PMC4331981.pdf
"018  http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):013-019 in other tissues, especially in the liver, and liver dysfunc - tion has been seen in diabetic patients with uncontrolled  blood sugar levels.",Non-OADS,/arxiv_data1/oa_pdf/90/19/2093-6966-v17-n01-013.PMC4331981.pdf
http://www.journal.ac019  Journal of Pharmacopuncture 2014;17(1):013-019 http://www.journal.ac experimentally induced diabetes.,Non-OADS,/arxiv_data1/oa_pdf/90/19/2093-6966-v17-n01-013.PMC4331981.pdf
"The constituents of the Chukyu (spine-healing) phar - Original article Received:  May 29, 2013     Accepted:  Jan 13, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[1]:035-043 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.005    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/ef/2093-6966-v17-n01-035.PMC4331982.pdf
"Tel: +82-62-670-6441 Fax: +82-62-670-6767 E-mail: kscndl@hanmail.net ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.ac1 Department of Acupuncture & Moxibustion Medicine, Wonkwang University Gwangju Korean Medical Hospital, Gwangju, Korea 2 ALS Center of Wonkwang University Gwangju Korean Medical Hospital, Gwangju, Korea 3 Department of Neuropsychiatry, Hospital of Korean Medicine, Kyung Hee University Medical center, Seoul, Korea 4  Department of Acupuncture & Moxibustion Medicine, Semyung University Korean Medical Hospital, Chungju, Korea 5  Department of Acupuncture & Moxibustion Medicine, Dongguk University College of Korean Medicine, Gyeongju, Korea 6  Department of Meridian & Acupoint, Wonkwang University College of Korean Medicine, Iksan, Korea",Non-OADS,/arxiv_data1/oa_pdf/0a/ef/2093-6966-v17-n01-035.PMC4331982.pdf
"036  http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):035-043 macopuncture are Cervi Parvum Cornu  (deer antlers),  Moschus  (musk), Angelicae Gigantis Radix , Cnidii Rhizo - ma, Ostericii Radix , Angelicae Pubescentis Radix , Astragali  Radix , and Scolopendra .",Non-OADS,/arxiv_data1/oa_pdf/0a/ef/2093-6966-v17-n01-035.PMC4331982.pdf
"http://www.journal.ac037 Ethic Committee of Biotoxtech Co., Ltd.. From the 1st day to 14th day after treatment, the general  symptoms were examined once a day.",Non-OADS,/arxiv_data1/oa_pdf/0a/ef/2093-6966-v17-n01-035.PMC4331982.pdf
"038  http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):035-043 Table 4  Body weights in grams N: Number of animals, S.D.",Non-OADS,/arxiv_data1/oa_pdf/0a/ef/2093-6966-v17-n01-035.PMC4331982.pdf
http://www.journal.ac039  Journal of Pharmacopuncture 2014;17(1):035-043 GroupDose  (mL/animal)WBC differential count (%)0.1 0.5 1.0 0 0.1 0.5G2 G3 G4 G1 G2 G3Mean S.D.,Non-OADS,/arxiv_data1/oa_pdf/0a/ef/2093-6966-v17-n01-035.PMC4331982.pdf
040  http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):035-043 1.0 G4Mean S.D.,Non-OADS,/arxiv_data1/oa_pdf/0a/ef/2093-6966-v17-n01-035.PMC4331982.pdf
http://www.journal.ac041  Journal of Pharmacopuncture 2014;17(1):035-043 0 0.1 0.5 1.0G1 G2 G3 G4N Mean S.D.,Non-OADS,/arxiv_data1/oa_pdf/0a/ef/2093-6966-v17-n01-035.PMC4331982.pdf
042  http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):035-043 Joo HJ.,Non-OADS,/arxiv_data1/oa_pdf/0a/ef/2093-6966-v17-n01-035.PMC4331982.pdf
http://www.journal.ac043 rean Acupuncture & Moxibustion Medicine Society.,Non-OADS,/arxiv_data1/oa_pdf/0a/ef/2093-6966-v17-n01-035.PMC4331982.pdf
"Gender, age, body weight, body length,  Brief report Received:  Dec 19, 2013     Accepted:  Jan 29, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[1]:070-073 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.009    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/2b/2093-6966-v17-n01-070.PMC4331983.pdf
Tel: +82-63-270-1554 Fax: +82-63-270-1199 E-mail: kwon0mi@wku.ac.kr ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.ac,Non-OADS,/arxiv_data1/oa_pdf/5d/2b/2093-6966-v17-n01-070.PMC4331983.pdf
"http://www.journal.ac 071 Journal of Pharmacopuncture 2013;17(1):070-073 body mass index (BMI), direction and angle of the mag - netic needles, right/left side points, and different measur - ing methods have been identified as factors affecting the  safety depth [5].",Non-OADS,/arxiv_data1/oa_pdf/5d/2b/2093-6966-v17-n01-070.PMC4331983.pdf
072  http://www.journal.ac Journal of Pharmacopuncture 2013;17(1):070-073 (Table 3).,Non-OADS,/arxiv_data1/oa_pdf/5d/2b/2093-6966-v17-n01-070.PMC4331983.pdf
"http://www.journal.ac073  Journal of Pharmacopuncture 2013;17(1):070-073 head length and circumference, as well as other factors,  have correlations with the SD, which is similar to results of  other studies on the correlations of SDs at abdominal acu - points with waist circumference and of SDs at acupoints  on the head with neck circumference.",Non-OADS,/arxiv_data1/oa_pdf/5d/2b/2093-6966-v17-n01-070.PMC4331983.pdf
"As the disease  runs its course, the human body, which is made up of  several components that together make a system, is in  Original article Received:  Nov 07, 2013     Accepted:  Jan 08, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[1]:020-026 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.003    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/83/2093-6966-v17-n01-020.PMC4331984.pdf
Tel: +82-42-470-9132 Fax: +82-42-470-9006 E-mail: altyhs@dju.kr ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.ac,Non-OADS,/arxiv_data1/oa_pdf/09/83/2093-6966-v17-n01-020.PMC4331984.pdf
"http://www.journal.ac 021 Journal of Pharmacopuncture 2013;16(4):036-042 http://www.journal.ac a constant cycle of attack, battle, and recovery.",Non-OADS,/arxiv_data1/oa_pdf/09/83/2093-6966-v17-n01-020.PMC4331984.pdf
022  http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):020-026 (combination group).,Non-OADS,/arxiv_data1/oa_pdf/09/83/2093-6966-v17-n01-020.PMC4331984.pdf
http://www.journal.ac023  Journal of Pharmacopuncture 2014;17(1):020-026 http://www.journal.ac and able to carry out work of a light or sedentary nature  (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/09/83/2093-6966-v17-n01-020.PMC4331984.pdf
024  http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):020-026 4.,Non-OADS,/arxiv_data1/oa_pdf/09/83/2093-6966-v17-n01-020.PMC4331984.pdf
"http://www.journal.ac025  Journal of Pharmacopuncture 2014;17(1):020-026 http://www.journal.ac Lin WW, Karin M. A cytokine-mediated link between  innate immunity, inflammation, and cancer.",Non-OADS,/arxiv_data1/oa_pdf/09/83/2093-6966-v17-n01-020.PMC4331984.pdf
026  http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):020-026 biol.,Non-OADS,/arxiv_data1/oa_pdf/09/83/2093-6966-v17-n01-020.PMC4331984.pdf
"Afterward, in DonguiBo - gam  and Bangyak Happyeon , it was prescribed for  stomach conditions as a tonifying medicine for vari - ous diseases and internal damage and was described  as being in strengthening the spirit, boosting ener - gy, helping the digestive system, improving appetite,  tonifying deficiency, growing muscles and removing  Original article Received:  Oct 31, 2013     Accepted:  Nov 26, 2013ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[1]:051-058 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.007    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/06/2093-6966-v17-n01-051.PMC4331985.pdf
"Tel: +82-31-961-9122  Fax: +82-31-961-9009 E-mail: chuckman@dongguk.edu ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.ac1 Department of Acupuncture & Moxibustion Medicine, Dongguk University College of Oriental Medicine, Goyang, Korea 2 Department of Acupuncture & Moxibustion Medicine, Wonkwang University College of Oriental Medicine, Gwangju, Korea",Non-OADS,/arxiv_data1/oa_pdf/b2/06/2093-6966-v17-n01-051.PMC4331985.pdf
"052  http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):051-058 dampness-heat [2,3].",Non-OADS,/arxiv_data1/oa_pdf/b2/06/2093-6966-v17-n01-051.PMC4331985.pdf
"http://www.journal.ac053 as mid-dose (G3), and 0.1 mL/animal as low-dose (G2).",Non-OADS,/arxiv_data1/oa_pdf/b2/06/2093-6966-v17-n01-051.PMC4331985.pdf
"During the necropsy performed on all the animals, or - gans and tissues from the entire body were checked thor -Journal of Pharmacopuncture 2014;17(1):051-058 http://www.journal.ac Table 2  Mean hematology parameters of Sprague-Dawley rats in the Guseonwangdo-go  glucose 5% group GSWG group/dose (mL)Male Female G1/0 6.76 ± 0.36 14.1 ± 0.6 43.6 ± 2.0 64.5 ± 2.6 20.9 ± 0.8 32.3 ± 0.2 1201 ± 123 4.8 ± 0.3 7.02 ± 0.99 16.5 ± 2 79.5 ± 1.8 2.2 ± 0.4 0.4 ± 0.1 0.3 ± 0.2 17.4 ± 0.6 13.5 ± 0.4G2/0.1 6.75 ± 0.12 13.8 ± 0.2 42.2 ± 0.9 62.6 ± 1.8 20.4 ± 0.2 32.7 ± 0.6 1199 ± 87 5.0 ± 0.1 7.98 ± 3.13 16.2 ± 3.7 78.9 ± 4.4 2.8 ± 1.2 0.5 ± 0.2 0.2 ± 0.1 17.9 ± 0.4 13.9 ± 0.7G3/0.5 6.88 ± 0.36 14.1 ± 0.7 43.0 ± 2.6 62.5 ± 1.2 20.5 ± 0.4 32.8 ± 0.4 1299 ± 246 4.7 ± 0.9 8.05 ± 2.31 17.0 ± 5.4 79.1 ± 5.7 2.2 ± 0.3 0.4 ± 0.2 0.2 ± 0.1 17.6 ± 0.8 14.2 ± 0.7G4/1.0 6.78 ± 0.26 13.8 ± 0.4 42.4 ± 1.4 62.6 ± 1.1 20.4 ± 0.4 32.5 ± 0.2 1280 ± 132 4.9 ± 0.6 7.85 ± 2.58 17.9 ± 5.8 78.6 ± 6.1 1.7 ± 0.3 0.7 ± 0.7 0.2 ± 0.1 17.6 ± 1.0 14.0 ± 0.6G1/0 6.64 ± 0.14 13.9 ± 0.5 41.0 ± 1.8 61.7 ± 2.2 20.8 ± 0.6 33.8 ± 0.3 1219 ± 22 3.1 ± 0.5 3.75 ± 0.65 17.5 ± 7.4 79.5 ± 7.6 1.4 ± 0.3 0.8 ± 0.4 0.1 ± 0.1 18.1 ± 0.6 13.5 ± 1.3G2/0.1 6.77 ± 0.47 13.7 ± 0.8 40.8 ± 1.7 60.4 ± 1.8 20.3 ± 0.3 33.6 ± 0.6 1293 ± 152 3.2 ± 0.5 3.57 ± 1.3 14.5 ± 3.1 82.0 ± 2.8 1.8 ± 0.2 0.8 ± 0.2 0.0 ± 0.1 18.4 ± 0.9 12.8 ± 2.3G3/0.5 7.04 ± 0.1 14.3 ± 0.5 42.3 ± 1.2 60.0 ± 1.0 20.3 ± 0.5 33.8 ± 0.4 1224 ± 229 2.9 ± 0.5 3.69 ± 0.67 14.7 ± 1.1 82.3 ± 0.8 1.7 ± 0.5 0.7 ± 0.4 0.1 ± 0.1 18.3 ± 0.4 13.9 ± 1.3G4/1.0 3.78 ± 0.33 13.7 ± 0.6 41.1 ± 1.5 60.7 ± 1.1 20.3 ± 0.5 33.4 ± 0.6 1290 ± 172 3.4 ± 1.0 4.22 ± 1.05 18.0 ± 8.6 78.8 ± 8.7 1.4 ± 0.3 1.0 ± 0.4 0.1 ± 0.1 18.2 ± 0.5 13.2 ± 1.5RBC (x106 cells/㎕) HGB (g/dL) HCT (%) RBC   PLT (x103 cells/㎕) Reti (%) WBC (x103 cells/㎕) WBC Differential Counting (%)    PT (sec) APTT (sec) The values are means ± SD.",Non-OADS,/arxiv_data1/oa_pdf/b2/06/2093-6966-v17-n01-051.PMC4331985.pdf
054  http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):051-058 oughly by visual inspection.,Non-OADS,/arxiv_data1/oa_pdf/b2/06/2093-6966-v17-n01-051.PMC4331985.pdf
http://www.journal.ac055  Journal of Pharmacopuncture 2014;17(1):051-058 http://www.journal.ac Table 5  Mean clinical chemistry of SD rats in the Guseonwangdo-go  glucose 20% group GSWG group /dose (mL)Male Female G1/0 28.5 ± 5.5 67.6 ± 6.5 786.6 ± 117.6 0.31 ± 0.09 133 ± 16 13.1 ± 2.4 0.36 ± 0.02 0.05 ± 0.02 69 ± 17 49 ± 21 5.2 ± 0.1 2.3 ± 0.1G2/0.1 28.5 ± 5.8 67.2 ± 9.5 867.1 ± 199.2 0.39 ± 0.08 127 ± 16 11.1 ± 1.8 0.37 ± 0.04 0.07 ± 0.03 80 ± 14 52 ± 19 5.2 ± 0.1 2.2 ± 0.1G3/0.5 27.7 ± 1.3 70.9 ± 3.5 873.4 ± 103.7 0.42 ± 0.12 138 ± 13 12.2 ± 1.4 0.35 ± 0.01 0.05 ± 0.02 77 ± 24 61 ± 27 5.2 ± 0.2 2.3 ± 0.1G4/1.0 28.6 ± 3.3 35.0 ± 6.2 883.9 ± 154.3 0.38 ± 0.09 115 ± 10 11.2 ± 1.2 0.37 ± 0.02 0.04 ± 0.01 71 ± 9 52 ± 11 2.2 ± 0.2 2.3 ± 0.2G1/0 21.1 ± 3.9 65.4 ± 6 476.9 ± 76.3 0.62 ± 0.11 125 ± 15 13.4 ± 1.8 0.4 ± 0.02 0.04 ± 0.01 81 ± 22 17 ± 10 5.5 ± 0.3 2.5 ± 0.1G2/0.1 22.9 ± 2.7 64.1 ± 2 379.3 ± 36.2 0.55 ± 0.13 127 ± 11 13.2 ± 1.8 0.37 ± 0.03 0.04 ± 0.02 81 ± 27 12 ± 4 5.4 ± 0.3 2.5 ± 0.1G3/0.5 22.5 ± 2.1 63.9 ± 5.1 467.9 ± 9.2 0.59 ± 0.2 128 ± 4 12.2 ± 1.1 0.37 ± 0.03 0.03 ± 0.01 67 ± 22 10 ± 3 5.3 ± 0.2 2.4 ± 0.1G4/1.0 20.1 ± 2.7 65.2 ± 6.5 461.0 ± 74.4 0.5 ± 0.22 130 ± 10 12.3 ± 1.5 0.38 ± 0.03 0.06 ± 0.05 85 ± 9 16 ± 6 5.5 ± 0.3 2.6 ± 0.2ALT (U/L) AST (U/L) ALP (U/L) GGT (U/L) Glu (mg/dL) BUN (mg/dL) Crea (mg/dL) T-Bili (mg/dL) T-Chol (mg/dL) TG (mg/dL) TP (g/dL) Alb (g/dL)Table 4  Mean clinical chemistry of SD rats in the Guseonwangdo-go  Glucose 5% group GSWG group /dose (mL)Male Female G1/0 26.5 ± 3.6 75.5 ± 7.4 940.5 ± 273.3 0.51 ± 0.26 140 ± 22 11.9 ± 0.5 0.40 ± 0.02 0.02 ± 0.01 73 ± 13 58 ± 38 5.3 ± 0.2 2.3 ± 0.1 0.75 ± 0.05 8.68 ± 0.36 10.3 ± 0.3 140 ± 2 4.8 ± 0.4 103 ± 1G2/0.1 26.2 ± 4.5 77.1 ± 7.1 776.6 ± 121.9 0.43 ± 0.09 121 ± 17 10.5 ± 1.7 0.39 ± 0.02 0.03 ± 0.01 73 ± 7 51 ± 25 5.3 ± 0.2 2.3 ± 0.1 0.75 ± 0.04 8.53 ± 0.21 10.3 ± 0.2 140 ± 1 4.5 ± 0.3 103 ± 2G3/0.5 23.1 ± 3.5 76.7 ± 6.1 855.5 ± 163.4 0.28 ± 0.09 130 ± 23 13.3 ± 0.9 0.39 ± 0.01 0.03 ± 0.01 59 ± 7 55 ± 20 5.3 ± 0.1 2.3 ± 0.1 0.78 ± 0.07 8.43 ± 0.49 10.4 ± 0.3 140 ± 1 4.3 ± 0.2 104 ± 1G4/1.0 27.6 ± 2.8 75.4 ± 11.2 764.9 ± 129.8 0.39 ± 0.07 132 ± 16 10.6 ± 1.2 0.40 ± 0.02 0.03 ± 0.02 69 ± 14 49 ± 15 5.3 ± 0.2 2.2 ± 0.1 0.74 ± 0.04 8.77 ± 0.38 10.4 ± 0.2 140 ± 1 4.7 ± 0.3 103 ± 1G1/0 24.9 ± 4.9 78.1 ± 8.8 492.4 ± 87.6 0.50 ± 0.21 123 ± 11 12.9 ± 1.8 0.42 ± 0.03 0.03 ± 0.01 76 ± 9 14 ± 4 5.5 ± 0.2 2.4 ± 0.0 0.79 ± 0.03 7.59 ± 0.66 10.3 ± 0.3 139 ± 0 4.6 ± 0.3 106 ± 2G2/0.1 22.1 ± 2.7 77.2 ± 6 498.2 ± 121.1 0.49 ± 0.14 123 ± 12 11.8 ± 1.7 0.42 ± 0.02 0.02 ± 0.00 67 ± 10 12 ± 3 5.6 ± 0.4 2.6 ± 0.2 0.85 ± 0.06 7.59 ± 0.46 10.1 ± 0.3 140 ± 0 4.4 ± 0.4 104 ± 1G3/0.5 22.0 ± 1.2 77.6 ± 8.4 530.9 ± 81.6 0.59 ± 0.17 120 ± 18 11.8 ± 0.5 0.41 ± 0.01 0.02 ± 0.01 80 ± 25 15 ± 3 5.7 ± 0.1 2.5 ± 0.14 0.79 ± 0.02 7.42 ± 0.61 10.3 ± 0.3 141 ± 1 4.5 ± 0 105 ± 1G4/1.0 24.2 ± 2.0 72.8 ± 11.6 473.1 ± 75.7 0.46 ± 0.14 120 ± 13 12.2 ± 0.7 0.42 ± 0.03 0.03 ± 0.01 86 ± 17 14 ± 6 5.7 ± 0.2 2.6 ± 0.1 0.81 ± 0.04 7.12 ± 0.43 10.2 ± 0.1 140 ± 2 4.4 ± 0.3 105 ± 2ALT (U/L) AST (U/L) ALP (U/L) GGT (U/L) Glu (mg/dL) BUN (mg/dL) Crea (mg/dL) T-Bili (mg/dL) T-Chol (mg/dL) TG (mg/dL) TP (g/dL) Alb (g/dL) A/G ratio P (mg/dL) Ca (mg/dL) Na (mmol/L) K (mmol/L)  Cl (mmol/L) The values are means ± SD.,Non-OADS,/arxiv_data1/oa_pdf/b2/06/2093-6966-v17-n01-051.PMC4331985.pdf
056  http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):051-058 drug.,Non-OADS,/arxiv_data1/oa_pdf/b2/06/2093-6966-v17-n01-051.PMC4331985.pdf
http://www.journal.ac057  Journal of Pharmacopuncture 2014;17(1):051-058 http://www.journal.ac mL/kg.,Non-OADS,/arxiv_data1/oa_pdf/b2/06/2093-6966-v17-n01-051.PMC4331985.pdf
Available from: http://www.law.go.kr/.,Non-OADS,/arxiv_data1/oa_pdf/b2/06/2093-6966-v17-n01-051.PMC4331985.pdf
Available from: http://www.law.,Non-OADS,/arxiv_data1/oa_pdf/b2/06/2093-6966-v17-n01-051.PMC4331985.pdf
058  http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):051-058 subacute toxicity and anti-cancer effects of cultivated  Wild Ginseng herbal acupuncture].,Non-OADS,/arxiv_data1/oa_pdf/b2/06/2093-6966-v17-n01-051.PMC4331985.pdf
"Neuropath - ic pain is caused by pathophysiological injury to the  central nerves or to the peripheral nerves and shows  Brief report Received:  Oct 22, 2013     Accepted:  Feb 12, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[1]:074-079 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.010    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/79/53/2093-6966-v17-n01-074.PMC4331986.pdf
"Tokyo Research Center, Kyushin Pharmaceutical Co., Ltd., 1-22-10, Wada,  Suginami-ku, Tokyo 166-0012, Japan Tel: +81-3-5385-3211 Fax: +81-3-5385-3219 E-mail: e-inoue@kyushin.co.jp ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.ac",Non-OADS,/arxiv_data1/oa_pdf/79/53/2093-6966-v17-n01-074.PMC4331986.pdf
http://www.journal.ac 075 Journal of Pharmacopuncture 2013;17(1):074-079 allodynia as one of its characteristic symptoms.,Non-OADS,/arxiv_data1/oa_pdf/79/53/2093-6966-v17-n01-074.PMC4331986.pdf
076  http://www.journal.ac Journal of Pharmacopuncture 2013;17(1):074-079 followed by the Dunnett’s multiple range test.,Non-OADS,/arxiv_data1/oa_pdf/79/53/2093-6966-v17-n01-074.PMC4331986.pdf
"http://www.journal.ac077  Journal of Pharmacopuncture 2013;17(1):074-079 Figure 3  Effects of KY, KYR, toad cake and fluvoxamine maleate (fluvoxamine) on tactile allodynia in Seltzer-model mice.",Non-OADS,/arxiv_data1/oa_pdf/79/53/2093-6966-v17-n01-074.PMC4331986.pdf
078  http://www.journal.ac Journal of Pharmacopuncture 2013;17(1):074-079 Ookoshi N. [Pain].,Non-OADS,/arxiv_data1/oa_pdf/79/53/2093-6966-v17-n01-074.PMC4331986.pdf
"http://www.journal.ac079  Journal of Pharmacopuncture 2013;17(1):074-079 T, Kawakami M. [Pharmacological studies of Senso  (Ch’an Su) containing drugs].",Non-OADS,/arxiv_data1/oa_pdf/79/53/2093-6966-v17-n01-074.PMC4331986.pdf
"Introduction Original article Received:  Dec 11, 2013     Accepted:  Jan 24, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[1]:007-012 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.001    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/40/2093-6966-v17-n01-007.PMC4331987.pdf
"Department of Acupuncture & Moxibustion Medicine, Semyung Univer - sity Oriental Medicine Hospital, Semyung University, 63, Sangbang 4-gil, Chungju,  Chungcheongbuk 380-080, Republic of Korea Tel : +82-43-841-1735 Fax : +82-43-856-1731  E-mail : acupley@semyung.ac.kr ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.acDepartment of Acupuncture & Moxibustion Medicine, Semyung University Oriental Medicine Hospital, Chungju, Korea",Non-OADS,/arxiv_data1/oa_pdf/84/40/2093-6966-v17-n01-007.PMC4331987.pdf
"008  http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):007-012 Inflammation is one of the self-protective abilities  against  tissue injury, and it has clinical symptoms like pain, heat,  redness, and loss of function [1].",Non-OADS,/arxiv_data1/oa_pdf/84/40/2093-6966-v17-n01-007.PMC4331987.pdf
http://www.journal.ac009 ard deviations.,OADS,/arxiv_data1/oa_pdf/84/40/2093-6966-v17-n01-007.PMC4331987.pdf
"010  http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):007-012 2.58 percent, respectively.",Non-OADS,/arxiv_data1/oa_pdf/84/40/2093-6966-v17-n01-007.PMC4331987.pdf
http://www.journal.ac011  Journal of Pharmacopuncture 2014;17(1):007-012 ed with 125- and 625- ㎍/mL Salviae Miltiorrhizae Radix   hot aqueous extract were significantly lower than the value  for the control group (Fig.,Non-OADS,/arxiv_data1/oa_pdf/84/40/2093-6966-v17-n01-007.PMC4331987.pdf
012  http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):007-012 on immunocytes and tumor cell lines].,Non-OADS,/arxiv_data1/oa_pdf/84/40/2093-6966-v17-n01-007.PMC4331987.pdf
"Introduction In view of growing awareness of the side-effects of  some orthodox medicines, people are turning more  towards alternative medicines with fewer and less-tox - ic side-effects [1], and homeopathy has become a ma - jor complementary and alternative medicine (CAM)  Original article Received:  Nov 07, 2013     Accepted:  Jan 08, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[1]:059-069 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.008    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/74/2093-6966-v17-n01-059.PMC4331988.pdf
"Email: prof_arkb@yahoo.co.in; khudabukhsh_48@rediffmail.com Tel: +91-33-2582-8750 Fax: +91-33-2582-8282 ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.acCytogenetics and Molecular Biology Laboratory, Department of Zoology, University of Kalyani, Kalyani-741235, India",Non-OADS,/arxiv_data1/oa_pdf/0a/74/2093-6966-v17-n01-059.PMC4331988.pdf
060  http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):059-069 in many countries today.,Non-OADS,/arxiv_data1/oa_pdf/0a/74/2093-6966-v17-n01-059.PMC4331988.pdf
http://www.journal.ac061 mo-2´-Deoxyuridine 5´-Triphosphate (Br-dUTP) [15] by  using BD FACS VerseTM.,Non-OADS,/arxiv_data1/oa_pdf/0a/74/2093-6966-v17-n01-059.PMC4331988.pdf
"(i) untreated, (ii) 6C pla - cebo-treated, (iii) 30C placebo-treated, (iv) Condurango 6C-treated,  and (v) Condurango 30C-treated cells.ⅰ ⅰ ⅱ ⅱ ⅲ ⅲ ⅳ ⅳ ⅴ ⅴ Figure 3  Analysis of cellular morphology by scanning electron mi - croscopy at (I) 2000x and (II) 6000x magnifications: (i) untreated,  (ii) 6C placebo-treated, (iii) 30C placebo-treated, (iv) Condurango  6C-treated and (v) Condurango 30C-treated cells.http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):059-069 drug-treated materials.",Non-OADS,/arxiv_data1/oa_pdf/0a/74/2093-6966-v17-n01-059.PMC4331988.pdf
"http://www.journal.ac063  Journal of Pharmacopuncture 2014;17(1):059-069 ⅰ A Bⅱ ⅲ ⅳ ⅴ Figure 4  Intracellular ROS-accumulation measured by (A) fluorimetry and (B) fluorescence microscopy: (i) untreated, (ii) 6C placebo-treated,  (iii) 30C placebo-treated, (iv) Condurango 6C-treated, and (v) Condurango 30C-treated cells.",Non-OADS,/arxiv_data1/oa_pdf/0a/74/2093-6966-v17-n01-059.PMC4331988.pdf
064  http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):059-069 Figure 6  Analysis of MMP changes by (A) fluorescence microscopy and (B) flowcytometry in Condurango 6C and 30C-treated cells against  drug-untreated cells.,Non-OADS,/arxiv_data1/oa_pdf/0a/74/2093-6966-v17-n01-059.PMC4331988.pdf
http://www.journal.ac065  Journal of Pharmacopuncture 2014;17(1):059-069 Figure 8  Changes in nuclear morphology by using (A) DAPI and (B) AO-EB-staining  in both drug-treated and untreated cells.,Non-OADS,/arxiv_data1/oa_pdf/0a/74/2093-6966-v17-n01-059.PMC4331988.pdf
066  http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):059-069 Figure 10  Study on cell-cycle distribution by using PI-staining and flowcytometric analysis.,Non-OADS,/arxiv_data1/oa_pdf/0a/74/2093-6966-v17-n01-059.PMC4331988.pdf
http://www.journal.ac067  Journal of Pharmacopuncture 2014;17(1):059-069 A gradual increase in the DAPI-fluorescence intensity  was observed in Condurango 6C and 30C-treated cells at  48 hours of treatment (Fig.,Non-OADS,/arxiv_data1/oa_pdf/0a/74/2093-6966-v17-n01-059.PMC4331988.pdf
068  http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):059-069 Jonas WB.,Non-OADS,/arxiv_data1/oa_pdf/0a/74/2093-6966-v17-n01-059.PMC4331988.pdf
"http://www.journal.ac069  Journal of Pharmacopuncture 2014;17(1):059-069 Dreij K, Rhrissorrakrai K, Gunsalus KC, Geacintov NE,  Scicchitano DA.",Non-OADS,/arxiv_data1/oa_pdf/0a/74/2093-6966-v17-n01-059.PMC4331988.pdf
"The fibrinolytic enzymes are classified  as serine protease and metalloprotease based on the  structure of the active site and in α-and β-fibrinoge - Original article Received:  Dec 31, 2013     Accepted:  Jan 29, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[1]:044-050 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.006    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/56/2093-6966-v17-n01-044.PMC4331989.pdf
Tel:+82-33-730-0543  Fax:+82-33-730-0540 E-mail: shchoi@sangji.ac.kr ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.ac,Non-OADS,/arxiv_data1/oa_pdf/c4/56/2093-6966-v17-n01-044.PMC4331989.pdf
http://www.journal.ac 045 Journal of Pharmacopuncture 2013;16(4):036-042 http://www.journal.ac nase based on the substrate specificity to α-and β-chain  of fibrinogen.,Non-OADS,/arxiv_data1/oa_pdf/c4/56/2093-6966-v17-n01-044.PMC4331989.pdf
046  http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):044-050 raphy as follows (Figs.,Non-OADS,/arxiv_data1/oa_pdf/c4/56/2093-6966-v17-n01-044.PMC4331989.pdf
http://www.journal.ac047 Fibrinolysis area(cm2)2.5 2.0 1.5 1.0 0.5 0.0 Figure 2  Gel filtration chromatography of the combined sample  from the Q-Sepharose column (Fig.,Non-OADS,/arxiv_data1/oa_pdf/c4/56/2093-6966-v17-n01-044.PMC4331989.pdf
"4, lane D).16 14 12 10 8 6 4 2 0 0           10           20          30          40           50          60 Fraction numberA280A280 FibrinolysisJournal of Pharmacopuncture 2014;17(1):044-050 http://www.journal.ac Figure 3  Ion exchange chromatography of the venom sample ob - tained from the Sephadex G-75 column (Fig.",Non-OADS,/arxiv_data1/oa_pdf/c4/56/2093-6966-v17-n01-044.PMC4331989.pdf
"048  http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):044-050 Mn2+, and Cu2+ inhibited the fibirinolytic activity weakly  and Mg2+ and Cs2+ had little effects on the fibrinolytic ac - tivity.",Non-OADS,/arxiv_data1/oa_pdf/c4/56/2093-6966-v17-n01-044.PMC4331989.pdf
"http://www.journal.ac049  Journal of Pharmacopuncture 2014;17(1):044-050 http://www.journal.ac 32kDa are 11.2% and 8.8%, respectively (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/c4/56/2093-6966-v17-n01-044.PMC4331989.pdf
"050  http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):044-050 Swenson S, Markland FS Jr. Snake venom fibrin(ogen) olytic enzymes.",OADS,/arxiv_data1/oa_pdf/c4/56/2093-6966-v17-n01-044.PMC4331989.pdf
"Retrieved Jan  2, 2014 from http://en.wikipedia.org/wiki/Gloydius_ blomhoffii.",Non-OADS,/arxiv_data1/oa_pdf/c4/56/2093-6966-v17-n01-044.PMC4331989.pdf
"Re - trieved Jan 2, 2014 from http://en.wikipedia.org/wiki/ Ussuri_mamush.6.",Non-OADS,/arxiv_data1/oa_pdf/c4/56/2093-6966-v17-n01-044.PMC4331989.pdf
"Introduction Pharmacopuncture refers to be in the limelight ac u- Original article Received:  Aug 29, 2013     Accepted:  Nov 08, 2013ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[1]:027-034 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.004    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/11/96/2093-6966-v17-n01-027.PMC4331990.pdf
"ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.ac1 Department of Acupuncture & Moxibustion Medicine, Woosuk University Hospital of Oriental Medicine, Jeonju, Korea 2 Department of Acupuncture & Moxibustion Medicine, Wonkwang University Oriental Medical Hospital, Kwangju, Korea 3 MyungGa Oriental Medical Clinic, Jeonju, Korea",Non-OADS,/arxiv_data1/oa_pdf/11/96/2093-6966-v17-n01-027.PMC4331990.pdf
"028  http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):027-034 puncture therapy that treat diseases by using techniques  such as warming (Chunghwa), alcohol extraction or press - ing to extract drugs from one or more oriental medicines  and then injecting them into specific acupoints related to  the disease and adjusting meridian functions [1].",Non-OADS,/arxiv_data1/oa_pdf/11/96/2093-6966-v17-n01-027.PMC4331990.pdf
http://www.journal.ac029 measurements.,Non-OADS,/arxiv_data1/oa_pdf/11/96/2093-6966-v17-n01-027.PMC4331990.pdf
"030  http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):027-034 the LD50 was impossible; however, a single intramuscular  dose of WCF at 1.0 mL/animal caused no mortalities.",Non-OADS,/arxiv_data1/oa_pdf/11/96/2093-6966-v17-n01-027.PMC4331990.pdf
http://www.journal.ac031  Journal of Pharmacopuncture 2014;17(1):027-034 Table 4  Clinical signs from day 1 to day 14 GroupWCF injection  [mL]Hours after dosing G1 G2 G3 G40 0.1 0.5 1.01.0 0 0 0Male Female Male Female Male Female Male FemaleSaline-solution injection [mL]SexClinical  signs 5 5 5 5 5 5 5 55 5 5 5 5 5 5 55 5 5 5 5 5 5 55 5 5 5 5 5 5 55 5 5 5 5 5 5 55 5 5 5 5 5 5 55 5 5 5 5 5 5 55 5 5 5 5 5 5 55 5 5 5 5 5 5 55 5 5 5 5 5 5 55 5 5 5 5 5 5 55 5 5 5 5 5 5 55 5 5 5 5 5 5 55 5 5 5 5 5 5 51 3 5 7 9 11 13 2 4 6 8 10 12 14 NOA NOA NOA NOA NOA NOA NOA NOA Figure 2  Body-weight changes in Sprague-Dawley rats.400 300 200 100 0400 300 200 100 0 0            2            4            6           8            10            12            1 4  0            2            4            6           8            10            12            1 4  Body weught (g) Body weught (g) Days after dosing (day) Days after dosing (day)4.,Non-OADS,/arxiv_data1/oa_pdf/11/96/2093-6966-v17-n01-027.PMC4331990.pdf
"032  http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):027-034 Table 5  Body weights GroupWCF injection  [mL]Weight in grams at 0, 3, 7, 14 days G1 G2 G3 G40 0.1 0.5 1.01.0 0 0 0Male Female Male Female Male Female Male FemaleMean S.D.",Non-OADS,/arxiv_data1/oa_pdf/11/96/2093-6966-v17-n01-027.PMC4331990.pdf
"http://www.journal.ac033  Journal of Pharmacopuncture 2014;17(1):027-034 Table 7  Clinical chemistry findings GroupWCF injection  WCF [mL]Male Female G1 G2 G3 G40 0.1 0.5 1.01.0 0 0 0∨ ∨ ∨ ∨∨ ∨ ∨ ∨No abnormalities found No abnormalities found No abnormalities found No abnormalities foundSaline-solution  injection [mL] Table 8  Necropsy findings Sex Group Dose (mL/animal) Number of animals No abnormalities foundMale G1 0 5 5G2 0.1 5 5G3 0.5 5 5G4 1.0 5 5Female G1 0 5 5G2 0.1 5 5G3 0.5 5 5G4 1.0 5 5 Table 9  Histopathological change findings Organ Sex Injection site Injection site Injection site Injection site Injection siteGroup Dose (mL/animal) Number of animals No abnormalities found Remarkable findingsMale G1 0 5 5 0G2 0.1 5 5 0G3 0.5 5 5 0G4 1.0 5 5 0Female G1 0 5 5 0G2 0.1 5 5 0G3 0.5 5 5 0G4 1.0 5 4 1* * Infiltration, mononuclear cells and multinucleated giant cells around eosinophilic materials.",Non-OADS,/arxiv_data1/oa_pdf/11/96/2093-6966-v17-n01-027.PMC4331990.pdf
034  http://www.journal.ac Journal of Pharmacopuncture 2014;17(1):027-034 ly to the skin and the eye mucous membrane].,Non-OADS,/arxiv_data1/oa_pdf/11/96/2093-6966-v17-n01-027.PMC4331990.pdf
"The weak point is that after the injection,  Original article Received:  Sep 13, 2013     Accepted:  May 15, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[2]:041-045 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.015    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/36/2093-6966-v17-n02-041.PMC4331991.pdf
"Department of Acupuncture & Moxibustion Medicine, Semyung Univer - sity Oriental Medicine Hospital, 63, Sangbang 4-gil, Chungju, Chungcheongbuk 380- 080, Korea Tel: +82-43-841-1735 Fax: +82-43-856-1731  E-mail: acupley@semyung.ac.kr ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.acDepartment of Acupuncture & Moxibustion Medicine, Semyung University Oriental Medicine Hospital, Chungju, Korea",Non-OADS,/arxiv_data1/oa_pdf/a0/36/2093-6966-v17-n02-041.PMC4331991.pdf
"042  http://www.journal.ac Journal of Pharmacopuncture 2014;17(2):041-045 an allergic reaction or localized skin stimulation or gen - eral body symptoms may occur, which worry the doctor  and the patients in the clinic and reduce the popularity of  pharmacopuncture [4].",Non-OADS,/arxiv_data1/oa_pdf/a0/36/2093-6966-v17-n02-041.PMC4331991.pdf
"http://www.journal.ac043 conducted when heterogeneity of the variance was recog - nized, and the Steel test was conducted post-hoc.",OADS,/arxiv_data1/oa_pdf/a0/36/2093-6966-v17-n02-041.PMC4331991.pdf
"044  http://www.journal.ac Journal of Pharmacopuncture 2014;17(2):041-045 In research and development of herbal formulae, in - tra-laboratory verification of effectiveness is an important  method to establish evidence-based Korean medicine  [11].",Non-OADS,/arxiv_data1/oa_pdf/a0/36/2093-6966-v17-n02-041.PMC4331991.pdf
"http://www.journal.ac045  Journal of Pharmacopuncture 2014;17(2):041-045 chemical tests, and necropsy.",Non-OADS,/arxiv_data1/oa_pdf/a0/36/2093-6966-v17-n02-041.PMC4331991.pdf
"As we successful Case report Received:  Jan 18, 2014     Accepted:  Feb 12, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[2]:080-083 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.020    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/81/55/2093-6966-v17-n02-080.PMC4331992.pdf
"School of Korean Medicine, Pusan National University, Yangsan, Kyungnam 626-770,  Korea Tel: +82-55-360-5630  Fax: +82-55-360-5689 E-mail: aran99@pusan.ac.kr ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.ac1 Department of Ophthalmology, Otolaryngology and Dermatology, Korean Medicine Hospital, Pusan National University, Yangsan, Korea 2 Department of Internal Medicine, Korean Medicine Hospital, Sangji University, Wonju, Korea",Non-OADS,/arxiv_data1/oa_pdf/81/55/2093-6966-v17-n02-080.PMC4331992.pdf
http://www.journal.ac081  Journal of Pharmacopuncture 2014;17(2):080-083 2.,Non-OADS,/arxiv_data1/oa_pdf/81/55/2093-6966-v17-n02-080.PMC4331992.pdf
"082  http://www.journal.ac Journal of Pharmacopuncture 2014;17(2):080-083 of AD are often damaged by scratching and can spread to  their surroundings because HSV is commonly found even  on unaffected regions, such as both hands [13].",Non-OADS,/arxiv_data1/oa_pdf/81/55/2093-6966-v17-n02-080.PMC4331992.pdf
http://www.journal.ac083 11.,Non-OADS,/arxiv_data1/oa_pdf/81/55/2093-6966-v17-n02-080.PMC4331992.pdf
"Abnormalities in lipid profiles associated  with obesity are characterized by elevated triglycer - Original article Received:  Jan 16, 2014     Accepted:  Feb 18, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[2]:034-040 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.014    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2e/26/2093-6966-v17-n02-034.PMC4331993.pdf
"Tel: +91-2692-234412 Ext.308 Fax: +91-2692-231041 E-mail:  narasimhacharya@yahoo.com ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.acLaboratory for Animal Sciences, Department of Biosciences, Sardar Patel University, Vallabh Vidyanagar, India",Non-OADS,/arxiv_data1/oa_pdf/2e/26/2093-6966-v17-n02-034.PMC4331993.pdf
http://www.journal.ac035 ides and low-density lipoproteins (LDLs) with abnormal  compositions and structures [4].,Non-OADS,/arxiv_data1/oa_pdf/2e/26/2093-6966-v17-n02-034.PMC4331993.pdf
036  http://www.journal.ac Journal of Pharmacopuncture 2014;17(2):034-040 glutathione (GSH) consumption as described by Flohe  and Gunzler [19].,Non-OADS,/arxiv_data1/oa_pdf/2e/26/2093-6966-v17-n02-034.PMC4331993.pdf
"http://www.journal.ac037  Journal of Pharmacopuncture 2014;17(2):034-040 Table 2  Effects of a multigrain-formulated diet on the hepatic and the fecal lipid profiles and on the HMG-CoA reductase activity of the  experimental animals Parameters CDDifference (%) FD vs. CDDifference (%) FDC vs. CDCCDC FDC FD Hepatic TL* Fecal TL* Hepatic TC* Fecal TC* Hepatic TG* Hepatic bile acid* Fecal bile acid* Hepatic HMG- CoA†18.67 ± 2.45 5.33 ± 1.33 21.31 ± 0.79 53.05 ± 3.15 1.70 ± 0.026 2.44 ± 0.02 6.57 ± 0.89 5.75 ± 0.4734.67 ± 2.86‡ 21.33 ± 1.33‡ 66.92 ± 1.42‡ 129.30 ± 6.83‡ 3.79 ± 0.29‡ 2.71 ± 0.25‡ 7.20 ± 0.69‡ 8.02 ± 0.07‡14.25 ± 0.27‡ 6.62 ± 0.08‡ 15.50 ± 0.36‡ 61.34 ± 0.34‡ 1.68 ± 0.014‡ 2.31 ± 0.01‡ 6.8 ± 0.83¶ 5.73 ± 0.23‡16.00 ± 1.03§|| 38.67 ± 1.33§|| 24.25 ± 0.46§|| 142.92 ± 5.26§|| 2.07 ± 0.22§|| 4.69 ± 0.07§|| 8.16 ± 1.00§|| 6.40 ± 0.11§||-23.67 +24.20 -27.26 +15.63 -1.17 +5.33 +3.50 -0.35-53.85 +81.29 -63.76 +10.53 -45.38 +73.06 +13.33 -20.20 Values are means ± SEMs (n = 5); P < 0.05 was considered as statistically significant; *mg/g †HMG-CoA reductase activity is inversely  proportional to the ratio of HMG-CoA to mevalonate; ‡compared with CD; §compared with FD; ||compared with CDC; CD, commercial  diet; FD: formulated diet; CDC, commercial diet with cholesterol; FDC, formulated diet with cholesterol; ¶not significant; TL, total lipid;  TC, total cholesterol; TG, triglycerides; HMG-CoA, 3-hydroxy-3-methyl-glutaryl-CoA.tein cholesterol (LDL-C), which is a predisposing factor for  cardiovascular disorders [23, 24].",Non-OADS,/arxiv_data1/oa_pdf/2e/26/2093-6966-v17-n02-034.PMC4331993.pdf
038  http://www.journal.ac Journal of Pharmacopuncture 2014;17(2):034-040 found between the FD and the CD and between the FDC  and the CDC groups.,OADS,/arxiv_data1/oa_pdf/2e/26/2093-6966-v17-n02-034.PMC4331993.pdf
http://www.journal.ac039  Journal of Pharmacopuncture 2014;17(2):034-040 ol content through its increased excretion [34-39].,Non-OADS,/arxiv_data1/oa_pdf/2e/26/2093-6966-v17-n02-034.PMC4331993.pdf
040  http://www.journal.ac Journal of Pharmacopuncture 2014;17(2):034-040 1974;11(3):151-69.,Non-OADS,/arxiv_data1/oa_pdf/2e/26/2093-6966-v17-n02-034.PMC4331993.pdf
2011; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/26/2093-6966-v17-n02-034.PMC4331993.pdf
"Acupunc - ture refers to the stimulation of certain points on the  Original article Received:  Oct 10, 2013     Accepted:  Apr 10, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[2]:027-033 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.013    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/70/89/2093-6966-v17-n02-027.PMC4331994.pdf
"Tel: +82-2-958-9188  Fax: +82-2-958-9186 E-mail: chosh@khu.ac.kr ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.ac1 Department of Neuropsychiatry, College of Korean Medicine, Kyung Hee University, Seoul, Korea 2 Department of Acupuncture & Moxibustion, Wonkwang Gwangju Oriental Medical Hospital, Gwangju, Korea  3 Research Center of Pharmacopuncture Medicine, Korean Pharmacopuncture Institute, Seoul, Korea 4  Department of Neuropsychiatry, Hospital of Korean Medicine, Kyung Hee University Medical Center, Seoul, Korea",Non-OADS,/arxiv_data1/oa_pdf/70/89/2093-6966-v17-n02-027.PMC4331994.pdf
028  http://www.journal.ac Journal of Pharmacopuncture 2014;17(2):027-033 body.,Non-OADS,/arxiv_data1/oa_pdf/70/89/2093-6966-v17-n02-027.PMC4331994.pdf
http://www.journal.ac029 with its floor divided into nine squares.,Non-OADS,/arxiv_data1/oa_pdf/70/89/2093-6966-v17-n02-027.PMC4331994.pdf
030  http://www.journal.ac Journal of Pharmacopuncture 2014;17(2):027-033 creased number of entries into the central zone compared  with the other groups (Fig.,Non-OADS,/arxiv_data1/oa_pdf/70/89/2093-6966-v17-n02-027.PMC4331994.pdf
http://www.journal.ac031 Figure 6  Antidepressant-like effects of Sumsu pharmacopuncture af - ter 2 weeks of chronic immobilization stress in the forced swimming  test.,Non-OADS,/arxiv_data1/oa_pdf/70/89/2093-6966-v17-n02-027.PMC4331994.pdf
032  http://www.journal.ac Journal of Pharmacopuncture 2014;17(2):027-033 Bae WS.,Non-OADS,/arxiv_data1/oa_pdf/70/89/2093-6966-v17-n02-027.PMC4331994.pdf
http://www.journal.ac033  Journal of Pharmacopuncture 2014;17(2):027-033 ase II in human leukemia cells and affects the cytotox - icity of anticancer drugs.,Non-OADS,/arxiv_data1/oa_pdf/70/89/2093-6966-v17-n02-027.PMC4331994.pdf
"The scolopendrid was first  Original article Received:  May 29, 2013     Accepted:  Jan 13, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[2]:057-066 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.017    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/89/88/2093-6966-v17-n02-057.PMC4331995.pdf
"ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.ac1  Department of Neurology, Inam Neuroscience Research Center, Sanbon Medical Center, College of Medicine, Wonkwang University,  Iksan, Korea 2   ALS/MND Center of Wonkwang University, Gwangju, Korea 3    Department of Neuropsychiatry, Hospital of Korean Medicine, Kyung Hee University Medical center, Seoul, Korea 4    Department of Acupuncture & Moxibustion Medicine, Semyung University Korean Medical Hospital, Chungju, Korea 5    Department of Acupuncture & Moxibustion Medicine, Dongguk University College of Korean Medicine, Goyang, Korea 6    Department of Meridian & Acupoint, Wonkwang University College of Korean Medicine, Gwangju, Korea",Non-OADS,/arxiv_data1/oa_pdf/89/88/2093-6966-v17-n02-057.PMC4331995.pdf
"058  http://www.journal.ac Journal of Pharmacopuncture 2014;17(2):057-066 mentioned in Sinnongbonchogyeong, a text in the Com - pendium of Material Medica that was used to treat infan - tile convulsion, erysipelas, kerion, scrofulosis and biting  injuries [3, 4].",Non-OADS,/arxiv_data1/oa_pdf/89/88/2093-6966-v17-n02-057.PMC4331995.pdf
"http://www.journal.ac059 ment, the general symptoms were examined once a day.",Non-OADS,/arxiv_data1/oa_pdf/89/88/2093-6966-v17-n02-057.PMC4331995.pdf
"060  http://www.journal.ac Journal of Pharmacopuncture 2014;17(2):057-066 are shown in Tables 6 and 7, respectively.",Non-OADS,/arxiv_data1/oa_pdf/89/88/2093-6966-v17-n02-057.PMC4331995.pdf
"http://www.journal.ac061 Group Dose of SP Sex                                 Days after administration 0 3 7 14 G1 0MaleMean 189.5 215.7 249.4 300.7 S. D. 8.4 11.1 16.2 25.9 N 5 5 5 5 FemaleMean 150.9 164.0 180.6 203.4 S. D. 6.9 7.1 6.2 7.6 N 5 5 5 5 G2 0.1MaleMean 191.6 218.9 255.1 316.6 S. D. 12.8 13.7 16.4 15.6 N 5 5 5 5 FemaleMean 153.7 163.1 177.8 198.1 S. D. 4.9 6.5 10.0 10.4 N 5 5 5 5 G3 0.5MaleMean 191.1 217.1 253.0 311.4 S. D. 11.5 13.0 15.5 19.7 N 5 5 5 5 FemaleMean 154.1 165.5 178.0 204.1 S. D. 6.3 5.3 7.8 14.7 N 5 5 5 5 G4 1.0MaleMean 188.6 213.1 246.2 295.8 S. D. 9.2 12.3 17.4 28.9 N 5 5 5 5 FemaleMean 154.0 167.2 183.1 210.6 S. D. 3.8 5.0 9.0 9.9 N 5 5 5 5Table 5  Body weights (g) S.D., standard deviation; N, number of animals.Journal of Pharmacopuncture 2014;17(2):057-066 Figure 1  Body weights in male SD rats Bodyweight (g) Days after do sing (day)400 300 200 100 0 0 2 4 6 8 10 12 14 Figure 2  Body weights in female SD rats Bodyweight (g) Days after do sing (day)400 300 200 100 0 0 2 4 6 8 10 12 14 Mean S. D. N",Non-OADS,/arxiv_data1/oa_pdf/89/88/2093-6966-v17-n02-057.PMC4331995.pdf
062  http://www.journal.ac Journal of Pharmacopuncture 2014;17(2):057-066 Table 6  Mean Hematology Parameters GroupDose  of SPSexMean S. D. NRBC (×103  cells/ μL)HGB (g/dL)HCT (%)RBC Indices PLT (×103  cells/ μL)Reti(%) MCV(fl)MCH (pg)MCHC (g/dL) G1 0MaleMean 7.15 14.6 44.9 63.0 20.4 32.4 1315 4.3 S. D. 0.43 0.4 1.3 2.0 0.8 0.5 95 0.5 N 5 5 5 5 5 5 5 5 FemaleMean 7.14 14.3 42.5 59.6 20.0 33.6 1277 2.7 S. D. 0.25 0.6 1.9 2.4 0.8 0.3 68 0.3 N 5 5 5 5 5 5 5 5 G2 0.1MaleMean 6.99 14.4 44.6 63.7 20.7 32.4 1367 5.0 S. D. 0.42 0.5 1.9 1.9 0.7 0.2 111 0.9 N 5 5 5 5 5 5 5 5 FemaleMean 7.13 14.4 42.8 60.0 20.3 33.7 1296 2.5 S. D. 0.37 0.5 1.7 1.2 0.5 0.4 175 0.5 N 5 5 5 5 5 5 5 5 G3 0.5MaleMean 6.94 14.2 43.5 62.7 20.4 32.6 1281 4.9 S. D. 0.22 0.3 0.7 1.8 0.7 0.3 52 0.4 N 5 5 5 5 5 5 5 5 FemaleMean 7.31 14.6 43.7 59.7 19.9 33.3 1284 2.9 S. D. 0.18 0.5 1.4 1.5 0.5 0.3 108 0.8 N 5 5 5 5 5 5 5 5 G4 1.0MaleMean 7.01 14.1 43.4 61.9 20.1 32.5 1330 4.3 S. D. 0.29 0.4 1.5 2.0 0.6 0.3 220 0.9 N 5 5 5 5 5 5 5 5 FemaleMean 7.20 14.4 43.3 60.2 19.9 33.2 1447 3.0 S. D. 0.30 0.3 0.9 1.5 0.5 0.3 51 0.6 N 5 5 5 5 5 5 5 5 GroupDose of SPSexMean S. D. NWBC (×103  cells/ μL)WBC Differential Counting (%)PT (sec)APTT (sec) NEU LYM MONO EOS BASO G1 0 MaleMean 6.67 15.9 79.9 2.1 0.5 0.1 17.6 13.9 S. D. 1.95 2.5 1.5 0.4 0.2 0.1 0.4 0.4 N 5 5 5 5 5 5 5 5 (Continued),Non-OADS,/arxiv_data1/oa_pdf/89/88/2093-6966-v17-n02-057.PMC4331995.pdf
"http://www.journal.ac063  Journal of Pharmacopuncture 2014;17(2):057-066 (Continued)GroupDose of SPSexMean S. D. NWBC (×103  cells/ μL)WBC Differential Counting (%)PT (sec)APTT (sec) NEU LYM MONO EOS BASO G1 0 FemaleMean 3.06 18.5 77.0 2.1 0.8 0.2 18.3 14.3 S. D. 0.32 5.9 6.2 0.6 0.2 0.1 0.4 1.0 N 5 5 5 5 5 5 5 5 G2 0.1MaleMean 8.49 14.7 80.9 2.3 0.4 0.2 17.2 14.1 S. D. 1.10 3.9 4.6 0.6 0.2 0.1 0.7 0.6 N 5 5 5 5 5 5 5 5 FemaleMean 4.09 13.7 81.9 2.0 0.8 0.2 18.1 12.9 S. D. 1.03 1.8 2.0 0.5 0.3 0.1 0.7 1.6 N 5 5 5 5 5 5 5 5 G3 0.5MaleMean 7.89 17.5 77.3 2.5 0.7 0.2 18.1 14.3 S. D. 1.38 6.9 7.8 0.6 0.4 0.0 0.5 0.5 N 5 5 5 5 5 5 5 5 FemaleMean 4.45 13.6 81.9 2.0 0.8 0.2 18.1 12.9 S. D. 1.03 1.8 2.0 0.5 0.3 0.1 0.7 1.6 N 5 5 5 5 5 5 5 5 G4 1.0MaleMean 7.08 16.8 78.9 2.2 0.4 0.2 17.7 13.6 S. D. 1.17 4.2 4.0 0.5 0.1 0.0 0.6 1.2 N 5 5 5 5 5 5 5 5 FemaleMean 4.59 14.3 81.8 1.6 0.9 0.2 18.3 14.0 S. D. 1.94 4.4 4.7 0.4 0.3 0.1 0.9 0.6 N 5 5 5 5 5 5 5 5 S.D., standard deviation; N, number of animals; RBC, red blood cell; HGB, hemoglobin; HCT, hematocrit; MCV , mean corpuscular cell  volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular cell hemoglobin concentration; WBC, white blood cell; PLT,  platelet; PT, prothrombin time; APTT, active partial thromboplastin time; NEU, neutrophils; LYM, lymphocytes; MONO, monocytes;  EOS, Eosinophils; BASO, basophils; Reti, reticulocytes.",Non-OADS,/arxiv_data1/oa_pdf/89/88/2093-6966-v17-n02-057.PMC4331995.pdf
http://www.journal.ac064 GroupDose of SPSexMean S. D. NALT  (U/L)AST (U/L)ALP (U/L)GGT (U/L)Glu (mg/ dL)BUN (mg/ dL)Crea (mg/ dL)T-Bili (mg/ dL)T-Chol (mg/ dL) G2 0.1MaleMean 26.2 77.6 799.6 0.33 125 11.8 0.36 0.03 60 S. D. 3.1 9.2 116.1 0.12 16 1.9 0.03 0.01 9 N 5 5 5 5 5 5 5 5 5 FemaleMean 22.3 68.6 461.5 0.66 121 11.1 0.39 0.03 76 S. D. 4.2 7.9 119.2 0.24 11 2.0 0.01 0.01 16 N 5 5 5 5 5 5 5 5 5 G3 0.5MaleMean 33.4 79.3 805.7 0.36 113 10.7 0.37 0.04 65 S. D. 3.8 12.8 169.0 0.24 15 1.2 0.02 0.01 18 N 5 5 5 5 5 5 5 5 5 FemaleMean 23.2 75.1 475.1 0.55 129 12.8 0.41 0.02 74 S. D. 5.2 13.4 131.6 0.15 11 1.8 0.02 0.01 13 N 5 5 5 5 5 5 5 5 5 G4 1.0MaleMean 29.5 71.4 844.8 0.42 127 13.3 0.36 0.03 61 S. D. 3.9 2.7 80.7 0.14 13 1.9 0.01 0.01 15 N 5 5 5 5 5 5 5 5 5 FemaleMean 22.1 67.2 441.6 0.43 135 12.0 0.38 0.02 76 S. D. 2.1 11.0 68.1 0.12 15 1.8 0.04 0.01 11 N 5 5 5 5 5 5 5 5 5Journal of Pharmacopuncture 2014;17(2):057-066 GroupDose of SPSexMean S. D. NTG (mg/ dL)TP (g/dL)Alb (g/dL)A/G ratioP (mg/ dL)Ca (mg/ dL)Na (mmol/ L)K (mmol/ L)Cl (mmol/ L) G1 0MaleMean 40 5.2 2.3 0.79 8.61 10.0 139 4.8 102 S. D. 16 0.1 0.1 0.05 0.30 0.2 2 0.2 2 N 5 5 5 5 5 5 5 5 5 FemaleMean 14 5.6 2.6 0.85 7.23 10.1 140 4.5 102 S. D. 2 0.2 0.1 0.07 0.40 0.1 2 0.2 2 N 5 5 5 5 5 5 5 5 5 G2 0.1MaleMean 54 5.3 2.3 0.77 8.32 10.2 139 4.9 103 S. D. 27 0.1 0.1 0.03 0.50 0.3 1 0.2 3 N 5 5 5 5 5 5 5 5 5 FemaleMean 15 5.5 2.5 0.83 7.44 10.0 140 4.5 102 S. D. 6 0.1 0.1 0.06 0.27 0.2 1 0.2 1 N 5 5 5 5 5 5 5 5 5 (Continued),Non-OADS,/arxiv_data1/oa_pdf/89/88/2093-6966-v17-n02-057.PMC4331995.pdf
http://www.journal.ac065 way to study safety assessments.,Non-OADS,/arxiv_data1/oa_pdf/89/88/2093-6966-v17-n02-057.PMC4331995.pdf
http://www.journal.ac066 13.,Non-OADS,/arxiv_data1/oa_pdf/89/88/2093-6966-v17-n02-057.PMC4331995.pdf
"All experiments  were conducted at Biotoxtech (Chungwon, Korea), an  authorized institution for non-clinical studies, under  the regulations of Good Laboratory Practice (GLP) of  Original article Received:  Mar 06, 2014     Accepted:  May 19, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[2]:046-056 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.016    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/80/13/2093-6966-v17-n02-046.PMC4331996.pdf
"Tel: +82-63-850-6983  Fax: +82-63-857-6458 E-mail: drpoint@wku.ac.kr ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.ac1 Department of Acupuncture & Moxibustion Medicine, Wonkwang Gwangju Oriental Medical Hospital, Gwangju, Korea 2 Department of Meridians & Acupoints, College of Oriental Medicine, Wonkwang University, Iksan, Korea",Non-OADS,/arxiv_data1/oa_pdf/80/13/2093-6966-v17-n02-046.PMC4331996.pdf
http://www.journal.ac 047 Korea Food & Drug Administration (KFDA) Notification  No.,Non-OADS,/arxiv_data1/oa_pdf/80/13/2093-6966-v17-n02-046.PMC4331996.pdf
"048  http://www.journal.ac Journal of Pharmacopuncture 2014;17(2):046-056 For the biochemical tests, the blood remaining after car - rying out the hematological tests was centrifuged at 3,000  rpm for 10 minutes, and the serum was collected.",Non-OADS,/arxiv_data1/oa_pdf/80/13/2093-6966-v17-n02-046.PMC4331996.pdf
http://www.journal.ac049  Journal of Pharmacopuncture 2014;17(2):046-056 Table 3  Summary of clinical signs Hours (Day 0) after dosing Clinical sign MaleSex Group/dose (mL/animal)No.,Non-OADS,/arxiv_data1/oa_pdf/80/13/2093-6966-v17-n02-046.PMC4331996.pdf
http://www.journal.ac050  Journal of Pharmacopuncture 2014;17(2):046-056 Table 4  Mean hematology parameters Sex: Male RBC Indices RBC IndicesGroup/dose (mL/animal)RBC (× 106 cells/ µL)PLT (× 106 cells/ µL)HGB (g/dL)MCV (fL) NEUMCH (pg) LYMMCHC (g/dL) MONO EOS BASOHCT (%)Reti (%) G1 0 G1 0PT (sec)APTT (sec)Mean S.D.,Non-OADS,/arxiv_data1/oa_pdf/80/13/2093-6966-v17-n02-046.PMC4331996.pdf
"http://www.journal.ac051 G4 1.0G3 0.5 Significantly different from control by Dunnett’s t-test: * P < 0.05 S.D., standard deviation; N, number of male SD rats Sex: Female RBC Indices RBC IndicesRBC (× 106 cells/ µL)PLT (× 106 cells/ µL)HGB (g/dL)MCV (fL) NEUMCH (pg) LYMMCHC (g/dL) MONO EOS BASOHCT (%)Reti (%) G1 0 PT (sec)APTT (sec)G2 0.1 G3 0.5 G4 1.0 G1 0 G2 0.1WBC (× 106 cells/ µL)Mean S.D.",OADS,/arxiv_data1/oa_pdf/80/13/2093-6966-v17-n02-046.PMC4331996.pdf
"http://www.journal.ac052  Journal of Pharmacopuncture 2014;17(2):046-056 G3 0.5 G4 1.0 Significantly different from control by Dunnett’s t-test: * P < 0.05 S.D., standard deviation; N, number of female SD rats; RBC, red blood cell; HGB, hemoglobin; HCT, hematocrit; MCH, mean corpus - cular hemoglobin; MCV , mean corpuscular cell volume; MCHC, mean corpuscular cell hemoglobin concentration; WBC, white blood  cell; PLT, platelet; PT, prothrombin time; APTT, active partial thromboplastin time; NEU, neutrophils; LYM, lymphocytes; MONO,  monocytes; EOS, Eosinophils; BASO, basophils; Reti, reticulocytes.",Non-OADS,/arxiv_data1/oa_pdf/80/13/2093-6966-v17-n02-046.PMC4331996.pdf
http://www.journal.ac053 Sex: Female AST (U/L) TP (g/dL)ALP (U/L) Alb (g/dL)GGT (U/L A/G ratioGlu (mg/dL) P (mg/dL)BUN (mg/dL) Ca (mg/dL)Crea (mg/dL) Na (mmol/L)T-Bili (mg/dL) K (mmol/L)T-Chol (mg/dL) Cl (mmol/L)ALT (U/L) TG (mg/dL)G1 0 G1 0G2 0.1 G3 0.5 G4 1.0Mean S.D.,Non-OADS,/arxiv_data1/oa_pdf/80/13/2093-6966-v17-n02-046.PMC4331996.pdf
"http://www.journal.ac054  Journal of Pharmacopuncture 2014;17(2):046-056 S.D., standard deviation; N, number of female SD rats; ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, gamma  glutamyltranspeptidase; ALP , alkaline phosphatase; Glu, glucose; BUN, blood urea nitrogen; Crea, creatinine; T-Bili, total bilirubin;  T-Chol, total cholesterol; TG, triglycerides; TP , total protein; Alb, albumin.G2 0.1 Table 6  Summary of necropsy findings Female Male Sex External surface and all organs in body cavity were unremarkable.",OADS,/arxiv_data1/oa_pdf/80/13/2093-6966-v17-n02-046.PMC4331996.pdf
http://www.journal.ac055 1.,Non-OADS,/arxiv_data1/oa_pdf/80/13/2093-6966-v17-n02-046.PMC4331996.pdf
Available from: http://www.law.,Non-OADS,/arxiv_data1/oa_pdf/80/13/2093-6966-v17-n02-046.PMC4331996.pdf
http://www.journal.ac056 10.,Non-OADS,/arxiv_data1/oa_pdf/80/13/2093-6966-v17-n02-046.PMC4331996.pdf
"Previous  studies have suggested that SMS exerts protective ef - fects against oxidative damage in the cells or tissues of  the cardiovascular system and the nervous system [3- Original article Received:  May 28, 2014     Accepted:  Jun 18, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[2]:067-072 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.018    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/fd/2093-6966-v17-n02-067.PMC4331997.pdf
"Tel: +82-2-958-9188 Fax: +82-2-958-9186 E-mail: chosh@khu.ac.kr ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.ac1  Department of Neuropsychiatry, College of Korean Medicine, Kyung Hee University, Seoul, Korea 2Department of Acupuncture & Moxibustion Medicine, Wonkwang Gwangju Oriental Medical Hospital, Gwangju, Korea 3 Department of Neuropsychiatry, Hospital of Korean Medicine, Kyung Hee University Medical Center, Seoul, Korea",Non-OADS,/arxiv_data1/oa_pdf/b7/fd/2093-6966-v17-n02-067.PMC4331997.pdf
068  http://www.journal.ac Journal of Pharmacopuncture 2014;17(2):067-072 5].,Non-OADS,/arxiv_data1/oa_pdf/b7/fd/2093-6966-v17-n02-067.PMC4331997.pdf
http://www.journal.ac069 days thereafter.,Non-OADS,/arxiv_data1/oa_pdf/b7/fd/2093-6966-v17-n02-067.PMC4331997.pdf
"070  http://www.journal.ac Journal of Pharmacopuncture 2014;17(2):067-072 has a protective effect against the accompanying renal is - chemic damage [19, 20].",Non-OADS,/arxiv_data1/oa_pdf/b7/fd/2093-6966-v17-n02-067.PMC4331997.pdf
"http://www.journal.ac071  Journal of Pharmacopuncture 2014;17(2):067-072 Korea Food and Drug Administration has testing-protocol  guidelines for the assessment of toxicity, and all experi - ments should be conducted following Good Laboratory  Practice (GLP) regulations [31].",Non-OADS,/arxiv_data1/oa_pdf/b7/fd/2093-6966-v17-n02-067.PMC4331997.pdf
072  http://www.journal.ac Journal of Pharmacopuncture 2014;17(2):067-072 18.,Non-OADS,/arxiv_data1/oa_pdf/b7/fd/2093-6966-v17-n02-067.PMC4331997.pdf
"According to the World Health organiza - tion (WHO, 2010), lung cancer is the most common - Original article Received:  Apr 11, 2014     Accepted:  Jun 09, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[2]:007-017 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.011    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/43/2093-6966-v17-n02-007.PMC4331998.pdf
"Tel:+91-33-2582-8750 Fax: +91-33-2582-8282 Email: prof_arkb@yahoo.co.in; khudabukhsh_48@rediffmail.com ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.acCytogenetics and Molecular Biology Laboratory, Department of Zoology, University of Kalyani, Kalyani, India",Non-OADS,/arxiv_data1/oa_pdf/6f/43/2093-6966-v17-n02-007.PMC4331998.pdf
"008  http://www.journal.ac Journal of Pharmacopuncture 2014;17(2):007-017 ly diagnosed cancer with 1.4 million new cases reported  every year [2, 3].",Non-OADS,/arxiv_data1/oa_pdf/6f/43/2093-6966-v17-n02-007.PMC4331998.pdf
http://www.journal.ac009 solved in 65% ethyl alcohol was prepared by mixing 1 mL  of crude extract with 20 mL of distilled water [14].,Non-OADS,/arxiv_data1/oa_pdf/6f/43/2093-6966-v17-n02-007.PMC4331998.pdf
010  http://www.journal.ac Journal of Pharmacopuncture 2014;17(2):007-017 Table 1  Primer sequences Primer Primer sequences Apaf-1                          Bax                               Bcl2                           Caspase- 3      Caspase 9      Cytochrome c               p53       PARP ICAD GAPDHFwd 5’- ACATTTC TCACGATGCTACC- 3’  Rev 5’- CAATTCATGAAGTGGCAA- 3’ Fwd 5’-AGTAACATGGAGCTGCAGAGG-3’ Rev 5’-ATGGTTCTGATCAGTTCCGG-3’ Fwd 5’-GTGACTTCCGATCAGGAAGG-3’ Rev 5’-CTTCCAGACATTCGGAGACC-3’ Fwd 5’-AGGGGTCATTTATGGGACA-3’ Rev 5’-TACACGGGATCTGTTTCTTTG-3’ Fwd’- 5’GCTCTTCCTTTGTTCATCTCC -3’ Rev’ - 5 CATCTGGCTCGGGGTTACTGC -3’ Fwd 5’-CGTGTCGACCTAATATGGGTGATGTTGAAAAGG- 3’ Rev 5’-ACAGATCTTTCTCATTAGTAGCCTTTTTAAG -3’ Fwd 5’-GGAAATTTGTATCCCGAGTATCTG-3’ Rev 5’-GTCTTCCAGTGTGATGATGGTAA-3’ Fwd 5’-GATTCCCCATCTCTTTCTTTACACA-3’ Rev 5’-GGGCAATAGTCATCACAGACGTT-3’ Fwd: 5’-ATGGTCAAGCCCAGACAGAG-3’ Rev: 5’-CGTGTTTTCAACATTTAATGCAA-3’ Fwd 5’-CCATGTTCGTCATGGGTGTGAACCA-3’ Rev 5’-GCCAGTAGAGGCAGGGATGATGTTC-3’ sorbent assay) with an ELISA reader.,Non-OADS,/arxiv_data1/oa_pdf/6f/43/2093-6966-v17-n02-007.PMC4331998.pdf
http://www.journal.ac011  Journal of Pharmacopuncture 2014;17(2):007-017 Table 2  AST-ALT estimate of the effect of Condurango (Con) on rats Histological analysis clearly demonstrated a uniform ar - rangement of lung alveolar spaces with regularly arranged  small nuclei-filled cells in normal lung sections.,Non-OADS,/arxiv_data1/oa_pdf/6f/43/2093-6966-v17-n02-007.PMC4331998.pdf
"012  http://www.journal.ac Journal of Pharmacopuncture 2014;17(2):007-017 A C E A B CF GB D Figure 2  Analysis of ROS accumulation of perfused lung epithelial cells at different time points: (A) normal, (B)-(D) cancer at the 5th, 6th and 7th  month, respectively, and (E)-(G) drug-fed groups at the 5th, 6th and 7th month, respectively.",Non-OADS,/arxiv_data1/oa_pdf/6f/43/2093-6966-v17-n02-007.PMC4331998.pdf
"http://www.journal.ac013  Journal of Pharmacopuncture 2014;17(2):007-017 http://www.journal.ac A B C D E FBax Bcl 2 Caspase-3 Cytochrome-c ICAD p53 Caspase-9 Apaf-1 PARP GAPDH Figure 4  RT-PCR, reverse transcriptase-polymerase chain reaction analysis of different pro-apoptotic genes (Bax, cytochrome-c, caspase-3,  caspase-9, p53, ICAD, apaf-1, PARP and anti-apoptotic gene (Bcl-2) t the 5th, 6th and 7th month of the Condurango-treated group with respect  to normal and cancer-bearing groups: (A) L2 - cancer, L3 - Condurango treatment (5th month), (B) L4 - cancer, L5 - Condurango treatment (6th  month), (C) L6 - cancer, L7 - Condurango treatment (7th month), L1 - normal.",Non-OADS,/arxiv_data1/oa_pdf/6f/43/2093-6966-v17-n02-007.PMC4331998.pdf
014  http://www.journal.ac Journal of Pharmacopuncture 2014;17(2):007-017 Figure 5  Protein expressions of different apoptotic markers by ELISA.,Non-OADS,/arxiv_data1/oa_pdf/6f/43/2093-6966-v17-n02-007.PMC4331998.pdf
"http://www.journal.ac015  Journal of Pharmacopuncture 2014;17(2):007-017 rats, a fact which was also supported by the study of the  mRNA level (Fig.",Non-OADS,/arxiv_data1/oa_pdf/6f/43/2093-6966-v17-n02-007.PMC4331998.pdf
"016  http://www.journal.ac Journal of Pharmacopuncture 2014;17(2):007-017 Mantena SK, Sharma SD, Katiyar SK.",Non-OADS,/arxiv_data1/oa_pdf/6f/43/2093-6966-v17-n02-007.PMC4331998.pdf
2009 (http://content.healthaffairs.org/con - tent/22/3/61.full).,Non-OADS,/arxiv_data1/oa_pdf/6f/43/2093-6966-v17-n02-007.PMC4331998.pdf
Available  from: http://www.cancer.gov/cancertopics/pdq/cam/ acupuncture/.,Non-OADS,/arxiv_data1/oa_pdf/6f/43/2093-6966-v17-n02-007.PMC4331998.pdf
"http://www.journal.ac017  Journal of Pharmacopuncture 2014;17(2):007-017 Tseng CL, Wu SY, Wang WH, Peng CL, Lin FH, Lin CC,  et al .",OADS,/arxiv_data1/oa_pdf/6f/43/2093-6966-v17-n02-007.PMC4331998.pdf
"The  Original articleISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[2]:073-079 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.019    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/97/2093-6966-v17-n02-073.PMC4331999.pdf
"Tel: +82-33-741-9257  Fax: +82-33-732-2124 E-mail: redphilips@hanmail.net ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.ac1 Department of Acupuncture & Moxibustion Medicine, Sangji University College of Oriental Medicine, Wonju, Korea 2 Research Center of the Korean Pharmacopuncture Institute, Seoul, Korea Received:  Nov 07, 2013     Accepted:  Feb 12, 2014",Non-OADS,/arxiv_data1/oa_pdf/3c/97/2093-6966-v17-n02-073.PMC4331999.pdf
"074  http://www.journal.ac Journal of Pharmacopuncture 2014;17(2):073-079 venom from live honey bees ( Apismellifera ) is artificially  extracted, refined and injected into acupoints pertaining  to a specific disorder [1].",Non-OADS,/arxiv_data1/oa_pdf/3c/97/2093-6966-v17-n02-073.PMC4331999.pdf
"http://www.journal.ac075 brain, pituitary gland, heart, lungs, liver, spleen, kidneys,  adrenal glands, testes, prostate, ovaries, and uterus.",Non-OADS,/arxiv_data1/oa_pdf/3c/97/2093-6966-v17-n02-073.PMC4331999.pdf
076  http://www.journal.ac Journal of Pharmacopuncture 2014;17(2):073-079 changes compared to the control group.,Non-OADS,/arxiv_data1/oa_pdf/3c/97/2093-6966-v17-n02-073.PMC4331999.pdf
"http://www.journal.ac077  Journal of Pharmacopuncture 2014;17(2):073-079 icant change, compared to the control group.",Non-OADS,/arxiv_data1/oa_pdf/3c/97/2093-6966-v17-n02-073.PMC4331999.pdf
078  http://www.journal.ac Journal of Pharmacopuncture 2014;17(2):073-079 Korean Pharmacopuncture Institute.,Non-OADS,/arxiv_data1/oa_pdf/3c/97/2093-6966-v17-n02-073.PMC4331999.pdf
"Supplementary material   Supplementary material associated with this article can  be found, in the online version, at http://suppl.journal.",Non-OADS,/arxiv_data1/oa_pdf/3c/97/2093-6966-v17-n02-073.PMC4331999.pdf
http://www.journal.ac079  Journal of Pharmacopuncture 2014;17(2):073-079 ciety.,Non-OADS,/arxiv_data1/oa_pdf/3c/97/2093-6966-v17-n02-073.PMC4331999.pdf
"Introduction Bee venom has strong analgesicand anti-inflam - Original article Received:  Nov 07, 2013     Accepted:  Feb 12, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[2]:018-026 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.012    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ce/70/2093-6966-v17-n02-018.PMC4332000.pdf
"Tel: +82-33-741-9257  Fax: +82-33-732-2124 E-mail: redphilips@hanmail.net ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.ac1 Department of Acupuncture & Moxibustion Medicine, Sangji University College of Oriental Medicine, Wonju, Korea 2 Division of Animal Resources and Life Science, Sangji University, Wonju, Korea 3 Department of Internal Medicine, Sangji University College of Oriental Medicine, Wonju, Korea 4  Research Center of the Korean Pharmacopuncture Institute, Seoul, Korea",Non-OADS,/arxiv_data1/oa_pdf/ce/70/2093-6966-v17-n02-018.PMC4332000.pdf
"http://www.journal.ac019 matory actions [1, 2], so bee venom pharmacopuncture  (BVP) shows high efficacy in the treatment of degenerative  arthritis [3-5], rheumatoid arthritis [6, 7], disc herniation  [8-10] and whiplash injury [11, 12].",Non-OADS,/arxiv_data1/oa_pdf/ce/70/2093-6966-v17-n02-018.PMC4332000.pdf
"020  http://www.journal.ac Journal of Pharmacopuncture 2014;17(2):018-026 thyroid, parathyroid, and adrenal glands, thymus, trachea,  heart, lungs, liver, spleen, kidneys, testes, prostate, ovaries,  uterus, salivary glands, stomach, duodenum, jejunum, il - eum, cecum, pancreas, epididymis, seminal vesicles, uri - nary bladder, sub-mandibular lymph node, eyes, harderi - an glands, skin, bone marrow (femur and sternum),  tongue, and spinal cord.",Non-OADS,/arxiv_data1/oa_pdf/ce/70/2093-6966-v17-n02-018.PMC4332000.pdf
http://www.journal.ac021  Journal of Pharmacopuncture 2014;17(2):018-026 age (0.28 mg/kg) group showed significant delays in pro - thrombin time (PT) and increases in eosinophils during  the 13-week toxicity test.,Non-OADS,/arxiv_data1/oa_pdf/ce/70/2093-6966-v17-n02-018.PMC4332000.pdf
"022  http://www.journal.ac Journal of Pharmacopuncture 2014;17(2):018-026 Significant difference from control by Student t-test: * P < 0.05; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP ,  alkaline phosphatase; Glu, glucose; BUN, blood urea nitrogen; Crea, creatinine; T-Bili, total bilirubin; T-Chol, total cholesterol; TG, tri - glycerides; TP , total protein; Alb, albumin.Table 2  Blood chemistry values for the SD rats during the 4-week recovery period study Group/ Dose  (mg/kg) Group/ Dose  (mg/kg)ALT (U/L) TP (g/dL)AST (U/L) Alb (g/dL)ALP (U/L) A/G ratioGlu (mg/dL) P (mg/dL)BUN (mg/dL) Ca (mg/dL)Crea (mg/dL) Na (mmol/L)T-Bili (mg/dL) K (mmol/L)T-Chol (mg/dL) Cl (mmol/L)TG (mg/dL) G1 0 G4 0.28 G1 0 G1 0.28Mean S.D.",Non-OADS,/arxiv_data1/oa_pdf/ce/70/2093-6966-v17-n02-018.PMC4332000.pdf
"http://www.journal.ac023  Journal of Pharmacopuncture 2014;17(2):018-026 Table 3  Histopathological findings for the SD rats during the 4-week recovery period study Grade- ±: minimal, +: mild <+>: presence in “presence or not” basis.Female Male Sex Organ/findings Adrenal Kidney Liver Lung  with bronchi Pancreas Salivary gland, sublingual Thymus ThyroidG1 0 5 1 1 1 0 0 1 2 1 0 0 1± ± ± + ± + ± + ± <+> +Group Dose (mg/kg) Number of animals Fatty degeneration, zona fasciculata, bilateral Basophilic tubules, focal, cortex Cell infiltration, mononuclear, focal Cell infiltration, mononuclear, focal Microgranuloma Appearance, macrophages Mononuclear cell, focal, around respiratory bronchiole Mineralization, arterial wall, focal Proliferation, ductular cell, focal Cell infiltration, mononuclear, periductular Cyst Hyperplasia, focal, follicular, rightG4 0.28 5 1 1 0 0 0 0 0 0 0 0 0G1 0 5 0 0 0 1 0 0 1 0 1 1 0G4 0.28 5 0 0 1 0 1 0 0 0 0 1 0kidney and adrenal gland weights.",Non-OADS,/arxiv_data1/oa_pdf/ce/70/2093-6966-v17-n02-018.PMC4332000.pdf
"024  http://www.journal.ac Journal of Pharmacopuncture 2014;17(2):018-026 A B Figure 2  Thigh muscle tissue obtained from 4-week recovery test of Sweet Bee Venom after a 13-week, repeated, intramuscular dose toxicity test  in Sprague-Dawley rats.",Non-OADS,/arxiv_data1/oa_pdf/ce/70/2093-6966-v17-n02-018.PMC4332000.pdf
"http://www.journal.ac025  Journal of Pharmacopuncture 2014;17(2):018-026 Kwon KL, Koh HK.",Non-OADS,/arxiv_data1/oa_pdf/ce/70/2093-6966-v17-n02-018.PMC4332000.pdf
026  http://www.journal.ac Journal of Pharmacopuncture 2014;17(2):018-026 2009;12(4):5-32.,Non-OADS,/arxiv_data1/oa_pdf/ce/70/2093-6966-v17-n02-018.PMC4332000.pdf
"Introduction Quercetin is a category in the class of flavonoids, and  Original article Received: Sep 12, 2014    Accepted: Oct 16, 2014ISSN 2093-6966 [Print], ISSN 2234-6856 [Online] Journal of Pharmacopuncture 2014;17[4]:036-049 DOI:   http://dx.doi.org/10.3831/KPI.2014.17.035    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)which permits unrestricted noncommercial use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/44/ff/2093-6966-v17-n04-036.PMC4332001.pdf
"School of Pharmaceutical Sciences, Universisti Sains Malaysia, 11800 Minden, Penang, Malaysia.Tel: +6016-4973020  Fax: +604-6570017E-mail: ang_leef@gmail.com ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.acSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, Penang, Malaysia",Non-OADS,/arxiv_data1/oa_pdf/44/ff/2093-6966-v17-n04-036.PMC4332001.pdf
http://www.journal.ac 037 a sub class of flavonol.,Non-OADS,/arxiv_data1/oa_pdf/44/ff/2093-6966-v17-n04-036.PMC4332001.pdf
"038  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):036-049 Figure 1  Chemical structures of quercetin, and the curcuminoids: curcumin, demethoxycurcumin and bisdemethoxycurcumin.",Non-OADS,/arxiv_data1/oa_pdf/44/ff/2093-6966-v17-n04-036.PMC4332001.pdf
"http://www.journal.ac039 > 10 for the LOD and the LOQ, respectively.",Non-OADS,/arxiv_data1/oa_pdf/44/ff/2093-6966-v17-n04-036.PMC4332001.pdf
"040  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):036-049 RSD, relative standard deviation; QUE, quercetin; BDMC, bisdemethoxycurcumin; DMC, demethoxycurcumin; CUR, curcumin.Concentration  (µg/mL)Retention time (n = 5) Peak area (n = 5) Mean (min) RSD (%) Mean (min) RSD (%) QUE 1.25 3.970 0.117 94937 0.676 5 3.972 0.066 367965 0.739 20 3.972 0.041 1438240 0.624 40 3.973 0.055 2781685 0.508 80 3.972 0.029 5582929 0.437 140 3.972 0.048 9735618 0.866 200 3.972 0.053 14073938 0.368 BDMC1.25 13.823 0.308 1859 1.611 5 13.840 0.095 8843 1.181 20 13.842 0.093 37086 1.089 40 13.843 0.087 71560 1.044 80 13.846 0.117 143659 1.073 140 13.846 0.134 249462 1.835 200 13.849 0.060 363457 0.850 DMC 1.25 15.214 0.227 14705 0.273 5 15.229 0.096 52692 0.540 20 15.230 0.074 204602 0.665 40 15.232 0.073 398446 0.436 80 15.237 0.099 798153 0.867 140 15.236 0.120 1384220 1.416 200 15.242 0.039 2015583 0.158 CUR 1.25 16.708 0.199 46645 0.856 5 16.718 0.077 182515 0.901 20 16.719 0.061 701982 0.700 40 16.720 0.064 1358591 0.299 80 16.725 0.096 2737751 0.423 140 16.725 0.108 4749355 0.897 200 16.734 0.067 6866971 0.313Table 2  Retention times and responses data of calibration standards of QUE, BDMC, DMC, and CUR were used to evaluate the retention time, the peak area,  the resolutions for the analyte peaks, the tailing factor, the  number of theoretical plates and the capacity factor.",Non-OADS,/arxiv_data1/oa_pdf/44/ff/2093-6966-v17-n04-036.PMC4332001.pdf
"http://www.journal.ac041  Journal of Pharmacopuncture 2014;17(4):036-049 Concentration  (µg/mL)Intra day*Inter day† Peak  ResponsePrecision  (RSD, %)Accuracy (%)Peak  ResponsePrecision  (RSD, %)Accuracy (%) QUE 3.75 263151 0.432 99.589 263350 0.323 99.665 100 7064599 0.717 100.821 7221470 0.646 103.060 160 11221611 0.806 100.010 11218287 0.968 100.070 BDMC3.75 6243 0.576 98.588 6181 0.854 97.669 100 182293 0.723 101.084 186683 0.878 103.513 160 286851 0.654 99.32746 288040 0.805 99.738 DMC 3.75 37700 0.635 100.310 37687 0.466 100.276 100 1010004 0.752 100.880 1037410 0.078 103.617 160 1590498 0.651 99.289 1594989 0.844 99.569 CUR 3.75 129618 0.655 98.292 129152 0.297 97.929 100 3456218 0.732 101.022 3544535 0.275 103.606 160 5448675 0.711 99.576 5454012 0.829 99.673 System suitabilityCom - poundChange in the normal organic composition of acetonitrile: 2% acetic acid (A) Normal condition Mean (n = 6)     RSD (%)(B) 38% : 62% v/v Mean (n = 6)     RSD (%)(C) 42% : 58% v/v Mean (n = 6)     RSD (%) Retention time, t R  (minutes)QUE 3.993 0.690 4.251 0.155 3.761 0.040 BDMC 13.951 0.342 17.645 0.374 11.280 0.084 DMC 15.340 0.291 19.543 0.285 12.330 0.084 CUR 16.829 0.245 21.617 0.296 13.464 0.082 Peak areaQUE 6853044 0.433 6836934 0.441 6867445 0.117 BDMC 167417 0.647 161504 0.801 146484 0.578 DMC 940836 0.404 903191 0.781 965307 0.071 CUR 3302593 0.236 3206134 0.555 3367309 0.114 Resolution, RQUE - - - - - - BDMC 32.498 0.379 36.449 0.471 29.120 0.063 DMC 2.908 0.208 3.272 2.369 2.736 0.181 CUR 2.850 0.237 3.243 1.648 2.666 0.124 Tailing factor, T fQUE 1.371 0.254 1.347 0.115 1.392 0.074 BDMC 1.533 0.364 1.283 2.314 1.080 0.200 DMC 1.160 0.484 1.083 0.151 1.431 0.082 CUR 1.094 0.094 1.076 0.284 1.114 0.037Table 3  Precisions and accuracies for intraday and interday repetitions for the quantitative detection of QUE, BDMC, DMC and CUR Table 4(a) Robustness – change in organic composition *Intra day repetitions for each concentration were analyzed on the same day.",Non-OADS,/arxiv_data1/oa_pdf/44/ff/2093-6966-v17-n04-036.PMC4332001.pdf
"042  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):036-049 (Continued)System suitabilityCom - poundChange in the acetic acid concentration (% v/v ) (A) Normal condition Mean (n = 6)     RSD (%)(B) 1.0% (pH 2.73) Mean (n = 6)      RSD (%)(C) 3.0% (pH 2.48) Mean (n = 6)    RSD (%) Retention time, t R  (minutes)QUE 3.972 0.175 4.054 0.064 3.893 0.071 BDMC 13.868 0.310 14.549 0.086 13.177 0.167 DMC 15.255 0.265 16.017 0.085 14.542 0.153 CUR 16.743 0.213 17.590 0.084 16.028 0.141 Peak areaQUE 7039483 0.562 6966950 0.525 6952833 0.630 BDMC 180475 0.541 176885 0.575 152439 0.895 DMC 1000716 0.736 987128 0.551 956266 0.670 CUR 3433379 0.754 3428762 0.533 3428762 0.558 Resolution, RQUE - - - - - - BDMC 32.327 0.172 33.254 0.244 31.950 0.268 DMC 2.900 0.370 2.974 0.303 3.033 0.527 CUR 2.840 0.429 2.904 0.339 2.966 0.608 Tailing factor, T fQUE 1.366 0.077 1.364 0.215 1.370 0.110 BDMC 1.493 1.377 1.463 0.331 1.060 0.139 DMC 1.160 1.075 1.137 0.103 1.325 0.823 CUR 1.085 0.148 1.092 0.050 1.083 0.108 Theoretical plate,  NQUE 8711.993 0.267 8877.546 0.460 8548.948 0.269 BDMC 15740.557 0.397 16067.808 0.689 16308.146 0.664 DMC 14041.181 0.701 14691.580 0.675 14241.082 1.031 CUR 15793.019 0.472 16098.239 0.701 15531.342 0.811 Capacity factor, k’QUE 0.656 1.783 0.680 1.484 0.610 0.803 BDMC 4.798 1.202 5.036 0.658 4.449 0.511 DMC 5.333 0.988 5.637 0.698 5.014 0.478 CUR 6.016 1.416 6.295 0.628 5.629 0.443System suitabilityCom - poundChange in the normal organic composition of acetonitrile: 2% acetic acid (A) Normal condition Mean (n = 6)     RSD (%)(B) 38% : 62% v/v Mean (n = 6)     RSD (%)(C) 42% : 58% v/v Mean (n = 6)     RSD (%) Table 4(b) Robustness – change in acetic acid concentrationTheoretical plate,  NQUE 8752.133 1.463 8857.791 0.312 8520.171 0.238 BDMC 15931.889 1.147 16311.011 0.058 16303.130 0.103 DMC 14298.287 1.761 16569.474 1.029 14210.321 0.233 CUR 16008.049 1.202 16543.754 0.535 15157.508 0.340 Capacity factor, k’QUE 0.680 0.344 0.777 0.906 0.601 0.327 BDMC 4.878 0.202 3.800 0.209 3.800 0.209 DMC 5.463 0.232 7.214 1.592 4.247 0.206 CUR 6.097 0.253 8.038 0.481 4.729 0.209",Non-OADS,/arxiv_data1/oa_pdf/44/ff/2093-6966-v17-n04-036.PMC4332001.pdf
"http://www.journal.ac043  Journal of Pharmacopuncture 2014;17(4):036-049 System suitabilityCom - poundChange in flow rate (A) Normal condition Mean (n = 6)      RSD (%)(B) 1.2 mL/minutes Mean (n = 6)      RSD (%)(C) 1.4 mL/minutes Mean (n = 6)      RSD (%) Retention time, t R  (minutes)QUE 3.972 0.175 4.291 0.105 3.696 0.130 BDMC 13.868 0.310 14.953 0.321 12.909 0.333 DMC 15.255 0.265 16.442 0.284 14.235 0.279 CUR 16.743 0.213 18.038 0.262 15.668 0.298 Peak areaQUE 7039483 0.562 7606272 0.662 6530571 0.497 BDMC 180475 0.541 194216 0.753 167111 1.593 DMC 1000716 0.736 1078076 0.714 928707 1.345 CUR 3433379 0.754 3700134 0.690 3185325 1.198 Resolution, RQUE - - - - - - BDMC 32.327 0.172 32.779 0.199 32.047 0.928 DMC 2.900 0.370 2.921 0.608 2.936 2.014 CUR 2.840 0.429 2.864 0.723 2.868 1.647 Tailing factor, T fQUE 1.366 0.077 1.360 0.183 1.371 0.287 BDMC 1.493 1.377 1.490 1.891 1.539 1.614 DMC 1.160 1.075 1.157 1.447 1.181 2.364 CUR 1.085 0.148 1.081 0.101 1.087 0.207 Theoretical plate,  NQUE 8711.993 0.267 9148.347 0.429 8249.430 0.420 BDMC 15740.557 0.397 16035.103 1.342 15696.046 2.851 DMC 14041.181 0.701 14374.944 1.036 13420.220 0.844 CUR 15793.019 0.472 16216.013 1.854 15379.165 2.364 Capacity factor, k’QUE 0.656 1.783 0.661 0.832 0.627 0.762 BDMC 4.798 1.202 4.780 0.942 4.750 3.067 DMC 5.351 0.661 5.355 0.497 5.350 2.846 CUR 5.966 0.632 5.985 0.500 5.862 0.427 System suitabilityCom - poundChange in column temperature (A) Normal condition Mean (n = 6)    RSD (%)(B) 30°C Mean (n = 6)      RSD (%)(C) 40°C Mean (n = 6)      RSD (%) Retention time, t R  (minutes)QUE 3.956 0.031 4.063 0.074 3.861 0.162 BDMC 13.673 0.070 14.647 0.172 12.810 0.268 DMC 15.037 0.064 15.980 0.153 14.167 0.236 CUR 16.502 0.064 17.423 0.143 15.657 0.196 Peak areaQUE 7628483 0.252 7620525 0.254 7633341 0.259 BDMC 196493 0.261 202870 0.253 172397 0.136 DMC 1091099 0.300 1124567 0.281 1058404 0.205 CUR 3738544 0.244 3836306 0.285 3643910 0.196 Resolution, RQUE - - - - - - BDMC 31.946 1.437 32.560 0.233 31.471 0.267 DMC 2.872 1.359 2.698 0.334 3.155 0.481 CUR 2.829 0.575 2.718 0.305 3.106 0.559Table 4(c) Robustness – change in flow rate  Table 4(d) Robustness – change in column temperature (Continued)",Non-OADS,/arxiv_data1/oa_pdf/44/ff/2093-6966-v17-n04-036.PMC4332001.pdf
"044  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):036-049 such as plant granule extracts, tablets and pills.",Non-OADS,/arxiv_data1/oa_pdf/44/ff/2093-6966-v17-n04-036.PMC4332001.pdf
"http://www.journal.ac045  Journal of Pharmacopuncture 2014;17(4):036-049 Figure 3  Combined chromatograms of quercetin (QUE), bisdemethoxycurcumin (BMDC), demethoxycurcumin (DMC), curcumin (CUR) ana- lyzed at different conditions: (a) acetonitrile: 2% acetic acid at a flow rate of 1.3 mL/minutes, 35°C (b) acetonitrile: different acetic acid concentra- tions (40% : 60% v/v) at a flow rate of 1.3 mL/min, 35°C (c) acetonitrile: 2% acetic acid (40% : 60% v/v) at different flow rates, 35°C (d) acetonitrile:  2% acetic acid (40% : 60% v/v) at a flow rate of 1.3 mL/min at different temperatures.A CB D its use as a cure for diseases or as a supplement for cer - tain purposes.",Non-OADS,/arxiv_data1/oa_pdf/44/ff/2093-6966-v17-n04-036.PMC4332001.pdf
046  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):036-049 Figure 4  Chromatograms for Chinese medicinal plant extracts (a) containing quercetin and (b) containing curcuminoids.,Non-OADS,/arxiv_data1/oa_pdf/44/ff/2093-6966-v17-n04-036.PMC4332001.pdf
http://www.journal.ac047  Journal of Pharmacopuncture 2014;17(4):036-049 within 19 minutes.,Non-OADS,/arxiv_data1/oa_pdf/44/ff/2093-6966-v17-n04-036.PMC4332001.pdf
"048  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):036-049 ada T, Kuwahara S, et al.",OADS,/arxiv_data1/oa_pdf/44/ff/2093-6966-v17-n04-036.PMC4332001.pdf
http://www.journal.ac049  Journal of Pharmacopuncture 2014;17(4):036-049 [internet].,Non-OADS,/arxiv_data1/oa_pdf/44/ff/2093-6966-v17-n04-036.PMC4332001.pdf
Available from:  http://www.ich.org/fileadmin/Public_Web_Site/ICH_ Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__ Guideline.pdf.,OADS,/arxiv_data1/oa_pdf/44/ff/2093-6966-v17-n04-036.PMC4332001.pdf
Available from:  http://www.fda.gov/downloads/Drugs/Guidances/ UCM134409.pdf.,Non-OADS,/arxiv_data1/oa_pdf/44/ff/2093-6966-v17-n04-036.PMC4332001.pdf
Available from: http://www.usp.org/sites/ default/files/usp_pdf/EN/products/usp2008p2sup- plement3.pdf.53.,OADS,/arxiv_data1/oa_pdf/44/ff/2093-6966-v17-n04-036.PMC4332001.pdf
"Though  various remedies exist, the therapeutic responses to  traditional treatments are relatively poor, and because  of the complicated symptoms, a diverse approach is  Case report Received:  Aug 20, 2014     Accepted:  Sep 01, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[4]:066-069 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.039    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ba/2a/2093-6966-v17-n04-066.PMC4332002.pdf
"Tel: +82-42-470-9132  Fax: +82-42-470-9006 E-mail: altyhs@dju.kr ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.ac1 East West Cancer Center, Dunsan Korean Medicine Hospital of Daejeon University, Daejeon, Korea 2 Department of Acupuncture and Moxibustion, Dunsan Korean Medicine Hospital of Daejeon University, Daejeon, Korea",Non-OADS,/arxiv_data1/oa_pdf/ba/2a/2093-6966-v17-n04-066.PMC4332002.pdf
http://www.journal.ac067 necessary [5].,Non-OADS,/arxiv_data1/oa_pdf/ba/2a/2093-6966-v17-n04-066.PMC4332002.pdf
068  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):066-069 oped while reducing western medicines.,Non-OADS,/arxiv_data1/oa_pdf/ba/2a/2093-6966-v17-n04-066.PMC4332002.pdf
"http://www.journal.ac069  Journal of Pharmacopuncture 2014;17(4):066-069 CRPS, many studies on anti-inflammatory drugs, nerve  blocks, vitamin therapy, and acupuncture for treating pa - tients with CRPS [11, 12].",Non-OADS,/arxiv_data1/oa_pdf/ba/2a/2093-6966-v17-n04-066.PMC4332002.pdf
"Because of these facts, Mecasin has been studied  for treating patients with joint pain, muscle spasms,  Original articleISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[4]:061-065 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.038    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/60/d3/2093-6966-v17-n04-061.PMC4332003.pdf
"Tel: +82-62-670-6441  Fax: +82-62-670-6767 E-mail: kscndl@hanmail.net ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.ac1  Department of Acupuncture & Moxibustion Medicine, Wonkwang University Gwangju Korean Medical Hospital, Gwangju, Korea 2    Nervous & Muscular System Disease Clinical Research Center of Wonkwang University Gwangju Korean Medical Hospital, Gwangju,  Korea 3    Department of Neurology, Inam Neuroscience Research Center, Sanbon Medical Center, College of Medicine, Wonkwang University,  Iksan, Korea 4   Department of Internal Medicine, Wonkwang University Gwangju Korean Medical Hospital, Gwangju, Korea Received:  Aug 20, 2014     Accepted:  Sep 17, 2014",Non-OADS,/arxiv_data1/oa_pdf/60/d3/2093-6966-v17-n04-061.PMC4332003.pdf
062  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):061-065 and arthralgia due to cold.,Non-OADS,/arxiv_data1/oa_pdf/60/d3/2093-6966-v17-n04-061.PMC4332003.pdf
"http://www.journal.ac 063 Journal of Pharmacopuncture 2014;17(4):061-065 one female rat in the 1,000-mg/kg group) were observed.",Non-OADS,/arxiv_data1/oa_pdf/60/d3/2093-6966-v17-n04-061.PMC4332003.pdf
064  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):061-065 Radix salviae miltiorrhizae has been used for treating  heart disease for several thousand years in the Orient.,Non-OADS,/arxiv_data1/oa_pdf/60/d3/2093-6966-v17-n04-061.PMC4332003.pdf
http://www.journal.ac065  Journal of Pharmacopuncture 2014;17(4):061-065 ing severe hypokalemic paralysis.,Non-OADS,/arxiv_data1/oa_pdf/60/d3/2093-6966-v17-n04-061.PMC4332003.pdf
"Mountain wild ginseng refers to ginseng (Panax gin - seng C. A. Meyer) of the Araliaceae family that is natu - Original articleISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[4]:027-035 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.034    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/9a/2093-6966-v17-n04-027.PMC4332004.pdf
"Tel: +82-33-765-2211  Fax: +82- 33-732-2124 E-mail: cslim-own@daum.net ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.ac1 Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Sangji University, Wonju, Korea 2 Department of Sasang Constitutional Medicine, College of Korean Medicine, Sangji University, Wonju, Korea 3 Department of Internal Medicine, College of Korean Medicine, Sangji University, Wonju, Korea 4 Research Center of the Korean Pharmacopuncture Institute, Seoul, Korea Received:  Oct 23, 2014     Accepted:  Nov 06, 2014",Non-OADS,/arxiv_data1/oa_pdf/55/9a/2093-6966-v17-n04-027.PMC4332004.pdf
028  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):027-035 rally grown in the mountains.,Non-OADS,/arxiv_data1/oa_pdf/55/9a/2093-6966-v17-n04-027.PMC4332004.pdf
"http://www.journal.ac029  Journal of Pharmacopuncture 2014;17(4):027-035 Table 1  Hematological parameters (group summary) Sex: Maletissues were routinely processed, embedded in paraffin,  and sectioned.",Non-OADS,/arxiv_data1/oa_pdf/55/9a/2093-6966-v17-n04-027.PMC4332004.pdf
030  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):027-035 Group / Dose (mL/kg)Mean  S.D.,Non-OADS,/arxiv_data1/oa_pdf/55/9a/2093-6966-v17-n04-027.PMC4332004.pdf
http://www.journal.ac031  Journal of Pharmacopuncture 2014;17(4):027-035 Group / Dose  (mL/kg)Mean  S.D.,Non-OADS,/arxiv_data1/oa_pdf/55/9a/2093-6966-v17-n04-027.PMC4332004.pdf
"032  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):027-035 occurred in the male and the female SD rats, and no sig - nificant differences in weights or food consumptions were  observed between the experimental groups and the con - trol group during the 4 weeks.",Non-OADS,/arxiv_data1/oa_pdf/55/9a/2093-6966-v17-n04-027.PMC4332004.pdf
http://www.journal.ac033  Journal of Pharmacopuncture 2014;17(4):027-035 Organ /  FindingsSex Male Female Group G1 G2 G3 G4 G1 G2 G3 G4 Dose (mL/kg) Saline MGP Saline MGP 10 2.5 5 10 10 2.5 5 10 No.,Non-OADS,/arxiv_data1/oa_pdf/55/9a/2093-6966-v17-n04-027.PMC4332004.pdf
034  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):027-035  Korean Pharmacopuncture Institute.,Non-OADS,/arxiv_data1/oa_pdf/55/9a/2093-6966-v17-n04-027.PMC4332004.pdf
http://www.journal.ac035 al.,Non-OADS,/arxiv_data1/oa_pdf/55/9a/2093-6966-v17-n04-027.PMC4332004.pdf
"The  process of the disease differs from patient to patient,  and much debate exists about the effects of conserva - Original article Received:  Aug 18, 2014     Accepted:  Aug 27, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[4]:022-026 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.033    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/49/2093-6966-v17-n04-022.PMC4332005.pdf
"Tel: +82-43-841-1735  Fax: +82-43-856-1731 E-mail: acupley@semyung.ac.kr ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.ac1 Department of Acupuncture & Moxibustion Medicine, Semyung University Korean Medicine Hospital, Chungju, Korea 2 Department of Acupuncture & Moxibustion Medicine, Semyung University Korean Medicine Hospital, Jecheon, Korea",Non-OADS,/arxiv_data1/oa_pdf/14/49/2093-6966-v17-n04-022.PMC4332005.pdf
http://www.journal.ac023 tive treatment and surgery.,Non-OADS,/arxiv_data1/oa_pdf/14/49/2093-6966-v17-n04-022.PMC4332005.pdf
"024  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):022-026 Categories Number of patients (n) Percentage (%) GenderMale 10 50.0 Female 10 50.0 Age group31 ─ 40 years old 2 10.0   41 ─ 50 years old 10 50.0  51 ─ 60 years old 4 20.0  61 ─ 70 years old 4 20.0 Duration of illness≤ 1 week 2 10.0 1 week ─ 1 month 5 25.0 1 month ─ 6 months 8 40.0 ≥ 6 months 5 25.0 LesionLeft 5 25.0 Right 15 75.0 VAS P-value* First visit 10.0 ± 0.00† 0.000Final visit 4.00 ± 2.47 Number of treatments Number of patients (n) First visit Final visit P-value* 1 ─ 5 11 10.0 ± 0.00†4.27 ± 2.07 0.246 6 ─ 10 5 10.0 ± 0.00 5.00 ± 2.78 11 or more 4 10.0 ± 0.00 2.00 ± 2.61 Age (years) Number of patients (n) First visit Final visit P-value* 31 ─ 40 2 10.0 ± 0.00†4.25 ± 1.76 0.81041 ─ 50 10 10.0 ± 0.00 4.20 ± 2.44 51 ─ 60 4 10.0 ± 0.00 2.87 ± 2.56 61 ─ 70 4 10.0 ± 0.00 4.50 ± 3.34Table 1  General Characteristics Table 2  Comparison of the visual analogue scale (VAS) scores before and after treatment Table 3  Comparison of the visual analogue scale (VAS) scores based on the number of treatments Table 4  Comparison of the visual analogue scale (VAS) scores based on age*Wilcoxon signed rank test, P < 0.05; †mean ± SD.",Non-OADS,/arxiv_data1/oa_pdf/14/49/2093-6966-v17-n04-022.PMC4332005.pdf
http://www.journal.ac025  Journal of Pharmacopuncture 2014;17(4):022-026 4.,Non-OADS,/arxiv_data1/oa_pdf/14/49/2093-6966-v17-n04-022.PMC4332005.pdf
"026  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):022-026 applied deep thermo-conductive acupuncture therapy  in 13 patients, and the VAS score decreased significantly  from 6.08 ± 1.54 to 3.31 ± 1.92 ( P = 0.005).",Non-OADS,/arxiv_data1/oa_pdf/14/49/2093-6966-v17-n04-022.PMC4332005.pdf
"Characteristics of the patients and their medi - cal history (Table 1)ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[4]:070-075 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.040    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/40/2093-6966-v17-n04-070.PMC4332006.pdf
"Tel: +82-33-741-9209  Fax: +82-33-732-2124 E-mail: sunguy2001@hanmail.net ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.acReceived:  Aug 21, 2014     Accepted:  Oct 13, 2014Korean Herbal Medicine for Treating Henoch-Schonlein  Purpura with Yin Deficiency: Five Case Reports Sung-Kyung Kim1, Seung-Seon Ryu1, Sunju Park2, Sang-Kyun Park3,  Woo-Jin Choi4, Seung-Ho Sun5* 1  Department of Clinical Medicine, Dongkyung Korean Medicine Clinic, Daejeon, Korea 2    Department of Preventive Medicine, College of Korean Medicine, Daejeon University, Daejeon, Korea 3    Department of Meridian & Acupoints, College of Korean Medicine, Sangji University, Wonju, Korea 4   Department of Neuropsychiatry, College of Korean Medicine, Sangji University, Wonju, Korea 5   Department of Internal Medicine, College of Korean Medicine, Sangji University, Wonju, Korea Case report Key Words allergic purpura, henoch-schonlein purpura, jarotang, Kore - an herbal medicine, yin deficiency",Non-OADS,/arxiv_data1/oa_pdf/6e/40/2093-6966-v17-n04-070.PMC4332006.pdf
"http://www.journal.ac071  Journal of Pharmacopuncture 2014;17(4):070-075 Table 1  Characteristics of the patients Outpatients Case 1 Case 2 Case 3 Case 4 Case 5 Gender/Age Male/5 Female/6 Female/11 Male/5 Male/6 Chief complaintpurpura,  arthritis in knee  joint,  edema of left  wrist,  abdominal pain,  facial edemapurpura,  thigh pain,  abdominal pain,  vomitingpurpura,  abdominal pain,  nausea,  lower extremity  and ankle painpurpura,  arthritis in knee  joint,  abdominal painpurpura,  pruritus DiagnosisHenoch- Schonlein PurpuraHenoch- Schonlein PurpuraHenoch- Schonlein PurpuraHenoch- Schonlein PurpuraHenoch- Schonlein Purpura Syndrome  differentiationYin deficiency Yin deficiency Yin deficiency Yin deficiency Yin deficiency OnsetEarly November  2012Early March  2013Late April  2013Early November  2012Late December  2012 Beginning of  treatment2 days after  onsetEarly May 201317 days after  onset3 days after  onset10 days after  onset Region of  purpuraboth lower  extremitiesboth lower  extremitiesboth lower  extremitiesboth lower  extremitiesboth lower  extremities Other symptomsNight sweating  dry throat,  rapid & fine  pulse,  red and dry  tongueDry stool,  mild insomnia  dry throat,  rapid & fine  pulse,  red and dry  tongueAnorexia,  indigestion,  abdominal pain,  nausea,  vexing heat,  epistaxis,  growth retarda - tion, rapid & fine  pulse, red and dry  tongueNight sweating,  speaking retarda - tion,  rapid & fine  pulse,  red and dry  tongueVexing heat in the  chest,  palms and soles,  night sweating,  epistaxis,  rapid & fine  pulse,  red and dry  tongue Disease before  onsetBronchitis &  colitisCommon cold Common cold Common cold Common cold Past history NoneAtopic dermatitis, rhinitis, stomati - tis, pneumoniaAtopic dermatitis,  rhinitisFebrile seizure (4 times)None Family history  None None None None None Treatment period 88 days 75 days 92 days 131 days 105 days Western medica - tion for purpuraNone None None None None Other Western  medicationsNone None None None None Laboratory testProteinuria &  hematouriaNormal Normal Normal Normal Adverse reactions None None None None None Dosage of  Jarotang  administered3.5 times adult  dosage per day  → 45 pouches of  60 mL5 times adult  dosage per day  → 45 pouches of  80 mL5.5 times adult  dosage per day  → 45 pouches of  90 mL3.5 times adult  dosage per day  → 45 pouches of  60 mL3.5 times adult  dosage per day  → 45 pouches of  60 mL",Non-OADS,/arxiv_data1/oa_pdf/6e/40/2093-6966-v17-n04-070.PMC4332006.pdf
072  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):070-075 Case 1 was treated for bronchitis and gastroenteritis.,Non-OADS,/arxiv_data1/oa_pdf/6e/40/2093-6966-v17-n04-070.PMC4332006.pdf
http://www.journal.ac073  Journal of Pharmacopuncture 2014;17(4):070-075 Table 2  Images before and after treatment  Before treatment After treatment Case 1 Case 2 Case 3 Case 4 (Continued),Non-OADS,/arxiv_data1/oa_pdf/6e/40/2093-6966-v17-n04-070.PMC4332006.pdf
"074  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):070-075 Blood heat ( 血熱 ), Yin deficiency ( 陰虚 ), and Qi deficiency  (氣虚 ) [11, 12].",Non-OADS,/arxiv_data1/oa_pdf/6e/40/2093-6966-v17-n04-070.PMC4332006.pdf
"http://www.journal.ac075  Journal of Pharmacopuncture 2014;17(4):070-075 search Fund, 2014.",Non-OADS,/arxiv_data1/oa_pdf/6e/40/2093-6966-v17-n04-070.PMC4332006.pdf
"Thus, ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[4]:055-060 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.037    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/65/2093-6966-v17-n04-055.PMC4332007.pdf
"Tel: +82-63-270-1073  Fax: +82-63-270-1533 E-mail: jcjoo@wku.ac.kr ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.acReceived:  Sep 01, 2014     Accepted:  Oct 17, 2014Clinical Study on Constitutional Herbal Tea for Treating  Chronic Fatigue Soo-Jung Park1, Young-Chun Bae2, Na-Rae Choi2, Seung-Yeob Ryu2, Young-Mi  Kwon3, Jong-Cheon Joo1, 2* 1  Department of Sasang Constitutional Medicine, Wonkwang University Jeonju Korean Medicine Hospital, Jeonju, Korea 2    Department of Sasang Constitutional Medicine, Wonkwang University College of Korean Medicine, Iksan, Korea 3    Department of Radiology, Wonkwang University College of Korean Medicine, Iksan, Korea Original article Key Words chalder fatigue scale, herbal tea, Sasang constitutional medi - cine, visual analogue scale",Non-OADS,/arxiv_data1/oa_pdf/88/65/2093-6966-v17-n04-055.PMC4332007.pdf
"056  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):055-060 various techniques, the visual analogue scale (VAS), the  numeric rating scale (NRS), the fatigue severity scale (FSS)  and the Chalder fatigue scale (CFS), are used for diagnos - ing fatigue [4-6].",Non-OADS,/arxiv_data1/oa_pdf/88/65/2093-6966-v17-n04-055.PMC4332007.pdf
http://www.journal.ac057  Journal of Pharmacopuncture 2014;17(4):055-060 month.,Non-OADS,/arxiv_data1/oa_pdf/88/65/2093-6966-v17-n04-055.PMC4332007.pdf
058  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):055-060 three constitutions were not significant ( P = 0.948) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/88/65/2093-6966-v17-n04-055.PMC4332007.pdf
"http://www.journal.ac059  Journal of Pharmacopuncture 2014;17(4):055-060 Soyangin (n = 20)Taeeumin (n = 20)Soeumin (n = 25)Total (n = 65)P-value   within  subjectsP-value  between  constitutions  BUN (mg/dL)Week 0 14.84 ± 4.01 14.85 ± 3.77 13.80 ± 3.84 14.52 ± 3.840.071 0.763Week 8 14.03 ± 3.43 14.42 ± 2.43 12.57 ± 2.66 13.73 ± 2.90 Creatinine (mg/dL)Week 0 1.03 ± 0.12 0.98 ± 0.19 1.00 ± 0.16 1.00 ± 0.160.036 0.458Week 8 1.01 ± 0.14 0.97 ± 0.21 0.97 ± 0.15 0.98 ± 0.17 AST (IU/L)Week 0 25.15 ± 5.59 23.55 ± 5.38 22.16 ± 5.03 23.51 ± 5.380.172 0.001Week 8 22.30 ± 6.26 21.30 ± 4.33 24.72 ± 5.06 22.92 ± 5.39 ALT (IU/L)Week 0 25.35 ± 11.57 23.85 ± 7.70 19.72 ± 5.81 22.72 ± 8.720.650 0.150Week 8 23.30 ± 9.60 22.95 ± 9.64 21.52 ± 7.62 22.51 ± 8.80 ALP (IU/L)Week 0 69.50 ± 17.87 65.00 ± 21.35 63.48 ± 14.21 65.80 ± 17.680.276 0.707Week 8 71.30 ± 15.79 64.90 ± 19.07 65.48 ± 19.43 67.09 ± 18.21Table 3  Changes in blood tests to evaluate safety according to Sasang constitution  All values are given as means ± standard deviation; n, number; BUN, blood urea nitrogen; AST, aspartate aminotransferase; ALT, alanine  aminotransferase; ALP , alkaline phosphatase.",Non-OADS,/arxiv_data1/oa_pdf/88/65/2093-6966-v17-n04-055.PMC4332007.pdf
"060  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):055-060 Kim CH, Shin HC, Won CW.",Non-OADS,/arxiv_data1/oa_pdf/88/65/2093-6966-v17-n04-055.PMC4332007.pdf
Available from:  http://scat.kiom.re.kr/#.,Non-OADS,/arxiv_data1/oa_pdf/88/65/2093-6966-v17-n04-055.PMC4332007.pdf
"Cervical pain in Western medicine is associated with  a ruptured cervical disk, cervical spine osteoarthritis,  cervical spondylosis, a spinal cord tumor, Torticollis,  damage to the cervical muscle and tendon, a cervi - cal sprain, neurogenic muscle tone on a cervical area,  Review articleISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[4]:007-014 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.031    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/73/f3/2093-6966-v17-n04-007.PMC4332008.pdf
"Tel: +82-63-220-8625  Fax: +82-63-220-8400 E-mail: nasiss@naver.com ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.acDepartment of Acupuncture & Moxibustion Medicine, Woosuk University Hospital of Korean Medicine, Jeonju, Korea Received:  Aug 20, 2014     Accepted:  Sep 17, 2014",Non-OADS,/arxiv_data1/oa_pdf/73/f3/2093-6966-v17-n04-007.PMC4332008.pdf
008  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):007-014 etc.,Non-OADS,/arxiv_data1/oa_pdf/73/f3/2093-6966-v17-n04-007.PMC4332008.pdf
"http://www.journal.ac009  Journal of Pharmacopuncture 2014;17(4):007-014 NThe lead  authorTitle of Study (translation from Korean)PharmacopuncturePublished year 5Seol H [32]Effects of jungsongouhyul herbal acupuncture (JSO) mul - ti-treatment for whiplash injury caused by a traffic accidentJungsongouhyul 2005 6Kim KT [22]A randomized controlled double-blinded study of bee venom  acupuncture therapy for a sprain of the C-spineBee venom 2005 7Kim KH [30]Clinical study on the effect of acupuncture and bee venom  acupuncture for patients with chronic whiplash injuryBee venom 2005 8Gang J [26]Case report on stenosis and herniation of the nucleus pulposus  treated with bee venom acupuncture therapyBee venom 2006 9Lee GM [36]Clinical study of carthami-flos herbal acupuncture treatment  for cervical disc herniation patientsCarthami-flos 2006 10Yoon IJ [31]Effect of jungsongouhyul herbal acupuncture therapy for neck  pain patientsJungsongouhyul 2006 11An BJ [21]Effect of bee venom acupuncture therapy for patients with  cervical spondylosisBee venom 2007 12 Song BY [25]A clinical study on the effects of sweet bee venom herbal acu - puncture for patients with whiplash injuryBee venom 2007 13Jang SY [20]Clinical study of herbal acupuncture for neck pain caused by  whiplash injuryCarthami-flos seeds &  Juglandis semen2007 14 Gwon HY [16]Clinical study on a case of cervical myelopathy with additional  scolopendrae corpus pharmacopunctureScolopendrae 2007 15 Shin HY [15]Clinical observation of improvement made by bee venom  therapy at cervical hyeopcheokhyeol for a case of upper limb  disability caused by cervical disc herniationsBee venom 2009 16Park JY [35]Clinical effects of carthami-flos pharmacopuncture on posteri - or neck pain of menopausal womenCarthami-flos 2010 17 Woo JH [19]Clinical study comparing the effects of chuna treatment and  ouhyul herbal acupuncture for patients with cervical pain  caused by traffic accidentsOuhyul 2011 18 Lim JK [33]Effects of acupuncture therapy in combination with soyeom  pharmacopuncture therapy for acute whiplash injuries caused  by traffic accidentsSoyeom 2011 19 Lee SJ [29]Facet joint bee venom acupuncture for 10 patients with whip - lash injuriesBee venom 2011 20Gang JH [23]Retrospective comparative study of bee venom pharmacop - uncture therapy in patients with a cervical herniated interver - tebral discBee venom 2011 21 Lim KM [34]Effects of soyeom and jungsongouhyul pharmacopuncture on  whiplash injuries caused by traffic accidentsJungsongouhyul 2012 22 Lee JS [18]Comparative study on the effect of pharmacopuncture treat - ment, chuna treatment, pharmacopuncture -chuna combined  treatment for neck pain caused by traffic accidentsJungsongouhyul 2012 23 Lee JH [17]Comparative study on the effect of pharmacopuncture treat - ment and chuna treatment for neck pain caused by traffic  accidentsHwangryunhaedok - tang2012 24Kim TH [13](A) retrospective study on the effects of shinbaro pharmacop - uncture and jungsongouhyul pharmacopuncture on whiplash  injuries caused by traffic accidentsShinbaro & Jungson - gouhyul2013 25Park SH [12]Comparative study on the effect of bee venom pharmacopunc - ture treatment and hwangryun pharmacopuncture treatment  of cervical disc herniationBee venom & Hwan - gryun2013",Non-OADS,/arxiv_data1/oa_pdf/73/f3/2093-6966-v17-n04-007.PMC4332008.pdf
"010  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):007-014 an Acupuncture & Moxibustion Society, 3 came from the  Journal of the Pharmacopuncture Institute, and 3 came  from the Journal of the Korean Academy of Oriental Reha - bilitation Medicine.",Non-OADS,/arxiv_data1/oa_pdf/73/f3/2093-6966-v17-n04-007.PMC4332008.pdf
"http://www.journal.ac011  Journal of Pharmacopuncture 2014;17(4):007-014 sponse-to-treatment time was 12.3 days while in the acu - puncture group, it was 15.6 days.",Non-OADS,/arxiv_data1/oa_pdf/73/f3/2093-6966-v17-n04-007.PMC4332008.pdf
012  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):007-014 with Bee venom pharmacopuncture showed a better re - sult than the group that received only the Bee venom  pharmacopuncture.,Non-OADS,/arxiv_data1/oa_pdf/73/f3/2093-6966-v17-n04-007.PMC4332008.pdf
"http://www.journal.ac013  Journal of Pharmacopuncture 2014;17(4):007-014 macopunctures used for cervical pain were Bee venom  pharmacopuncture, Carthami-flos pharmacopuncture,  Scolopendra pharmacopuncture, Ouhyul pharmacopunc - turen, Hwangryun pharmacopuncture, Corpus pharma - copuncture, Soyeom pharmacopuncture, Hwangryunhae - doktang pharmacopuncture, Shinbaro phamacopuncture.",Non-OADS,/arxiv_data1/oa_pdf/73/f3/2093-6966-v17-n04-007.PMC4332008.pdf
"014  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):007-014 Park GB, Shin KH, Song GH, Jo JH.",Non-OADS,/arxiv_data1/oa_pdf/73/f3/2093-6966-v17-n04-007.PMC4332008.pdf
"Pharmacopuncture  has been used and studied widely in Korea since the  Review articleISSN 2093-6966 [Print], ISSN 2234-6856 [Online] Journal of Pharmacopuncture 2014;17[4]:015-021 DOI:   http://dx.doi.org/10.3831/KPI.2014.17.032    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)which permits unrestricted noncommercial use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/19/2093-6966-v17-n04-015.PMC4332009.pdf
"Department of Acupuncture & Moxibustion Medicine, Sangji University College of Korean Medicine, 283, Woosan, Wonju, Gangwon 220-955, Korea.Tel: +82-33-741-9257  Fax: +82-33-732-2124E-mail: redphilips@hanmail.net ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.ac Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Sangji University, Wonju, Korea Received: Aug 27, 2014    Accepted: Sep 04, 2014",Non-OADS,/arxiv_data1/oa_pdf/9c/19/2093-6966-v17-n04-015.PMC4332009.pdf
"016  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):015-021 fundamental principle of pharmacopuncture, which ad- ministers a specific herbal medicine at a specific point,  was introduced in 1967 by Nam [2] because pharmacop- uncture can be used to treat various diseases, depending  on to the characteristics of the components of the herbal  medicine and the method used to manufacture the phar - macopuncture [2, 3].",Non-OADS,/arxiv_data1/oa_pdf/9c/19/2093-6966-v17-n04-015.PMC4332009.pdf
http://www.journal.ac017  Journal of Pharmacopuncture 2014;17(4):015-021 457 papers.,Non-OADS,/arxiv_data1/oa_pdf/9c/19/2093-6966-v17-n04-015.PMC4332009.pdf
"018  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):015-021 Table 1 Types of pharmacopuncture in experimental and clinical studies Pharmacopuncture Experimental % Clinical % Total %  Bee venom 58 21.2 66 28.0 124 24.4  Placenta 8 2.9 17 7.2 25 4.9  Sweet bee vemon 0 0.0 24 10.2 24 4.7  Mountain-ginseng 3 1.1 21 8.9 24 4.7  Anti-inflammatory 7 2.6 16 6.8 23 4.5  Cornu Cervi Parvum 12 4.4 5 2.1 17 3.3  Hwangyeonhaedoktang 4 1.5 13 5.5 17 3.3  Neutral-natured blood stasis 6 2.2 9 3.8 15 2.9  Fel Ursi, Bovis Calculus & Moschus 7 2.6 7 3.0 14 2.8  Scolopendra 4 1.5 7 3.0 11 2.2  Carthami Semen 2 0.7 9 3.8 11 2.2  Fel Ursi-Bovis Calculus 5 1.8 2 0.8 7 1.4  Juglandis Semen 3 1.1 3 1.3 6 1.2  Moxi-Tar 5 1.8 0 0.0 5 1.0  Thread embedding 0 0.0 5 2.1 5 1.0  Rehmanniae Radix 3 1.1 2 0.8 5 1.0  Shinbaro 0 0.0 5 2.1 5 1.0  Ulmus Davidiana Planchon 4 1.5 1 0.4 5 1.0  Astragali Radix 2 0.7 3 1.3 5 1.0  Glycyrrhiza Uralensis 3 1.1 0 0.0 3 0.6  Angelica Gigantis 3 1.1 0 0.0 3 0.6  Ganoderma lucidum 3 1.1 0 0.0 3 0.6  Aconiti ciliare tuber 3 1.1 0 0.0 3 0.6  Cinnamomi Ramulus 2 0.7 0 0.0 2 0.4  Persicae Semen 1 0.4 1 0.4 2 0.4  Ephedrae Herba 2 0.7 0 0.0 2 0.4  Mahuang-Chuanwu 1 0.4 1 0.4 2 0.4  Bacillus-Fermented Scutellariae Radix 2 0.7 0 0.0 2 0.4  Sayeoksanhap-Peongweisan-Gamibang 2 0.7 0 0.0 2 0.4  Crataegi Fructus 2 0.7 0 0.0 2 0.4  Zizyphi Spinosi Semen − − 2 0.8 2 0.4  Pinus Densiflora Gnarl 2 0.7 0 0.0 2 0.4  Artemisiae argyi 2 0.7 0 0.0 2 0.4  Yongdamsagan-tang 2 0.7 0 0.0 2 0.4  Bovis Calculus 2 0.7 0 0.0 2 0.4  Clematidis Radix 2 0.7 0 0.0 2 0.4  Cinnamomum Cassia 2 0.7 0 0.0 2 0.4  Artemisiae Capillaris Herba 2 0.7 0 0.0 2 0.4  Rhizoma Atractylodis 2 0.7 0 0.0 2 0.4  Cnidii Rhizoma 2 0.7 0 0.0 2 0.4  Gastrodiae Elata 2 0.7 0 0.0 2 0.4  Harpagophytum Radix 0 0.0 2 0.8 2 0.4  (Continued)",Non-OADS,/arxiv_data1/oa_pdf/9c/19/2093-6966-v17-n04-015.PMC4332009.pdf
http://www.journal.ac019  Journal of Pharmacopuncture 2014;17(4):015-021 Pharmacopuncture Experimental % Clinical % Total %  Paljeong-San 2 0.7 0 0.0 2 0.4  Carthami-Flos 2 0.7 0 0.0 2 0.4  Carthami Semen & Cornu Cervi Parvum (HN) 0 0.0 2 0.8 2 0.4  Total 262 100.0 195 100.0 509 100.0  Table 2 Diseases and topics on pharmacopuncture in experimental and clinical studies Diseases Experimental % Clinical % Total % Musculoskeletal diseases 55 21.0 80 41.0 135 30.0  Rheumatoid arthritis 34 13.0 − − − − Osteoporosis 12 4.6 − − − − Osteoarthritis 6 2.3 − − − − Low back pain − − 23 11.8 − − Nuchal pain − − 15 7.7 − − Shoulder pain − − 14 7.2 − − Knee pain − − 11 5.6 − − Others 3 1.2 17 8.7 − − Nervous system diseases 28 10.7 46 23.6 74 15.8  Anti-cancer effect 16 6.1 12 6.2 28 6.1  Obestiy 19 7.3 2 1.0 21 4.6  Digestive disease 17 6.5 3 1.5 20 4.4  Toxicity test 19 7.3 1 0.5 20 4.4  Urinary disease 14 5.3 5 2.6 19 4.2  Circulatory disease 18 6.9 1 0.5 19 4.2  Skin disease 9 3.4 9 4.6 18 3.9  Anti-inflammatory effect 16 6.1 0 0.0 16 3.5  Autonomic nerve function 0 0.0 15 7.7 15 3.3  Antioxidant 12 4.6 0 0.0 12 2.6  Anti-allergic effect 10 3.8 0 0.0 10 2.2  Others 29 11.1 21 10.8 50 10.9  Total 262 100.0 195 100.0 457 100.0  Table 3 Research types on clinical studies Research types No.,Non-OADS,/arxiv_data1/oa_pdf/9c/19/2093-6966-v17-n04-015.PMC4332009.pdf
"020  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):015-021 Table 4 Journals publish in pharmacopuncture studies in Korea from 2007 to 2013 Journals Experimental % Clinical % Total % The Journal of Korean Acupuncture & Moxi- bustion Medicine Society85 32.4 61 31.3 146 31.9  Journal of Pharmacopuncture 47 17.9 55 28.2 102 22.3  Korean Journal of Acupuncture 54 20.6 3 1.5 57 12.5  Journal of Oriental Rehabilitation Medicine 19 7.3 10 5.1 29 6.3  Journal of Acupuncture and Meridian Studies2 0.8 9 4.6 11 2.4  The Journal of Daejeon Oriental Medicine 1 0.4 9 4.6 10 2.2  Korean Journal of Oriental Physiology & Pathology7 2.7 3 1.5 10 2.2  The Journal of Korean Oriental Internal Medicine5 1.9 2 1.0 7 1.5  Journal of Korea Immuno-Yakchim Society 4 1.5 3 1.5 7 1.5  The Journal of Korea CHUNA Manual Medi- cine for spine & nerves0 0.0 7 3.6 7 1.5  Korean Journal of Apiculture 6 2.3 0 0.0 6 1.3  Journal of Veterinary Clinics 3 1.1 3 1.5 6 1.3  The Korean Journal of Sports Medicine 0 0.0 5 2.6 5 1.1  Korean Journal of Pharmacognosy 5 1.9 0 0.0 5 1.1  Journal of Oriental Neuropsychiatry 3 1.1 1 0.5 4 0.9  Korean Journal of Veterinary Service 4 1.5 0 0.0 4 0.9  Journal of Life Science 3 1.1 0 0.0 3 0.7  The Journal of Korean Oriental Medical  Ophthalmology and Otolaryngology and  Dermatology1 0.4 2 1.0 3 0.7  The Association of the Spine&Joint Korean  Medicine0 0.0 3 1.5 3 0.7  The Journal of Korean Oriental Medicine 1 0.4 2 1.0 3 0.7  The Korea Journal of Herbology 2 0.8 0 0.0 2 0.4  The Journal of Oriental Obstetrics and Gynecology0 0.0 2 1.0 2 0.4  Yakhak hoeji 2 0.8 0 0.0 2 0.4  The Journal of East-West Medicine 0 0.0 2 1.0 2 0.4  Others 8 3.1 13 6.7 21 4.6 Total 262 100.0 195 100.0 457 100.0  bution, metabolism, and excretion of pharmacopuncture.",Non-OADS,/arxiv_data1/oa_pdf/9c/19/2093-6966-v17-n04-015.PMC4332009.pdf
http://www.journal.ac021 5.,Non-OADS,/arxiv_data1/oa_pdf/9c/19/2093-6966-v17-n04-015.PMC4332009.pdf
"Digital infrared thermographic imaging (DITI) is an  examination that screens any existing disorders and  any improvements or deteriorations of symptoms in  Original articleISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[4]:050-054 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.036    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/9a/2093-6966-v17-n04-050.PMC4332010.pdf
"Tel: +82-33-741-9257  Fax: +82- 33-732-2124 E-mail: redphilips@hanmail.net ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.ac1  Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Sangji University, Wonju, Korea 2    Department of Meridian, College of Korean Medicine, Sangji University, Wonju, Korea Received:  Sep 11, 2014     Accepted:  Oct 01, 2014",Non-OADS,/arxiv_data1/oa_pdf/ed/9a/2093-6966-v17-n04-050.PMC4332010.pdf
http://www.journal.ac051 the body through computer imaging that detects traces  of infrared light on the surface of the skin on the human  body [3].,Non-OADS,/arxiv_data1/oa_pdf/ed/9a/2093-6966-v17-n04-050.PMC4332010.pdf
052  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):050-054 confidence intervals.,Non-OADS,/arxiv_data1/oa_pdf/ed/9a/2093-6966-v17-n04-050.PMC4332010.pdf
http://www.journal.ac053 knee.,Non-OADS,/arxiv_data1/oa_pdf/ed/9a/2093-6966-v17-n04-050.PMC4332010.pdf
054  http://www.journal.ac Journal of Pharmacopuncture 2014;17(4):050-054 The Acupuncture and Moxibustion Textbook Compi - lation Committee.,Non-OADS,/arxiv_data1/oa_pdf/ed/9a/2093-6966-v17-n04-050.PMC4332010.pdf
"Among these diseases, the gastric ulcer is  defined as a disturbance of the integrity of the gastric  Original article Received:  Jul 07, 2013     Accepted:  Jul 17, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[3]:040-049 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.025    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/5e/2093-6966-v17-n03-040.PMC4332011.pdf
"Tel: +82-51-850-8935  Fax: +82-51-867-5162 E-mail: 3rdmed@hanmail.net ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.ac1Department of Acupuncture & Moxibustion, Dong-Eui University College of Korean Medicine, Busan, Korea 2Department of Internal Medicine, Dong-Eui University College of Korean Medicine, Busan, Korea  3Department of Anatomy, Dong-Eui University College of Korean Medicine, Busan, Korea",Non-OADS,/arxiv_data1/oa_pdf/7f/5e/2093-6966-v17-n03-040.PMC4332011.pdf
http://www.journal.ac041 mucosa that causes a local defect or excavation due to ac - tive inflammation [1].,Non-OADS,/arxiv_data1/oa_pdf/7f/5e/2093-6966-v17-n03-040.PMC4332011.pdf
042 http://www.journal.ac Journal of Pharmacopuncture 2014;17(3):040-049 All values are reported as means ± standard errors (S.Es).,Non-OADS,/arxiv_data1/oa_pdf/7f/5e/2093-6966-v17-n03-040.PMC4332011.pdf
http://www.journal.ac043  Journal of Pharmacopuncture 2014;17(3):040-049 Figure 1  Gross appearance of an EtOH/HCl-induced acute gastric ulcer in a rat.,Non-OADS,/arxiv_data1/oa_pdf/7f/5e/2093-6966-v17-n03-040.PMC4332011.pdf
044  http://www.journal.ac Journal of Pharmacopuncture 2014;17(3):040-049 pharmacopuncture treatment is performed by injecting  small amounts of extracted medicinal materials at acu - points or in affected areas in order to obtain the combined  efficacies of acupuncture and herbs.,Non-OADS,/arxiv_data1/oa_pdf/7f/5e/2093-6966-v17-n03-040.PMC4332011.pdf
"http://www.journal.ac045  Journal of Pharmacopuncture 2014;17(3):040-049 are mediated by the generation of free radicals, we hypoth - esized that GLP might inhibit ethanol-induced gastric mu - cosal lesions through a protective effect that might directly  involve its antioxidant property.",Non-OADS,/arxiv_data1/oa_pdf/7f/5e/2093-6966-v17-n03-040.PMC4332011.pdf
046  http://www.journal.ac Journal of Pharmacopuncture 2014;17(3):040-049 Figure 6  Immunohistochemical staining of Bcl-2 proteins in EtOH/HCl-induced acute gastric ulcers in rats.,Non-OADS,/arxiv_data1/oa_pdf/7f/5e/2093-6966-v17-n03-040.PMC4332011.pdf
http://www.journal.ac047  Journal of Pharmacopuncture 2014;17(3):040-049 Figure 8  Immunohistochemical staining of TGF- β1 proteins in EtOH/HCl-induced acute gastric ulcers in rats.,Non-OADS,/arxiv_data1/oa_pdf/7f/5e/2093-6966-v17-n03-040.PMC4332011.pdf
"048  http://www.journal.ac Journal of Pharmacopuncture 2014;17(3):040-049 Arakawa T, Watanabe T, Tanigawa T, Tominaga K, Fu - jiwara Y, Morimoto K. Quality of ulcer healing in gas - trointestinal tract: its pathophysiology and clinical rel - evance.",OADS,/arxiv_data1/oa_pdf/7f/5e/2093-6966-v17-n03-040.PMC4332011.pdf
http://www.journal.ac049 71.,Non-OADS,/arxiv_data1/oa_pdf/7f/5e/2093-6966-v17-n03-040.PMC4332011.pdf
"Despite the availability of modern medicine  Original article Received:  Aug 18, 2014     Accepted:  Aug 27, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[3]:007-015 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.021    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/bb/2093-6966-v17-n03-007.PMC4332012.pdf
"Tel: +0091-9433098372  Fax: +0091-33- 2837-1078 E-mail: subhashmandal@yahoo.com ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.acPharmacognosy and Phytotherapy Research Laboratory, Division of Pharmacognosy, Department of Pharmaceutical Technology, Jadav - pur University, Kolkata, India",Non-OADS,/arxiv_data1/oa_pdf/da/bb/2093-6966-v17-n03-007.PMC4332012.pdf
"008  http://www.journal.ac Journal of Pharmacopuncture 2014;17(3):007-015 throughout all countries, herbal medicines have often re - mained popular for historical and cultural reasons.",Non-OADS,/arxiv_data1/oa_pdf/da/bb/2093-6966-v17-n03-007.PMC4332012.pdf
http://www.journal.ac009 All the treatments were administered by force-feeding.,Non-OADS,/arxiv_data1/oa_pdf/da/bb/2093-6966-v17-n03-007.PMC4332012.pdf
010  http://www.journal.ac Journal of Pharmacopuncture 2014;17(3):007-015 pattern.,Non-OADS,/arxiv_data1/oa_pdf/da/bb/2093-6966-v17-n03-007.PMC4332012.pdf
http://www.journal.ac011  Journal of Pharmacopuncture 2014;17(3):007-015 to the treatment with petroleum ether extract in any of the  analyzed organs.,Non-OADS,/arxiv_data1/oa_pdf/da/bb/2093-6966-v17-n03-007.PMC4332012.pdf
012  http://www.journal.ac Journal of Pharmacopuncture 2014;17(3):007-015 ative rapid way to detect toxic compounds in low amounts  [20].,Non-OADS,/arxiv_data1/oa_pdf/da/bb/2093-6966-v17-n03-007.PMC4332012.pdf
http://www.journal.ac013  Journal of Pharmacopuncture 2014;17(3):007-015 been accepted in practice for a sub-acute oral toxicity  study.,Non-OADS,/arxiv_data1/oa_pdf/da/bb/2093-6966-v17-n03-007.PMC4332012.pdf
"014  http://www.journal.ac Journal of Pharmacopuncture 2014;17(3):007-015 Da Costa JM, Campos AR, Brito SA, Pereira CKB,  Souza EO, Rodrigues FFG.",Non-OADS,/arxiv_data1/oa_pdf/da/bb/2093-6966-v17-n03-007.PMC4332012.pdf
"http://www.journal.ac015  Journal of Pharmacopuncture 2014;17(3):007-015 P , John bastin TMM.",Non-OADS,/arxiv_data1/oa_pdf/da/bb/2093-6966-v17-n03-007.PMC4332012.pdf
"(2000) [3] conducted the only  Original article Received:  Jul 23, 2014     Accepted:  Aug 20, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[3]:025-030 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.023    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/32/43/2093-6966-v17-n03-025.PMC4332013.pdf
"Tel: +82-31-961-9122  Fax: +82-31-961-9009 E-mail: chuckman@dongguk.edu ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.acDepartment of Acupuncture &Moxibustion Medicine, Dongguk University College of Korean Medicine, Goyang, Korea",Non-OADS,/arxiv_data1/oa_pdf/32/43/2093-6966-v17-n03-025.PMC4332013.pdf
026  http://www.journal.ac Journal of Pharmacopuncture 2014;17(3):025-030 study on  Guseonwangdo-go  in Korea.,Non-OADS,/arxiv_data1/oa_pdf/32/43/2093-6966-v17-n03-025.PMC4332013.pdf
"http://www.journal.ac027 The body weights were measured on the day of the injec - tion and on the 3rd, 7th, and 14th day after the injection.",Non-OADS,/arxiv_data1/oa_pdf/32/43/2093-6966-v17-n03-025.PMC4332013.pdf
028  http://www.journal.ac Journal of Pharmacopuncture 2014;17(3):025-030 3.,Non-OADS,/arxiv_data1/oa_pdf/32/43/2093-6966-v17-n03-025.PMC4332013.pdf
http://www.journal.ac029  Journal of Pharmacopuncture 2014;17(3):025-030 ulation tissues were observed around the injection site -  perivascular area of the lateral vein - of one female rat of  G4.,Non-OADS,/arxiv_data1/oa_pdf/32/43/2093-6966-v17-n03-025.PMC4332013.pdf
"030  http://www.journal.ac Journal of Pharmacopuncture 2014;17(3):025-030 Korean Acupuncture & Moxibustion Medicine Society,  Board of Publication.",Non-OADS,/arxiv_data1/oa_pdf/32/43/2093-6966-v17-n03-025.PMC4332013.pdf
Available from: http://www.law.,Non-OADS,/arxiv_data1/oa_pdf/32/43/2093-6966-v17-n03-025.PMC4332013.pdf
Available from: http://www.mfds.,Non-OADS,/arxiv_data1/oa_pdf/32/43/2093-6966-v17-n03-025.PMC4332013.pdf
"While  Case report Received:  Aug 20, 2014     Accepted:  Aug 29, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[3]:062-069 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.028    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/6d/2093-6966-v17-n03-062.PMC4332014.pdf
"East-West Cancer Center, Dunsan Korean Medical Hospital of Daejeon  University, 176-75 Daedukdaero, Seo-gu, Daejeon 302-122, Korea Tel: +82-42-470-9132  Fax: +82-42-470-9006 E-mail: altyhs@dju.kr ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.acEast-West Cancer Center, Dunsan Korean Medical Hospital of Daejeon University, Daejeon, Korea",Non-OADS,/arxiv_data1/oa_pdf/d0/6d/2093-6966-v17-n03-062.PMC4332014.pdf
"http://www.journal.ac063 existing acupuncture treatment incorporates physical  stimulation of associated meridians and acupoints, phar - macopuncture adds the medicinal effect of herbs injected  to the regular effect of acupuncture.",Non-OADS,/arxiv_data1/oa_pdf/d0/6d/2093-6966-v17-n03-062.PMC4332014.pdf
"064  http://www.journal.ac Journal of Pharmacopuncture 2014;17(3):062-069 improved (Table 1, Fig.",Non-OADS,/arxiv_data1/oa_pdf/d0/6d/2093-6966-v17-n03-062.PMC4332014.pdf
"http://www.journal.ac065  Journal of Pharmacopuncture 2014;17(3):062-069 ziness, nausea, vomiting, insomnia, fatigue, diarrhea, and  dyspnea.",Non-OADS,/arxiv_data1/oa_pdf/d0/6d/2093-6966-v17-n03-062.PMC4332014.pdf
"066  http://www.journal.ac Journal of Pharmacopuncture 2014;17(3):062-069 ample, 12/03/2013: at 17:00, 0.5 ample, and 12/11/2013: at  12:00, 0.5 ample.",Non-OADS,/arxiv_data1/oa_pdf/d0/6d/2093-6966-v17-n03-062.PMC4332014.pdf
"http://www.journal.ac067  Journal of Pharmacopuncture 2014;17(3):062-069 treatment, the patient’s condition was improved enough  so that only a 1 mL injection of Diclofenac sodium was  needed to effectively manage his sporadic pain episodes  (Fig.",Non-OADS,/arxiv_data1/oa_pdf/d0/6d/2093-6966-v17-n03-062.PMC4332014.pdf
068  http://www.journal.ac Journal of Pharmacopuncture 2014;17(3):062-069 3.,Non-OADS,/arxiv_data1/oa_pdf/d0/6d/2093-6966-v17-n03-062.PMC4332014.pdf
http://www.journal.ac069 seng pharmacopuncture.,Non-OADS,/arxiv_data1/oa_pdf/d0/6d/2093-6966-v17-n03-062.PMC4332014.pdf
"According to the criteria  for NF1 established by the National Institute of Health,  the diagnosis of NF1 requires the presence of two or  more of the following major criteria [2, 3]:  Case report Received:  Jun 09, 2014     Accepted:  Jul 07, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[3]:074-077 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.030    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2d/19/2093-6966-v17-n03-074.PMC4332015.pdf
"Tel: +82-33-741-9257  FAX: +82-33-732-2124 E-mail: redphilips@hanmail.net ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.ac1 Department of Oriental Medicine, Seil Hospital, Wonju, Korea 2 Ginseng & Venom, Sangji University College of Korean Medicine, Wonju, Korea 3 Department of Acupuncture & Moxibustion Medicine, Sangji University College of Korean Medicine, Wonju, Korea Six or more café-au-lait spots (greater than 0.5 cm  in prepubertal children or greater than 1.5 cm in  postpubertal individuals).",Non-OADS,/arxiv_data1/oa_pdf/2d/19/2093-6966-v17-n03-074.PMC4332015.pdf
http://www.journal.ac075 A plexiform neurofibroma (PNF) is a benign nerve tumor  resulting from aberrant growth of the cells of the nerve  sheath.,Non-OADS,/arxiv_data1/oa_pdf/2d/19/2093-6966-v17-n03-074.PMC4332015.pdf
"076  http://www.journal.ac Journal of Pharmacopuncture 2014;17(3):074-077 She also showed symptoms of general weakness, coldness  of the hands and the feet, and skin rashes.",Non-OADS,/arxiv_data1/oa_pdf/2d/19/2093-6966-v17-n03-074.PMC4332015.pdf
http://www.journal.ac077 observations of this patient are needed in order to confirm  whether SBV and MGP treatment was effective in this case.,Non-OADS,/arxiv_data1/oa_pdf/2d/19/2093-6966-v17-n03-074.PMC4332015.pdf
"Evil Qi, such as  Wind, Cold, Summer Heat, Dampness, Blood, Phlegm,  Review article Received:  Jul 02, 2014     Accepted:  Sep 10, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[3]:057-061 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.027    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e2/97/2093-6966-v17-n03-057.PMC4332016.pdf
"Department of Sasang Constitutional Medicine, Sangji University Korean  Medicine Hospital, 80 Sangjidae-gil, Wonju, Gangwon-do 220-717, Korea Tel: +82-33-741-9203  Fax: +82-33-741-9141 E-mail: hiruok@sangji.ac.kr ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.acDepartment of Sasang Constitutional Medicine, Sangji University College of Korean Medicine, Wonju, Korea",Non-OADS,/arxiv_data1/oa_pdf/e2/97/2093-6966-v17-n03-057.PMC4332016.pdf
Praat software: one example of an objective eval           uation method058 http://www.journal.ac Journal of Pharmacopuncture 2014;17(3):057-061,Non-OADS,/arxiv_data1/oa_pdf/e2/97/2093-6966-v17-n03-057.PMC4332016.pdf
"http://www.journal.ac 059 Journal of Pharmacopuncture 2014;17(3):057-061 The human voice can be evaluated in two ways, one of  which is hearing by the ears and the other is using hard - ware or a software program.",Non-OADS,/arxiv_data1/oa_pdf/e2/97/2093-6966-v17-n03-057.PMC4332016.pdf
"Among those pro - grams, Praat software ( http://www.fon.hum.uva.nl/praat/ download_win.html ), which can analyze and transform  the voice, is free and useful [6].",Non-OADS,/arxiv_data1/oa_pdf/e2/97/2093-6966-v17-n03-057.PMC4332016.pdf
"060 http://www.journal.ac Journal of Pharmacopuncture 2014;17(3):057-061 A patient with a vocal pathology, such as dysarthria, dys - phonia, aphonia, hoarseness, Parkinson’s disease, etc.,  can also be evaluated using the VAS.",Non-OADS,/arxiv_data1/oa_pdf/e2/97/2093-6966-v17-n03-057.PMC4332016.pdf
"http://www.journal.ac061  Journal of Pharmacopuncture 2014;17(3):057-061 high-pitched voice and of the Spleen for a soft voice, reso - nance through the Liver and the Spleen, and the emotion - al effect through the Heart and the Pericardium [9].",Non-OADS,/arxiv_data1/oa_pdf/e2/97/2093-6966-v17-n03-057.PMC4332016.pdf
"Therefore, many patients with SDs tend to seek current  medical intervention for management of their SDs, es - pecially erectile dysfunction (ED), such as medication,  intraurethral suppositories or intracavernosal injec - Case report Received:  Jun 30, 2014     Accepted:  Jul 31, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[3]:070-073 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.029    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1b/27/2093-6966-v17-n03-070.PMC4332018.pdf
"Tel: +82-33-741-9203  Fax: +82-33-741-9141 E-mail: hiruok@sangji.ac.kr ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.ac1 Korean Uzbekistan Friendship Oriental Medicine Hospital, Tashkent, Uzbekistan 2 Department of Sasang Constitutional Medicine, Sangji University College of Korean Medicine, Wonju, Korea",Non-OADS,/arxiv_data1/oa_pdf/1b/27/2093-6966-v17-n03-070.PMC4332018.pdf
"http://www.journal.ac071 tions, implantation of a penile prosthesis, and hormonal  therapy or psychotherapy [6].",Non-OADS,/arxiv_data1/oa_pdf/1b/27/2093-6966-v17-n03-070.PMC4332018.pdf
072  http://www.journal.ac Journal of Pharmacopuncture 2014;17(3):070-073 play an important role in tonifying in cases of emotional  and physical exhaustion.,Non-OADS,/arxiv_data1/oa_pdf/1b/27/2093-6966-v17-n03-070.PMC4332018.pdf
http://www.journal.ac073 observing such features may be helpful.,Non-OADS,/arxiv_data1/oa_pdf/1b/27/2093-6966-v17-n03-070.PMC4332018.pdf
"Heavy consumption of alcohol is well known to be  Original article Received:  Aug 25, 2014     Accepted:  Sep 11, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[3]:016-024 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.022    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/49/2093-6966-v17-n03-016.PMC4332019.pdf
"Department of Acupuncture & Moxibution, College of Korean Med - icine, Dong-Eui University, San 45-1, Yangjung 2-Dong, Busanjin-Gu, Busan 614-710,  Korea Tel: +82-51-850-8613  Fax: +82-51-867-5162 E-mail: kmdkch@deu.ac.kr ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.ac1 Department of Acupuncture & Moxibution, College of Korean Medicine and Research Institute of Korean Medicine, Dong-Eui University,    Busan, Korea 2 Department of Oriental Rehabilitation Medicine, College of Korean Medicine, Dong-Eui University, Busan, Korea",Non-OADS,/arxiv_data1/oa_pdf/06/49/2093-6966-v17-n03-016.PMC4332019.pdf
http://www.journal.ac017 associated with liver damage.,Non-OADS,/arxiv_data1/oa_pdf/06/49/2093-6966-v17-n03-016.PMC4332019.pdf
018  http://www.journal.ac Journal of Pharmacopuncture 2014;17(3):016-024 in Fig.,Non-OADS,/arxiv_data1/oa_pdf/06/49/2093-6966-v17-n03-016.PMC4332019.pdf
http://www.journal.ac019  Journal of Pharmacopuncture 2014;17(3):016-024 Figure 1  Liver sections stained with H&E.,Non-OADS,/arxiv_data1/oa_pdf/06/49/2093-6966-v17-n03-016.PMC4332019.pdf
020  http://www.journal.ac Journal of Pharmacopuncture 2014;17(3):016-024 Figure 2  Effect of Ganoderma lucidum  pharmacopuncture (GLP) on acute EtOH-induced changes in plasma aspartate aminotransferase (AST).,Non-OADS,/arxiv_data1/oa_pdf/06/49/2093-6966-v17-n03-016.PMC4332019.pdf
http://www.journal.ac021  Journal of Pharmacopuncture 2014;17(3):016-024 Figure 4  Total superoxide dismutase (SOD) activities in acute liver injury.,Non-OADS,/arxiv_data1/oa_pdf/06/49/2093-6966-v17-n03-016.PMC4332019.pdf
022  http://www.journal.ac Journal of Pharmacopuncture 2014;17(3):016-024 injury induced by EtOH intoxication (Fig.,Non-OADS,/arxiv_data1/oa_pdf/06/49/2093-6966-v17-n03-016.PMC4332019.pdf
"http://www.journal.ac023  Journal of Pharmacopuncture 2014;17(3):016-024 Gao B, Bataller R. Alcoholic liver disease: pathogen - esis and new therapeutic targets.",Non-OADS,/arxiv_data1/oa_pdf/06/49/2093-6966-v17-n03-016.PMC4332019.pdf
024  http://www.journal.ac Journal of Pharmacopuncture 2014;17(3):016-024 liver injury.,Non-OADS,/arxiv_data1/oa_pdf/06/49/2093-6966-v17-n03-016.PMC4332019.pdf
"Original article Received:  Aug 13, 2014     Accepted:  Aug 22, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2014;17[3]:031-039 DOI:    http://dx.doi.org/10.3831/KPI.2014.17.024    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/a4/2093-6966-v17-n03-031.PMC4332020.pdf
"Tel: +82-63-220-8625  Fax: +82-63-220-8400 E-mail: nasiss@naver.com ⓒ 2014 Korean Pharmacopuncture Institute                      http://www.journal.acDepartment of Acupuncture & Moxibustion Medicine, Woosuk University Hospital of Korean Medicine, Jeonju, Korea",Non-OADS,/arxiv_data1/oa_pdf/4d/a4/2093-6966-v17-n03-031.PMC4332020.pdf
032  http://www.journal.ac Journal of Pharmacopuncture 2014;17(3):031-039 Carthamus tinctorious L.  (Carthami-flos) is an annual  safflower belonging to the family Compositae.,Non-OADS,/arxiv_data1/oa_pdf/4d/a4/2093-6966-v17-n03-031.PMC4332020.pdf
http://www.journal.ac033 the tail vein.,Non-OADS,/arxiv_data1/oa_pdf/4d/a4/2093-6966-v17-n03-031.PMC4332020.pdf
034  http://www.journal.ac Journal of Pharmacopuncture 2014;17(3):031-039 Table 4  Mean body weights 0 3 7 14 0~14Group G1 G2 G3 G40 0.125 0.25 0.5Male Female Male Female Male Female Male FemaleMean S.D.,Non-OADS,/arxiv_data1/oa_pdf/4d/a4/2093-6966-v17-n03-031.PMC4332020.pdf
"http://www.journal.ac035  Journal of Pharmacopuncture 2014;17(3):031-039 Significantly different from control by Dunnett’s t-test: * P < 0.01; S.D., standard deviation; N, number of animals; RBC, red blood cell;  HGB, hemoglobin; HCT, hematocrit; MCV , mean corpuscular cell volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpus - cular cell hemoglobin concentration; WBC, white blood cell; PLT, platelet; PT, prothrombin time; APTT, active partial thromboplastin  time; NEU, neutrophils; LYM, lymphocytes; MONO, monocytes; EOS, Eosinophils; BASO, basophils; Reti, reticulocytes.",Non-OADS,/arxiv_data1/oa_pdf/4d/a4/2093-6966-v17-n03-031.PMC4332020.pdf
"036  http://www.journal.ac Journal of Pharmacopuncture 2014;17(3):031-039 Significantly different from control by Dunnett’s t-test: * P < 0.05, †P < 0.01; S.D., standard deviation; N, number of animals; ALT, alanine  aminotransferase; AST, aspartate aminotransferase; GGT, gamma glutamyltranspeptidase; ALP , alkaline phosphatase; Glu, glucose;  BUN, blood urea nitrogen; Crea, creatinine; T-Bili, total bilirubin; T-Chol, total cholesterol; TG, triglycerides; TP , total protein; Alb, al - bumin.Group SexDose of  WCF (mL)TG (mg/dL)TP (g/dL)Alb (g/dL)A/G  ratioP (mg/dL)Ca (mg/dL)Na (mmol/L)K (mmol/L)Cl (mmol/L) 0 0.125 0.25 0.5M F M F M F M FMean S.D.",Non-OADS,/arxiv_data1/oa_pdf/4d/a4/2093-6966-v17-n03-031.PMC4332020.pdf
http://www.journal.ac037  Journal of Pharmacopuncture 2014;17(3):031-039 Table 7  Necropsy findings Table 8  Histopathological findings External surface and all organs in the body cavity were unremark - able.,Non-OADS,/arxiv_data1/oa_pdf/4d/a4/2093-6966-v17-n03-031.PMC4332020.pdf
Conflict of interest The authors declare that there are no conflict of interest.References  http://www.journal.ac Journal of Pharmacopuncture 2014;17(3):031-039  Korean Pharmacopuncture Institute.,Non-OADS,/arxiv_data1/oa_pdf/4d/a4/2093-6966-v17-n03-031.PMC4332020.pdf
http://www.journal.ac039 solution into chung-wan (CV12)].,OADS,/arxiv_data1/oa_pdf/4d/a4/2093-6966-v17-n03-031.PMC4332020.pdf
Website  http://www.teses.usp.br/teses/disponiveis/41/41134/tde-09092013-112458/  [accessed 1 September 2014].,Non-OADS,/arxiv_data1/oa_pdf/fc/54/apps.1400087.PMC4332141.pdf
The source code  is available at  https://github.com/gburleigh/MatrixConverter/ .,OADS,/arxiv_data1/oa_pdf/8e/0f/apps.1400088.PMC4332142.pdf
"A platform-independent binary executable, as well as sample data sets and a user’s manual, are also available at  https://github.com/gburleigh/MatrixConverter/tree/master/distribution .",OADS,/arxiv_data1/oa_pdf/8e/0f/apps.1400088.PMC4332142.pdf
"  Methods and Results:   MatrixConverter is an open source program written in Java; a platform-independent binary executable,  as well as sample data sets and a user’s manual, are available at   https://github.com/gburleigh/MatrixConverter/tree/master/distribution.",OADS,/arxiv_data1/oa_pdf/8e/0f/apps.1400088.PMC4332142.pdf
"The original cycad phenomic character set, the input for Matrix-Converter, was obtained by parsing the taxonomic descriptions available at the cycad pages ( http://plantnet.rbgsyd.nsw.gov.au/PlantNet/cycad/ ) with CharaParser beta version 0.1 ( Cui, 2012 ).",OADS,/arxiv_data1/oa_pdf/8e/0f/apps.1400088.PMC4332142.pdf
Such a character data set can be gen-erated using the “Text Capture” and “Matrix Generation” features on the ETC website (Explorer of Taxonomic Concepts;  http://etc.cs.umb.edu/etcsite/ ).,OADS,/arxiv_data1/oa_pdf/8e/0f/apps.1400088.PMC4332142.pdf
Website  http://macclade.org  [accessed 20 January 2015].,Non-OADS,/arxiv_data1/oa_pdf/8e/0f/apps.1400088.PMC4332142.pdf
Website  http://mesquiteproject.org  [accessed 20 January 2015].,Non-OADS,/arxiv_data1/oa_pdf/8e/0f/apps.1400088.PMC4332142.pdf
Website  http://www.R-project.org  [accessed 20 January 2015].,Non-OADS,/arxiv_data1/oa_pdf/8e/0f/apps.1400088.PMC4332142.pdf
"PCR products for 81 DNA samples from two varieties were electrophoresed on an ABI PRISM 3100 Genetic Analyzer (Applied Biosystems) and Geneious 7.0.4 software (Biomatters Ltd., Auckland, New Zealand; http://www.geneious.com/) was used to assess the fragment sizes.",OADS,/arxiv_data1/oa_pdf/b8/51/apps.1400101.PMC4332144.pdf
"Sequence data were trimmed of adapters and low-quality sequences (q < 10) using cutadapt ( http://code.google.com/p/cutadapt/; Martin, 2011 ), and the Perl script resyncMates.pl ( https://github.com/perc yfal/ratatosk.ext.scilife/ blob/master/scripts/resyncMates.pl ) was used to maintain proper read pairing where one of a pair was removed by cutadapt.",OADS,/arxiv_data1/oa_pdf/5f/10/apps.1400111.PMC4332146.pdf
"Putative functions of transcripts were assigned based on  comparisons to transcripts derived from the common bean ( Phaseolus vulgaris    L.) genome sequencing project ( Schmutz et al., 2014 ;  http://www.phytozome.net/commonbean.php ) with BLASTn and an  E -value cut-off of e-30.",OADS,/arxiv_data1/oa_pdf/5f/10/apps.1400111.PMC4332146.pdf
"SSRs were  identiﬁ  ed in the transcriptomes by running misa.pl (http://pgrc.ipk-gatersleben .de/misa/) with the minimum number of repeats set at 8, 6, and 4 for dinucleo-tides, trinucleotides, and tetranucleotides, respectively.",OADS,/arxiv_data1/oa_pdf/5f/10/apps.1400111.PMC4332146.pdf
"For 12 such loci (picked at random, except for avoiding short loci, <300 bp), the sequences were aligned using Clustal Omega ( Sievers and Hig-gins, 2014 ) and checked for presences of introns by comparison to the bean genome ( Schmutz et al., 2014 ; http://www.phytozome.net/commonbean.php); degenerate primers were then designed to ﬂ  ank the introns using Primaclade  ( Gadberry et al., 2005 ;  Table 2 )  .",OADS,/arxiv_data1/oa_pdf/5f/10/apps.1400111.PMC4332146.pdf
Between 7.9 and 16.6 million paired-end 100-bp reads were generated  for each of the bean samples (reads have been deposited in the National Center for Biotechnology Information [NCBI] Sequence Read Archive [http://www.ncbi.nlm.nih.gov/sra] under BioProject ID PRJNA273585).,OADS,/arxiv_data1/oa_pdf/5f/10/apps.1400111.PMC4332146.pdf
"The FASTA-formatted transcriptome se-quences are available from the Dryad   Digital Repository (http://dx.doi.org/10.5061/dryad.k9h76;  Chapman, 2015 ).",OADS,/arxiv_data1/oa_pdf/5f/10/apps.1400111.PMC4332146.pdf
"http://dx.doi.org/10.5061/dryad.k9h76       C HAPMAN    ,    M. A.   ,    J.-C.     C HANG    ,     D .",OADS,/arxiv_data1/oa_pdf/5f/10/apps.1400111.PMC4332146.pdf
Website  http://www.n2africa.org/sites/n2africa.org/ﬁ  les/images/images/ N2Africa_Nutritional%20beneﬁ  ts%20of%20legume%20consumption% 20at%20household%20level%20in%20rural%20areas%20of%20sub-Saharan%20Africa.pdf  [accessed 26 January 2015].,Non-OADS,/arxiv_data1/oa_pdf/5f/10/apps.1400111.PMC4332146.pdf
Website  http://www.mobot.org/MOBOT/research/APweb  [accessed 26 January 2015].,Non-OADS,/arxiv_data1/oa_pdf/5f/10/apps.1400111.PMC4332146.pdf
"DNA sequences were visualized with Geneious 6.1 software (Biomatters Ltd., Auckland, New Zealand; http://www.geneious.com/) to ensure quality sequences and were examined for microsatellite re-gions using the online Tandem Repeats Finder ( Benson, 1999 ).",OADS,/arxiv_data1/oa_pdf/0e/93/apps.1400119.PMC4332147.pdf
Free com-puter program and documentation distributed by author at  http://hydrodictyon.eeb.uconn.edu/people/plewis/software  [accessed 20 December 2013].,OADS,/arxiv_data1/oa_pdf/0e/93/apps.1400119.PMC4332147.pdf
Website  http://plants.usda.gov  [accessed 14 January 2015].,OADS,/arxiv_data1/oa_pdf/0e/93/apps.1400119.PMC4332147.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/jnnp-2012-304131).,Non-OADS,/arxiv_data1/oa_pdf/3d/a1/jnnp-2012-304131.PMC4332158.pdf
"1MRC Centre for Neuromuscular Disease, National Hospital forNeurology and Neurosurgery,London, UK 2Institute of Neurology, University College London,London, UK 3Institute of Clinical Neuroscience, Royal Prince Alfred Hospital, University ofSydney, Sydney, New SouthWales, Australia 4Department of Neurology, St Vincent ’s Hospital, Sydney, New South Wales, Australia 5Department of Neurology, Royal North Shore Hospital and Kolling Institute of MedicalResearch, University of Sydney,Sydney, New South Wales, Australia Correspondence to Professor Dimitri M Kullmann,UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK;d.kullmann@ion.ucl.ac.uk Received 24 October 2012 Revised 18 December 2012 Accepted 27 December 2012 Published Online First24 January 2013 ▸http://dx.doi.org/10.1136/ jnnp-2012-304857 To cite: Tomlinson SE, Rajakulendran S, Tan SV, et al.J Neurol Neurosurg Psychiatry 2013; 84: 1107 –1112.ABSTRACT Background and objective Heterozygous mutations inKCNA1 cause episodic ataxia type 1 (EA1), an ion channel disorder characterised by brief paroxysms ofcerebellar dysfunction and persistent neuromyotonia.",Non-OADS,/arxiv_data1/oa_pdf/3d/a1/jnnp-2012-304131.PMC4332158.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 V a c h e rH ,M o h a p a t r aD P ,T r i m m e rJ S .L o c a l i z a t i o na n dt a r g e t i n go fv o l t a g e - d e p e n d e n t i o nc h a n n e l si nm a m m a l i a nc e n t r a ln e u r o n s .",Non-OADS,/arxiv_data1/oa_pdf/3d/a1/jnnp-2012-304131.PMC4332158.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/dc/2b/jjm-07-11974.PMC4332231.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/33/47/jjm-07-12251.PMC4332232.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/8a/c5/jjm-07-12289.PMC4332233.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/87/51/jjm-07-12346.PMC4332234.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/05/ab/jjm-07-12776.PMC4332237.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/65/dd/jjm-07-13122.PMC4332238.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/88/80/jjm-07-13134.PMC4332239.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/3d/29/jjm-07-13504.PMC4332240.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/b8/c1/jjm-07-17114.PMC4332241.pdf
This article is distributed under the terms of an Attribution–Noncommercial–   Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201406120/DC1.,Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi   .org/10.1083/jcb.118.5.122 3 Casares, S., C.S.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1084/jem.190.4.54 3 Celli, L., J.J. Ryckewaert, E. Delachanal, and A. Duperray.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/   10.4049/jimmunol.177.6.411 3 Chen, W., and C. Zhu.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1111/imr.1212 2 Chen, J., W. Yang, M. Kim, C.V. Carman, and T.A.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1073/   pnas.060566610 3 Chen, W., J. Lou, and C. Zhu.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1074/jbc   .M110.15577 0 Chen, X., C. Xie, N. Nishida, Z. Li, T. Walz, and T.A.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10   .1016/S1074-7613(00)80177- 6 Comrie, W., A. Babich, and J.K. Burkhardt.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.4049/jimmunol.100310 2 Delon, J., K. Kaibuchi, and R.N.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/   10.3109/1541906980900448 1 Dustin, M.L., S.Y.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.4049/   jimmunol.177.7.427 1 Feigelson, S.W., R. Pasvolsky, S. Cemerski, Z. Shulman, V. Grabovsky, T.  Ilani, A. Sagiv, F. Lemaitre, C. Laudanna, A.S. Shaw, and R. Alon.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1074/jbc.M111.29959 4 Fisher, P.J., P.A.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"112:5037– 5045. http://dx.doi.org/10.1182/blood-2008-04-14952 6 Gérard, A., O. Khan, P. Beemiller, E. Oswald, J. Hu, M. Matloubian, and M.F.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1038/ni.254 7 Girard, T., M. El-Far, D. Gaucher, O. Acuto, G. Beaulé, F. Michel, W.  Mourad, and R.P.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.4049/jimmunol   .166.3.145 2 Al-Alwan, M.M., R.S.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/   10.4049/jimmunol.171.9.447 9 Allenspach, E.J., P. Cullinan, J. Tong, Q. Tang, A.G. Tesciuba, J.L.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10   .1016/S1074-7613(01)00224- 2 Appel, H., L. Gauthier, J. Pyrdol, and K.W.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1016/   S0006-3495(76)85755- 4 Babich, A., S. Li, R.S.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"197:775– 787. http://dx.doi.org/10.1083/jcb.20120101 8 Baker, R.G., C.J.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1128/MCB.00283-0 9 Barnden, M.J., J. Allison, W.R. Heath, and F.R.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1046/j.1440-1711.1998   .00709. x Barreiro, O., M. Yanez-Mo, J.M.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1083/jcb.20011212 6 Benvenuti, F., S. Hugues, M. Walmsley, S. Ruf, L. Fetler, M. Popoff, V.L.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1126/science.109915 9 Billadeau, D.D., J.C. Nolz, and T.S.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/   10.1038/nri202 1 Boniface, J.J., J.D.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)80629- 9 Bouma, G., A. Mendoza-Naranjo, M.P.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/   10.1182/blood-2011-03-34026 5 Bretscher, A., K. Edwards, and R.G.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/   10.1002/eji.20042585 7 Burkhardt, J.K., E. Carrizosa, and M.H.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/   10.1146/annurev.immunol.26.021607.09034 7 Cabañas, C., and N. Hogg.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/   10.1073/pnas.90.12.583 8 Cairo, C.W., R. Mirchev, and D.E.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1016/j.immuni.2006.06.01 2 Carpén, O., P. Pallai, D.E.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi   .org/10.1182/blood-2011-12-39743 0 Liu, B., W. Chen, B.D.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1016/j.cell.2014.02.05 3 Lu, C., M. Ferzly, J. Takagi, and T.A.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"166:5629– 5637. http://dx.doi.org/10.4049/jimmunol.166.9.562 9 Ma, Z., and T.H.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1016/j.it.2009.09.00 8 Ma, Z., K.A.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1084/jem.182.5.123 1 Monks, C.R., B.A.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1038/2576 4 Nguyen, K., N.R.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1016/j.immuni.2008.04.01 9 Ni, H.T., M.J. Deeths, and M.F.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.4049/jimmunol   .166.11.652 3 O’Connor, R.S., X. Hao, K. Shen, K. Bashour, T. Akimova, W.W. Hancock,  L.C.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1091/mbc.E06-08-074 4 Oh, H.M., M.S.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1016/j   .yexcr.2010.10.00 4 Parameswaran, N., R. Suresh, V. Bal, S. Rath, and A. George.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.4049/   jimmunol.175.4.220 1 Perez, O.D., D. Mitchell, G.C.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"4:1083– 1092. http://dx.doi.org/10.1038/ni98 4 Reichardt, P., B. Dornbach, S. Rong, S. Beissert, F. Gueler, K. Loser, and M.  Gunzer.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi   .org/10.1182/blood-2006-10-05379 3 Ross, R., H. Jonuleit, M. Bros, X.L.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
http://dx.doi.org/10.1046/j.1523-1747.2000.00112.,Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1016/j.immuni.2008.05.01 7 Scholer, A., S. Hugues, A. Boissonnas, L. Fetler, and S. Amigorena.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1016/j.immuni.2007.12.01 6 Schürpf, T., and T.A.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1038/emboj.2011.33 3 Sprague, B.L., and J.G.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1016/j.tcb   .2004.12.00 1 Springer, T.A., and M.L.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
http://dx.doi    .org/10.1016/j.ceb.2011.10.00 4CD86 cytoplasmic tail is necessary for cytoskeletal association and  effective co-stimulation.,OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"423:301– 307. http://dx.doi.org/10.1016/j.bbrc.2012.05.11 6 Grakoui, A., S.K.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi   .org/10.1126/science.285.5425.22 1 Gross, C.C., J.A.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.4049/jimmunol.100076 1 Hamad, A.R., S.M.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1084/jem.188.9.163 3 Hogg, N., I. Patzak, and F. Willenbrock.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/   10.1073/pnas.94.7.316 2 Huppa, J.B., M. Axmann, M.A.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1038/   nature0874 6 John, B., T.H.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1371/   journal.ppat.100050 5 Judokusumo, E., E. Tabdanov, S. Kumari, M.L.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1016/j.bpj.2011.12.01 1 Jun, C.D., M. Shimaoka, C.V. Carman, J. Takagi, and T.A.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/   10.1073/pnas.12118699 8 Kim, M., C.V. Carman, and T.A.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1126/science.108417 4 Kim, S.T., K. Takeuchi, Z.Y.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"3:76. http://dx.doi   .org/10.3389/fimmu.2012.0007 6 Kinashi, T. 2005.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1038/   nri164 6 Kong, F., A.J.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1083/jcb.20081000 2 Kong, F., Z. Li, W.M.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/   10.1016/j.molcel.2013.01.01 5 Lefort, C.T., Y.M.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi   .org/10.4049/jimmunol.090098 3 Levitsky, H.I., A. Lazenby, R.J. Hayashi, and D.M.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1084/jem.179.4.121 5 Li, D., J.J. Molldrem, and Q. Ma.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1074/jbc   .M109.00286 5 Li, Y.C., B.M.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.4049/jimmunol.090077 5 Liu, G., A.T. Place, Z. Chen, V.M.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1074/jbc.M111.27632 9 Tadokoro, S., S.J.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1111/j.1365- 2567.2010.03366. x Treanor, B., D. Depoil, A. Gonzalez-Granja, P. Barral, M. Weber, O. Dushek,  A. Bruckbauer, and F.D.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.12.00 5 Tseng, S.Y., M. Liu, and M.L.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.4049/   jimmunol.175.12.782 9 Varga, G., N. Nippe, S. Balkow, T. Peters, M.K.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1038/   jid.2009.39 8 Verdijk, P., P.A.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi   .org/10.1002/eji.20032424 1 Wang, Y ., K. Shibuya, Y .",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1093/intimm/dxn07 0 Wang, H., B. Wei, G. Bismuth, and C.E.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1073/   pnas.090051010 6 Xie, J., J.B. Huppa, E.W.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1038/ni.234 4 Xu, H., J.A.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1084/jem.180.1.9 5 Yang, Y., C.D.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1016/S1097-   2765(04)00204- 7 Zhu, J., C.V. Carman, M. Kim, M. Shimaoka, T.A.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi   .org/10.1182/blood-2007-03-08007 7 Zhu, J., B.H.",Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
"http://dx.doi.org/10.1016/j.molcel.2008.11.01 8 Zhu, J., J. Zhu, and T.A.",OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
http://dx.doi.org/10.1083/jcb   .20121203 7,Non-OADS,/arxiv_data1/oa_pdf/12/11/JCB_201406120.PMC4332244.pdf
This article is distributed under the terms of an Attribution–Noncommercial–   Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
Protein quantification significance analysis Downstream data analysis was performed using the Perseus statistical frame - work (http://www.perseus-framework.org/) version 1.5.0.0.,OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi   .org/10.1007/s10863-009-9214- x Bolte, S., and F.P.",Non-OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
http://dx.doi   .org/10.1111/j.1365-2818.2006.01706.,Non-OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi.org/10.1038/348125a 0 Chen, H., S.A. Detmer, A.J.",OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi.org/10.1083/jcb.20021104 6 Chen, H., J.M.",OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi.org/10.1016/j.cell.2007.06.02 6 Cox, J., and M. Mann.",OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi.org/   10.1038/nbt.151 1 Cox, J., N. Neuhauser, A. Michalski, R.A. Scheltema, J.V.",OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi   .org/10.1021/pr101065 j de Brito, O.M., and L. Scorrano.",Non-OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi.org/10.1038/   nature0753 4 Detmer, S.A., and D.C. Chan.",OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi.org/10.1083/   jcb.20061108 0 Detmer, S.A., C. Vande Velde, D.W. Cleveland, and D.C. Chan.",Non-OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi.org/10.1093/hmg/ddm31 4 Duarte, A., C. Poderoso, M. Cooke, G. Soria, F. Cornejo Maciel, V. Gottifredi,  and E.J.",Non-OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi.org/10.1371/journal   .pone.004582 9 Duarte, A., A.F.",Non-OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi   .org/10.1371/journal.pone.010038 7 Frangakis, A.S., and R. Hegerl.",Non-OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi.org/10.1006/jsbi.2001.440 6 Galinier, A., A. Carrière, Y. Fernandez, A.M. Bessac, S. Caspar-Bauguil, B.  Periquet, M. Comtat, J.P. Thouvenot, and L. Casteilla.",Non-OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi.org/10.1016/j.febslet   .2004.10.06 7 Guillet, V., N. Gueguen, C. Verny, M. Ferre, C. Homedan, D. Loiseau,  V. Procaccio, P. Amati-Bonneau, D. Bonneau, P. Reynier, and A.  Chevrollier.",Non-OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi.org/10.1007/s10048-   009-0207- z Hansson, A., N. Hance, E. Dufour, A. Rantanen, K. Hultenby, D.A.",Non-OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi   .org/10.1073/pnas.030871010 0 Henneman, L., A.G. van Cruchten, S.W.",Non-OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi   .org/10.1016/j.ab.2008.08.02 3 Huang, W., B.T.",OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi.org/10.1038/nprot.2008.21 1 Kanehisa, M., and S. Goto.",OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi.org/10.1093/ nar/  28.1.2 7Taqman probes: 16S (Mm03975671_s1), ATP6 (Mm03649417-g1), b-actin  (Mm01205647-g1), and 18S (Hs99999901_s1), from Life Technologies.",OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
Online supplemental material is avail - able at http://www.jcb.org/cgi/content/full/jcb.201411100/DC1.,Non-OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
Additional data are available in the JCB DataViewer at http://dx.doi   .org/10.1083/jcb.201411100.d v. We thank Lysann Schmitz for technical assistance with the bioenergetic char - acterization of heart mitochondria.,Non-OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi   .org/10.1038/7555 6 Belgardt, B.F., J. Mauer, F.T.",OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi.org/10.1091/mbc   .12.8.224 5 Sterky, F.H., S. Lee, R. Wibom, L. Olson, and N.-G. Larsson.",OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi   .org/10.2169/internalmedicine.51.667 6 Tran, U.C., and C.F.",OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi.org/10.1016/j.mito   .2007.03.00 7 Wang, Y., and S. Hekimi.",OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi   .org/10.3109/10409238.2012.74156 4 Wasilewski, M., M. Semenzato, S.M.",Non-OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi.org/10.1016/j.cub.2012.04.05 4 Weibel, E.R.",OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"150:111– 116. http://dx.doi.org/10.1016/0003-2697(85)90447- 6 Züchner, S., I.V .I.",OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"36:660) http://dx.doi.org/10.1038/ng134 1Keller, G.A., M. Pazirandeh, and S. Krisans.",Non-OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi.org/10.1083/jcb.103.3.87 5 Kovacs, W.J., P.L.",OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
http://dx.doi   .org/10.1046/j.0014-2956.2001.02409.,Non-OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi.org/10.1006/jsbi.1996.001 3 Kulak, N.A., G. Pichler, I. Paron, N. Nagaraj, and M. Mann.",OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi   .org/10.1038/nmeth.283 4 Kuznetsov, A.V., J. Troppmair, R. Sucher, M. Hermann, V. Saks, and R.  Margreiter.",OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi.org/10.1016/j.bbabio.2006.03.01 4 Lee, S., F.H.",OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi.org/10.1002/ana.2108 6 Misko, A., S. Jiang, I. Wegorzewska, J. Milbrandt, and R.H. Baloh.",Non-OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi.org/10.1172/JCI2908 9 Motori, E., J. Puyal, N. Toni, A. Ghanem, C. Angeloni, M. Malaguti, G.  Cantelli-Forti, B. Berninger, K.-K. Conzelmann, M. Götz, et al.",Non-OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi.org/10.1016/j.cmet.2013.11.00 5 Mourier, A., B. Ruzzenente, T. Brandt, W. Kühlbrandt, and N.-G. Larsson.",OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi.org/10.1093/hmg/ddt65 2 Olivier, L.M., and S.K.",OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi.org/10.1016/   S1388-1981(00)00139- 6 Ong, S.-E., and M. Mann.",OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi.org/10.1128/MCB.00911-1 0 Papanicolaou, K.N., G.A.",Non-OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi.org/10.1152/ajpheart   .00833.201 1  Pham, A.H., S. Meng, Q.N.",OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi.org/10   .1093/hmg/dds31 1 Rojo, M., F. Legros, D. Chateau, and A. Lombès.",Non-OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
"http://dx.doi.org/10   .1073/pnas.110822010 9 Signorelli, P., and Y.A.",OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
http://dx.doi.org/10.1016/S0076-6879   (02)45023- 9,OADS,/arxiv_data1/oa_pdf/c2/d1/JCB_201411100.PMC4332246.pdf
This article is distributed under the terms of an Attribution–Noncommercial–   Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
Online supplemental material is avail - able at http://www.jcb.org/cgi/content/full/jcb.201406121/DC1.,Non-OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"197:775– 787. http://dx.doi.org/10.1083/jcb.20120101 8 Baker, R.G., C.J.",Non-OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1128/MCB.00283-0 9 Beemiller, P., and M.F.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi   .org/10.1101/cshperspect.a00244 4 Billadeau, D.D., J.C. Nolz, and T.S.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/   10.1038/nri202 1 Bunnell, S.C., V. Kapoor, R.P.",Non-OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1016/S1074-7613(01)00112- 1 Burkhardt, J.K., E. Carrizosa, and M.H.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/   10.1146/annurev.immunol.26.021607.09034 7 Cairo, C.W., R. Mirchev, and D.E.",Non-OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1016/j.immuni.2006.06.01 2 Campi, G., R. Varma, and M.L.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1084/jem.2005118 2 Carman, C.V., and T.A.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1016/j.ceb.2003.08.00 3 Chen, J., W. Yang, M. Kim, C.V. Carman, and T.A.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
http://dx.doi.org/10.1073/   pnas.060566610 3with 400 µl of L-15 medium and equilibrated to 37°C on the microscope  stage.,OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1038/   nri164 6 Kong, F., A.J.",Non-OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1083/jcb.20081000 2 Kong, F., Z. Li, W.M.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/   10.1016/j.molcel.2013.01.01 5 Kumari, S., S. Vardhana, M. Cammer, S. Curado, L. Santos, M.P.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"3:230. http://dx.doi.org/10   .3389/fimmu.2012.0023 0 Lefort, C.T., Y.M.",Non-OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi   .org/10.4049/jimmunol.090098 3 Li, D., J.J. Molldrem, and Q. Ma.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1074/jbc   .M109.00286 5 Li, Y.C., B.M.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.4049/jimmunol.090077 5 Liu, B., W. Chen, B.D.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1016/j.cell.2014.02.05 3 Lu, C., M. Ferzly, J. Takagi, and T.A.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"166:5629– 5637. http://dx.doi.org/10.4049/jimmunol.166.9.562 9 Ma, Z., K.A.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.4049/   jimmunol.100243 8 Margadant, F., L.L.",Non-OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/   10.1371/journal.pbio.100122 3 Monks, C.R., B.A.",Non-OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1038/2576 4 Morin, N.A., P.W.",Non-OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/   10.1084/jem.2007154 3 Nguyen, K., N.R.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1016/j.immuni.2008.04.01 9 Nishida, N., C. Xie, M. Shimaoka, Y. Cheng, T. Walz, and T.A.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1016/   j.immuni.2006.07.01 6 Nolz, J.C., R.B.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1128/MCB.00136-0 7 O’Connor, R.S., X. Hao, K. Shen, K. Bashour, T. Akimova, W.W. Hancock,  L.C.",Non-OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1074/jbc   .M41270120 0 Perez, O.D., D. Mitchell, G.C.",Non-OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"4:1083– 1092. http://dx.doi.org/10.1038/ni98 4Chen, W., J. Lou, E.A.",Non-OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1083/jcb.20120109 1 Chen, X., C. Xie, N. Nishida, Z. Li, T. Walz, and T.A.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1038/nature1295 1 Ciobanasu, C., B. Faivre, and C. Le Clainche.",Non-OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1016/j.ejcb.2013.10.00 9 Comrie, W., S. Li, S. Boyle, and J.K. Burkhardt.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10   .1038/ni136 9 Dransfield, I., and N. Hogg.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/   10.3109/1541906980900448 1 Dustin, M.L., T. Starr, R. Varma, and V.K.",Non-OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.4049/jimmunol   .110348 7 Grakoui, A., S.K.",Non-OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi   .org/10.1126/science.285.5425.22 1 Griffiths, G.M., A. Tsun, and J.C. Stinchcombe.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"189:399– 406. http://dx.doi.org/10.1083/jcb.20100202 7 Gross, C.C., J.A.",Non-OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.4049/jimmunol.100076 1 Hartman, N.C., J.A.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1152/ajpcell.00122.201 3 Hogg, N., I. Patzak, and F. Willenbrock.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10   .1073/pnas.94.7.316 2 Judokusumo, E., E. Tabdanov, S. Kumari, M.L.",Non-OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1016/j.bpj.2011.12.01 1 Kaizuka, Y., A.D. Douglass, R. Varma, M.L.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1126/science.108417 4 Kim, M., C.V. Carman, W. Yang, A. Salas, and T.A.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
http://dx.doi.org/10.1083/jcb.20040416 0,Non-OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi   .org/10.1182/blood-2007-03-08007 7 Zhu, J., B.H.",Non-OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1016/j.molcel.2008.11.01 8 Zhu, J., J. Zhu, and T.A.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1083/   jcb.20121203 7Riedl, J., A.H. Crevenna, K. Kessenbrock, J.H.",Non-OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi   .org/10.1038/nmeth.122 0 Schürpf, T., and T.A.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1038/emboj.2011.33 3 Shimaoka, M., T. Xiao, J.H.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1016/   S0092-8674(02)01257- 6 Sims, T.N., T.J. Soos, H.S.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi   .org/10.1016/j.cell.2007.03.03 7 Smith, A., Y.R.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1083/   jcb.20041203 2 Springer, T.A., and M.L.",Non-OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1182/   blood-2005-12-02016 4 Tabassam, F.H., H. Umehara, J.Y.",Non-OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1016/S0092-   8674(02)00935- 2 Thauland, T.J., and D.C. Parker.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1111/j.1365- 2567.2010.03366. x Thomas, W.E., V. Vogel, and E. Sokurenko.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1146/annurev   .biophys.37.032807.12580 4 Vardhana, S., K. Choudhuri, R. Varma, and M.L.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi   .org/10.1016/j.immuni.2010.04.00 5 V arga, G., N. Nippe, S. Balkow, T. Peters, M.K.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1038/jid.2009.39 8 Varma, R., G. Campi, T. Yokosuka, T. Saito, and M.L.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1016/j.immuni.2006.04.01 0 Wang, H., B. Wei, G. Bismuth, and C.E.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1038/ni.234 4 Yi, J., X.S.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"http://dx.doi.org/10.1091/mbc.E11-08-073 1 Yokosuka, T., K. Sakata-Sogawa, W. Kobayashi, M. Hiroshima, A. Hashimoto- Tane, M. Tokunaga, M.L.",OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
http://dx.doi   .org/10.1242/jcs.09821 0,Non-OADS,/arxiv_data1/oa_pdf/b2/9a/JCB_201406121.PMC4332248.pdf
"Our observations demonstrate an  unanticipated level of interchangeability between the two  most prominent chromosomal landmarks.Telomeres and centromeres have interchangeable  roles in promoting meiotic spindle formation Alex Fennell,1,2* Alfonso Fernández-Álvarez,1,2* Kazunori Tomita,3 and Julia Promisel Cooper1,2 1Telomere Biology Section, Laboratory of Biochemistry and Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 2Telomere Biology Laboratory, Cancer Research UK, London Research Institute, London WC2A 3LY, England, UK 3Chromosome Maintenance Group, UCL Cancer Institute, University College London, London WC1E 6DD, England, UK This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No  Mirror Sites license for the first six months after the publication date (see http://www.rupress   .org/terms).",Non-OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/10.1016/S1534-   5807(04)00059- 0 Folco, H.D., A.L.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/10.1126/science.115094 4 Greider, C.W., and E.H. Blackburn.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/10.1016/0092-8674(85)90170- 9 Grimm, C., J. Kohli, J. Murray, and K. Maundrell.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/10.1007/BF0033130 7 Hagan, I., and M. Yanagida.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/10.1083/   jcb.129.4.103 3 Hall, I.M., K. Noma, and S.I.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/   10.1073/pnas.23268809 9 Harper, N.C., R. Rillo, S. Jover-Gil, Z.J.",Non-OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/10.1007/s00294005030 6 Heald, R., R. Tournebize, A. Habermann, E. Karsenti, and A. Hyman.",Non-OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/10.1083/jcb.138.3.61 5 Hemerly, A.S., S.G. Prasanth, K. Siddiqui, and B. Stillman.",Non-OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"323:789– 793. http://dx.doi.org/10.1126/science.116674 5 Hou, H., Z. Zhou, Y. Wang, J. Wang, S.P.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/10.1146/annurev-genet-102108-13484 1 Jin, Y., S. Uzawa, and W.Z.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi   .org/10.1016/S0168-9525(97)01298- 5 Klutstein, M., A. Fennell, A. Fernández-Álvarez, and J.P. Cooper.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/10   .1016/j.devcel.2011.07.01 1 Méndez-Lago, M., J.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/10.1093/nar/gkp08 5 Moreno, S., A. Klar, and P. Nurse.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/10.1016/0076-6879(91)94059- L Nabetani, A., T. Koujin, C. Tsutsumi, T. Haraguchi, and Y. Hiraoka.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/10.1007/s00412010015 3 Nakamura, Y., A. Arai, Y. Takebe, and M. Masuda.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi   .org/10.1016/j.ab.2011.01.03 9 Ohta, M., M. Sato, and M. Yamamoto.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
http://dx.doi.org/10.1091/mbc.E11-11-095 1peroxidase–conjugated anti–rabbit IgG (GE Healthcare) were used as sec - ondary antibodies.,Non-OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
Online supplemental material is available at   http://www.jcb.org/cgi/content/full/jcb.201409058/DC1.,Non-OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/10.1214/ss/117701145 4 Artandi, S.E., and J.P. Cooper.",Non-OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/10.1016/j   .molcel.2009.11.03 0 Asakawa, H., A. Hayashi, T. Haraguchi, and Y. Hiraoka.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"16:2325– 2338. http://dx.doi.org/10.1091/mbc.E04-11-099 6 Cheeseman, I.M., and A. Desai.",Non-OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi   .org/10.1038/nrm231 0 Chikashige, Y., D.Q.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi   .org/10.1126/science.814666 1 Chikashige, Y., D.Q.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/10.1093/emboj/16.1.19 3 Chikashige, Y., C. Tsutsumi, M. Yamane, K. Okamasa, T. Haraguchi, and Y.  Hiraoka.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi   .org/10.1016/j.cell.2006.01.04 8 Chikashige, Y., M. Yamane, K. Okamasa, C. Mori, N. Fukuta, A. Matsuda,  T. Haraguchi, and Y. Hiraoka.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/10.1247/csf.1400 7 Dehé, P.M., and J.P. Cooper.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/10.1016/j   .febslet.2010.07.04 5 de Lange, T. 2009.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/10.1126/science.117063 3 Ding, D.Q., Y. Chikashige, T. Haraguchi, and Y. Hiraoka.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"112:423– 440. http://dx.doi.org/10.1016/S0092-8674(03)00083- 7 Prasanth, S.G., K.V.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/10   .1038/nmeth95 3 Saito, T.T., T. Tougan, D. Okuzaki, T. Kasama, and H. Nojima.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/10   .1242/jcs.0162 9 Sakuno, T., K. Tada, and Y. Watanabe.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi   .org/10.1038/nature0787 6 Sato, A., B. Isaac, C.M.",Non-OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/10.1016/j.cell.2009.10.03 9 Scherthan, H. 2001.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/10.1038/3508508 6 Shibuya, H., K. Ishiguro, and Y. Watanabe.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/10.1038/ncb289 6 Stimpson, K.M., and B.A.",Non-OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi   .org/10.1016/j.ceb.2010.07.00 2 Takeo, S., and R.S.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/10.1371/journal   .pgen.100280 7 Tanaka, K., T. Kohda, A. Yamashita, N. Nonaka, and M. Yamamoto.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi   .org/10.1016/j.cub.2005.07.05 8 Tomita, K., and J.P. Cooper.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/10.1016/j.cell.2007.05.02 4 Tomita, K., C. Bez, A. Fennell, and J.P. Cooper.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi   .org/10.1083/jcb.20031206 1 Watanabe, Y.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/   10.1038/nrm334 9 Wen, R., G. Moore, and P.J.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/10.1371/journal.pone.004468 1 Yamamoto, A., R.R.",Non-OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"http://dx.doi.org/10.1083/jcb.145.6.123 3 Yanowitz, J.",Non-OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"22:744– 751. http://dx.doi.org/10.1016/j.ceb.2010.08.01 6 Yokobayashi, S., and Y. Watanabe.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"123:803– 817. http://dx.doi.org/10.1016/j.cell.2005.09.01 3 Yoshida, M., S. Katsuyama, K. Tateho, H. Nakamura, J. Miyoshi, T. Ohba, H.  Matsuhara, F. Miki, K. Okazaki, T. Haraguchi, et al.",OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
http://dx.doi.org/10.1083/jcb.20120716 8,Non-OADS,/arxiv_data1/oa_pdf/fb/eb/JCB_201409058.PMC4332249.pdf
"The time has come to revisit the old literature  and to resurrect the organisms that are buried there, both  to uncover new mechanisms and to marvel at the richness  of the cellular world.In praise of other model organisms Graham Warren Max F. Perutz Laboratories, University and Medical University of Vienna, 1030 Vienna, Austria © 2015 Warren  This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/ec/e8/JCB_201412145.PMC4332250.pdf
"http://dx.doi.org/10   .1002/anie.20100238 7 Blobel, G. 2000.",Non-OADS,/arxiv_data1/oa_pdf/ec/e8/JCB_201412145.PMC4332250.pdf
"http://dx.doi.org/10.1002/1439-7633(20000818)1:2<86::AID-CBIC86>   3.0.CO;2- A Case, R.M.",OADS,/arxiv_data1/oa_pdf/ec/e8/JCB_201412145.PMC4332250.pdf
http://dx.doi.org/10.1111/j.1469-185X.1978.tb01437.,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/JCB_201412145.PMC4332250.pdf
"http://dx.doi.org/10.1023/A:102207731780 1 Nurse, P.M. 2002.",Non-OADS,/arxiv_data1/oa_pdf/ec/e8/JCB_201412145.PMC4332250.pdf
"http://dx.doi.org/10.1023/A:102201770187 1 O’Clair, R.M., and R.A. Cloney.",Non-OADS,/arxiv_data1/oa_pdf/ec/e8/JCB_201412145.PMC4332250.pdf
"http://dx.doi.org/10.1126/science.109630 3 the questions that most fascinate you, even if it means straying  beyond the confines of the crown eukaryotes.",Non-OADS,/arxiv_data1/oa_pdf/ec/e8/JCB_201412145.PMC4332250.pdf
"Asl not only targets Plk4 to centrioles but also  modulates Plk4 stability and activity, explaining the ability  of overexpressed Asl to drive centriole amplification.Two Polo-like kinase 4 binding domains in Asterless  perform distinct roles in regulating kinase stability Joseph E. Klebba,1,2* Brian J. Galletta,3* Jonathan Nye,1,2 Karen M. Plevock,3,4 Daniel W. Buster,1,2   Natalie A. Hollingsworth,1,2 Kevin C. Slep,4 Nasser M. Rusan,3** and Gregory C. Rogers1,2** 1Department of Cellular and Molecular Medicine and 2University of Arizona Cancer Center, University of Arizona, Tucson, AZ 85724 3National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892 4Department of Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No  Mirror Sites license for the first six months after the publication date (see http://www.rupress   .org/terms).",Non-OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201410105/DC1.,Non-OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"http://dx.doi.org/10.1016/j.ceb.2012.10.01 6 Bennett, M.A., J.F.",OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"27:307– 315. http://dx.doi.org/10.1016/j.tig.2011.05.00 4 Blachon, S., J. Gopalakrishnan, Y. Omori, A. Polyanovsky, A.",Non-OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"http://dx.doi.org/10.1534/genetics   .108.09514 1 Bornens, M. 2012.",Non-OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"335:422– 426. http://dx.doi.org/10.1126/science.120903 7 Brito, D.A., S.M.",Non-OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"http://dx.doi.org/10.1016/j.ceb.2012.01.00 3 Brownlee, C.W., J.E.",OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"http://dx.doi.org/10.1038/ncb234 5 Pesin, J.A., and T.L.",OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"http://dx.doi.org/10.1126/science   .114295 0 Rogers, G.C., N.M. Rusan, D.M.",OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"http://jcb.rupress.org/   content/184/2/225.lon g Rogers, S.L., and G.C.",Non-OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"http://dx.doi.org/10.1038/nprot.2008.1 8 Rossignol, P., S. Collier, M. Bush, P. Shaw, and J.H.",Non-OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"http://dx.doi.org/10.1242/   jcs.00411 9 Rothbauer, U., K. Zolghadr, S. Muyldermans, A. Schepers, M.C.",Non-OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"7:282– 289. http://dx.doi.org/10.1074/mcp.M700342-MCP20 0 Shimada, M., and K. Komatsu.",OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"http://dx.doi.org/10.1269/jrr.0903 9 Slevin, L.K., J. Nye, D.C. Pinkerton, D.W. Buster, G.C.",Non-OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"http://dx.doi.org/10.1038/ng.97 1 Sonnen, K.F., A.M. Gabryjonczyk, E. Anselm, Y.D.",Non-OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"http://dx.doi.org/10   .1242/jcs.12950 2 Stevens, N.R., J. Dobbelaere, K. Brunk, A. Franz, and J.W.",Non-OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"http://dx.doi.org/10.1083/jcb.20091001 6 Tang, N., and W.F.",OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"http://dx.doi.org/10.1242/jcs.03808 3 Varmark, H., S. Llamazares, E. Rebollo, B. Lange, J. Reina, H. Schwarz, and C.  Gonzalez.",Non-OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"17:1735– 1745. http://dx.doi.org/10.1016/j.cub.2007.09.03 1 Vitre, B.D., and D.W. Cleveland.",Non-OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
http://dx.doi   .org/10.1016/j.ceb.2012.10.00 6induce centriole amplification.,OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"http://dx.doi   .org/10.1083/jcb.20110708 6 Buster, D.W., S.G. Daniel, H.Q.",Non-OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"http://dx.doi   .org/10.1083/jcb.20120718 3 Cizmecioglu, O., M. Arnold, R. Bahtz, F. Settele, L. Ehret, U. Haselmann-Weiss,  C. Antony, and I. Hoffmann.",Non-OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"http://dx.doi.org/10.1083/jcb.20100710 7 Cunha-Ferreira, I., A. Rodrigues-Martins, I. Bento, M. Riparbelli, W. Zhang,  E. Laue, G. Callaini, D.M.",Non-OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"http://dx.doi.org/10.1016/   j.cub.2008.11.03 7 Cunha-Ferreira, I., I. Bento, A. Pimenta-Marques, S.C. Jana, M. Lince-Faria, P.  Duarte, J. Borrego-Pinto, S. Gilberto, T. Amado, D. Brito, et al.",OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"http://dx.doi.org/10.1016/   j.cub.2013.09.03 7 Dzhindzhev, N.S., Q.D.",OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"http://dx.doi.org/10.1038/nature0944 5 Fode, C., C. Binkert, and J.W.",OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"2:120104. http://dx.doi   .org/10.1098/rsob.12010 4 Guderian, G., J. Westendorf, A. Uldschmid, and E.A.",OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"http://dx.doi.org/10   .1242/jcs.06850 2 Guernsey, D.L., H. Jiang, J. Hussin, M. Arnold, K. Bouyakdan, S. Perry, T.  Babineau-Sturk, J. Beis, N. Dumas, S.C. Evans, et al.",Non-OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"http://dx.doi   .org/10.1016/j.ajhg.2010.06.00 3 Hatch, E.M., A. Kulukian, A.J.",OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"http://dx.doi.org/10.1083/jcb.20100604 9 Holland, A.J., W. Lan, S. Niessen, H. Hoover, and D.W. Cleveland.",Non-OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"http://dx.doi   .org/10.1083/jcb.20091110 2 Kalay, E., G. Yigit, Y. Aslan, K.E.",Non-OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"http://dx.doi.org/10.1016/j.ceb.2013.04.01 1 Kim, T.S., J.E.",OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"http://dx.doi   .org/10.1016/j.cub.2013.09.01 9 Kleylein-Sohn, J., J. Westendorf, M. Le Clech, R. Habedanck, Y .D.",OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"http://dx.doi.org/10.1016/j.devcel.2007   .07.00 2 Krämer, A., J. Lukas, and J. Bartek.",OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"http://dx.doi.org/10.4161/cc.3.11.125 2 Mennella, V., B. Keszthelyi, K.L.",Non-OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"http://dx.doi   .org/10.1038/ncb259 7 Nakamura, T., H. Saito, and M. Takekawa.",OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
"4:1775. http://dx.doi.org/10.1038/ncomms275 2 Nigg, E.A., and J.W.",OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
http://dx.doi.org/10.1016/j.cell.2009.10.03 6,OADS,/arxiv_data1/oa_pdf/96/30/JCB_201410105.PMC4332252.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1016/j.celrep.2014.07.04 8 Bähler, J., J.Q.",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1002/(SICI)1097-0061   (199807)14:10<943::AID-YEA292>3.0.CO;2- Y Balasubramanian, M.K., D. McCollum, L. Chang, K.C.",Non-OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1101/gad.224154.11 3 Brandt, D.T., S. Marion, G. Griffiths, T. Watanabe, K. Kaibuchi, and R. Grosse.",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1083/jcb.20061207 1 Burke, T.A., J.R. Christensen, E. Barone, C. Suarez, V. Sirotkin, and D.R.",Non-OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1016/j.cub.2014.01.07 2 Carnahan, R.H., and K.L.",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"162:851– 862. http://dx.doi.org/10.1083/jcb.20030501 2 Chang, F., A. Woollard, and P. Nurse.",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10   .1083/jcb.137.1.16 9 Chesarone, M.A., A.G. DuPage, and B.L.",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1038/nrm281 6 Coffman, V .C., A.H. Nile, I.J.",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1091/mbc.E09-05-042 8 Coffman, V .C., J.A.",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1083/jcb.20130502 2 Copeland, S.J., B.J.",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi   .org/10.1074/jbc.M70383420 0 Fankhauser, C., A. Reymond, L. Cerutti, S. Utzig, K. Hofmann, and V .",Non-OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1016/0092-   8674(95)90432- 8 Fujiwara, T., K. Tanaka, A. Mino, M. Kikyo, K. Takahashi, K. Shimizu, and Y .",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/   10.1091/mbc.9.5.122 1 Hachet, O., and V .",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1101/gad.169720 8 Hagan, I.M.",Non-OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1016/j.cub.2014.05.03 4 Keeney, J.B., and J.D.",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/   10.1083/jcb.20050809 1 Vjestica, A., X.Z.",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1091/mbc.E07-07-066 3 Wach, A., A. Brachat, R. Pöhlmann, and P. Philippsen.",Non-OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1002/yea.32010131 0 Wachtler, V., Y. Huang, J. Karagiannis, and M.K.",Non-OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1091/mbc.E05-11-108 6 Wang, N., L. Lo Presti, Y.H.",Non-OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi   .org/10.1083/jcb.20130814 6 Watanabe, S., K. Okawa, T. Miki, S. Sakamoto, T. Morinaga, K. Segawa, T. Arakawa,  M. Kinoshita, T. Ishizaki, and S. Narumiya.",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1091/mbc.E10-04-032 4 Waters, J.C. 2009.",Non-OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1083/jcb.20090309 7 Wu, J.Q., and T.D.",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/ 10.1126/   science.111323 0 Wu, J.Q., J. Bähler, and J.R. Pringle.",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1091/mbc.12.4.106 1 Wu, J.Q., J.R. Kuhn, D.R.",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1016/S1534-   5807(03)00324- 1 Wu, J.Q., V. Sirotkin, D.R.",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi   .org/10.1083/jcb.20060203 2 Yonetani, A., R.J. Lustig, J.B. Moseley, T. Takeda, B.L.",Non-OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1091/ mbc.E07-07-073 1Kessels, M.M., J. Dong, W. Leibig, P. Westermann, and B. Qualmann.",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi   .org/10.1242/jcs.0287 7 Kostan, J., U. Salzer, A. Orlova, I. Törö, V .",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi   .org/10.15252/embr.20143926 7 Kovar, D.R., and T.D.",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi   .org/10.1038/ncb1204-115 8 Kovar, D.R., J.R. Kuhn, A.L.",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi   .org/10.1083/jcb.20021107 8 Laporte, D., V .C.",Non-OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1083/jcb.20100817 1 Liu, W., F.H.",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1091/ mbc.E11-07-063 1 Nabeshima, K., T. Nakagawa, A.F.",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"9:3211– 3225. http://dx.doi.org/10.1091/mbc.9.11.321 1 Nakano, K., K. Satoh, A. Morimatsu, M. Ohnuma, and I. Mabuchi.",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1091/mbc.12.11.351 5 Naqvi, N.I., K. Eng, K.L.",Non-OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1093/emboj/18.4.85 4 Nurse, P., P. Thuriaux, and K. Nasmyth.",Non-OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1007/BF0026808 5 Pelham, R.J., and F. Chang.",Non-OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10   .1038/nature0099 9 Qualmann, B., J. Roos, P.J.",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/   10.1091/mbc.10.2.50 1 Roberts-Galbraith, R.H., and K.L.",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.4161/cc.9.20.1358 7 Roberts-Galbraith, R.H., J.S.",Non-OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1083/jcb.20080604 4 Roberts-Galbraith, R.H., M.D.",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1016/j.molcel.2010.06.01 2 Rousso, T., A.M. Shewan, K.E.",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.7554/eLife.0066 6 Seth, A., C. Otomo, and M.K.",Non-OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/   10.1083/jcb.20060500 6 Shaner, N.C., G.G.",Non-OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1038/nmeth.241 3 Tao, E.Y., M. Calvert, and M.K.",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1016/j.cub.2014.07.07 4 Tebbs, I.R., and T.D.",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
"http://dx.doi.org/10.1091/mbc.E12-   10-077 5 Tsujita, K., S. Suetsugu, N. Sasaki, M. Furutani, T. Oikawa, and T. Takenawa.",OADS,/arxiv_data1/oa_pdf/cd/cf/JCB_201411097.PMC4332253.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://jcb.rupress.org/content/150/4/807.lon g Allard, J., and A. Mogilner.",Non-OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1016/   j.ceb.2012.08.01 2 Arjonen, A., R. Kaukonen, and J. Ivaska.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.4161/   cam.5.5.1772 3 Arrieumerlou, C., and T. Meyer.",Non-OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi   .org/10.1016/j.devcel.2004.12.00 7 Bear, J.E., and J.M.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"30:74– 82. http://dx.doi.org/10.1016/j.ceb.2014.06.00 5 Berg, J.S., and R.E.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1016/j.cell.2008.06.05 4 Chen, H.C., and J.L.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10   .1091/mbc.12.2.26 5 Cuevas, B.D., Y. Lu, M. Mao, J. Zhang, R. LaPushin, K. Siminovitch, and G.B.",Non-OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1074/jbc.M10055620 0 Dang, I., R. Gorelik, C. Sousa-Blin, E. Derivery, C. Guérin, J. Linkner, M.  Nemethova, J.G.",Non-OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/   10.1038/361721a 0 Dent, E.W., S.L.",Non-OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1101/cshperspect.a00180 0 Elkhatib, N., M.B.",Non-OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1016/j.cub.2014.05.02 3 Even-Ram, S., and K.M.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1016/j.ceb.2005.08.01 5 Everett, R.D.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1128/JVI.00021-1 0 Foxman, E.F., E.J.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1083/jcb.147.3.57 7 Galbraith, C.G., K.M.",Non-OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1126/science.113790 4Chemotaxis and haptotaxis assays Microfluidic devices were prepared as previously described (Wu et al.,  2012).",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
6 A. Online supplemental material is avail - able at http://www.jcb.org/cgi/content/full/jcb.201406102/DC1.,Non-OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi   .org/10.1126/science.109205 3 Rotty, J.D., C. Wu, and J.E.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1038/nrm349 2 Rotty, J.D., C. Wu, E.M. Haynes, J.D.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.4161/   cam.4.2.1074 5 Schneider, I.C., and J.M.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1083/jcb.20050902 8 Schneider, I.C., E.M. Parrish, and J.M.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi   .org/10.1529/biophysj.105.06121 8 Teddy, J.M., and P.M. Kulesa.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"131:6141– 6151. http://dx.doi.org/10.1242/dev.0153 4 Vasioukhin, V., C. Bauer, M. Yin, and E. Fuchs.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"100:209– 219. http://dx.doi.org/10.1016/S0092-8674(00)81559- 7 Vicente-Manzanares, M., C.K.",Non-OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi   .org/10.1242/jcs.01856 4 Vignjevic, D., S. Kojima, Y. Aratyn, O. Danciu, T. Svitkina, and G.G.",Non-OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1083/jcb.20060301 3 Weiger, M.C., C.-C. Wang, M. Krajcovic, A.T. Melvin, J.J. Rhoden, and J.M.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1242/jcs.03756 4 Weiger, M.C., S. Ahmed, E.S.",Non-OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1016/j.bpj   .2009.09.05 1 Welf, E.S., S. Ahmed, H.E.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1083/jcb   .20110815 2 Welf, E.S., H.E.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1091/mbc.E13-06-031 1 Wood, W., A. Jacinto, R. Grose, S. Woolner, J. Gale, C. Wilson, and P. Martin.",Non-OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1038/ncb87 5 Wu, C., S.B.",Non-OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1016/j.cell.2011.12.03 4 Wu, Y .I., D. Frey, O.I.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1038/nature0824 1 Xu, J., F. Wang, A.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1016/S0092-8674(03)00555- 5 Yamashiro, S., Y .",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10   .1091/mbc.9.5.99 3 Yang, C., and T. Svitkina.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.4161/   cam.5.5.1697 1 Yoshigi, M., L.M.",Non-OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1016/j.yexcr.2007   .10.02 6 Guilluy, C., V. Swaminathan, R. Garcia-Mata, E.T.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10   .1038/ncb285 9 Iglesias, P.A., and P.N.",Non-OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1016/j.ceb.2011.11.00 9 Johnson, H.E., and J.M.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"61:14.14.1–14.14: 24.  http://dx.doi.org/10.1002/0471143030.cb1414s6 1 Korobova, F., and T. Svitkina.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1091/mbc.E07-09-096 4 Kraynov, V.S., C. Chamberlain, G.M.",Non-OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1126/science   .290.5490.33 3 Lara Rodriguez, L., and I.C.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/   10.1039/c3ib40137 e Laukaitis, C.M., D.J.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1083/jcb.153.7.142 7 Lebensohn, A.M., and M.W.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1016/j.molcel.2009.10.02 4 Li, A., J.C. Dawson, M. Forero-Vargas, H.J.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1016/j.cub.2009.12.03 5 Li, A., J.P. Morton, Y. Ma, S.A. Karim, Y. Zhou, W.J.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1053/j.gastro.2014.01.04 6 Luikart, B.W., W. Zhang, G.A.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1529/   biophysj.105.07038 3 Machesky, L.M., and A. Li.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.4161/cib.3   .3.1155 6 Mattila, P.K., and P. Lappalainen.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi   .org/10.1038/nrm240 6 Nemethova, M., S. Auinger, and J.V.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1083/jcb.20070913 4 Partridge, M.A., and E.E.",Non-OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1091/mbc   .E06-06-049 6 Petrie, R.J., A.D. Doyle, and K.M.",Non-OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1091/mbc.6.10.134 9 Reiske, H.R., S.C. Kao, L.A. Cary, J.L.",OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
http://dx.doi   .org/10.1074/jbc.274.18.1236 1,Non-OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
"http://dx.doi.org/10.1242/jcs.0079 2 Zanet, J., A. Jayo, S. Plaza, T. Millard, M. Parsons, and B. Stramer.",Non-OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
http://dx.doi.org/10.1083/jcb.20111013 5,Non-OADS,/arxiv_data1/oa_pdf/31/5a/JCB_201406102.PMC4332254.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b3/1d/opth-9-235.PMC4332255.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 235–243Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  235Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7529 7an evaluation of retaine™ ophthalmic emulsion  in the management of tear film stability and  ocular  surface staining in patients diagnosed with dry eye Correspondence: george Ousler iii Ora, inc, 300 Brickstone square,  andover, Ma 01810, Usa Tel +1 978 685 8900 Fax +1 978 689 0020 email gousler@oraclinical.co m george Ousler iii1 Douglas K Devries2 Paul M Karpecki3 Joseph B Ciolino4 1Ora, inc, andover, M a, Usa; 2eye  Care associates of nevada, sparks,   nV, Usa; 3Koffler Vision group,   lexington, KY, Usa; 4Massachusetts  eye and ear, Boston, M a, Usa  Abstract:  A single-center, open-label study consisting of two visits over the course of  approximately 2 weeks was conducted to evaluate the efficacy of Retaine™ ophthalmic emul - sion in improving the signs and symptoms of dry eye.",Non-OADS,/arxiv_data1/oa_pdf/b3/1d/opth-9-235.PMC4332255.pdf
"Affecting one in three patients who seek treatment from an eye care  practitioner, dry eye is one of the most common ophthalmic diseases and can drasti - cally impact the quality of life (QoL) of those plagued by the disease.3Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Ousler III et al Running head recto: Evaluation of Retaine™ DOI: http://dx.doi.org/10.2147/OPTH.S75297",Non-OADS,/arxiv_data1/oa_pdf/b3/1d/opth-9-235.PMC4332255.pdf
The study is listed on  http://clinicaltrials.go v as NCT02139033.,Non-OADS,/arxiv_data1/oa_pdf/b3/1d/opth-9-235.PMC4332255.pdf
Available from: http://abstracts.iovs.org/ cgi/content/abstract/45/5/8 2.,Non-OADS,/arxiv_data1/oa_pdf/b3/1d/opth-9-235.PMC4332255.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/b3/1d/opth-9-235.PMC4332255.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/1d/opth-9-235.PMC4332255.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b4/54/ppa-9-245.PMC4332256.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 245–247Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  245Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/PPA.S7870 6Assessment of selected quality fields of nursing  care in neurosurgical wards rita Cassia Vieira1 Manoel Jacobsen teixeira2 Wellingson Silva Paiva2 1School of Nursing, 2Division of  Neurological Surgery, University of  Sao Paulo Medical School, Sao Paulo,   BrazilDear editor We read with great interest the recent study by Ślusarz et al1 published in the Patient  Preference and Adherence  journal.",Non-OADS,/arxiv_data1/oa_pdf/b4/54/ppa-9-245.PMC4332256.pdf
"2014;8:1113–1121.Correspondence: Wellingson S Paiva 255 Eneas Aguiar Street, Office 4079, Sao  Paulo 05403010, Brazil tel +55 11 2661 7226 Fax +55 11 2548 6906 email wellingsonpaiva@yahoo.com.b r Journal name: Patient Preference and Adherence Article Designation: Letter Y ear: 2015 Volume: 9 Running head verso: Vieira et al Running head recto: Nursing care in neurosurgical wards DOI: http://dx.doi.org/10.2147/PPA.S78706",Non-OADS,/arxiv_data1/oa_pdf/b4/54/ppa-9-245.PMC4332256.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/b4/54/ppa-9-245.PMC4332256.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/84/88/opth-9-263.PMC4332257.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 263–270Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  263Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7518 0simulation of airbag impact on eyes with different  axial lengths after transsclerally fixated posterior  chamber intraocular lens by using finite  element analysis Correspondence: Jane huang Department of Ophthalmology, Fukuoka  University school of Medicine, 7-45-1  nanakuma, Jonan-ku, Fukuoka 814-0180,  Japan Tel +81 92 801 1011 Fax +81 92 865 4445 email janehuang@jcom.home.ne.j p Jane huang1 eiichi Uchio1 satoru goto2 1Department of Ophthalmology,   Fukuoka University school of  Medicine, Fukuoka, 2nihon esi KK  T echnical Division, T okyo, JapanPurpose:  To determine the biomechanical response of an impacting airbag on eyes with different  axial lengths with transsclerally fixated posterior chamber intraocular lens (PC IOL).",Non-OADS,/arxiv_data1/oa_pdf/84/88/opth-9-263.PMC4332257.pdf
In a 1991–1998 Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Huang et al Running head recto: Airbag impact on eyes DOI: http://dx.doi.org/10.2147/OPTH.S75180,Non-OADS,/arxiv_data1/oa_pdf/84/88/opth-9-263.PMC4332257.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/84/88/opth-9-263.PMC4332257.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/84/88/opth-9-263.PMC4332257.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c6/ba/ott-8-395.PMC4332258.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 395–400OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  395Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7910 2The clue of a possible etiology about spontaneous  regression of hepatocellular carcinoma:  a perspective on pathology Zhuo Wang1,*  Zun-Fu Ke1,*  Xiao-Fang Lu1  Can-Jiao Luo1  Y ong-Dong Liu1  Zhong-Wei Lin2  Lian-Tang Wang1 1Department of p athology, The  First affiliated Hospital of sun  Yat-sen University, Guangzhou,   people’s republic of China;   2Department of Cardiology, The First  affiliated Hospital of Guangdong  pharmaceutical University, Guangzhou,   people’s republic of China *These authors contributed equally  to this workAbstract:  Spontaneous regression of hepatocellular carcinoma (HCC) is a rare event.",Non-OADS,/arxiv_data1/oa_pdf/c6/ba/ott-8-395.PMC4332258.pdf
"The Correspondence: Lian-Tang Wang  Department of pathology, The First  Affiliated Hospital of Sun Yat-Sen  University, 58 Zhongshan road II,  Guangzhou, 510080, people’s republic  of China  Tel +86 20 8733 1780  Fax +86 20 8733 1780  email wanglt@mail.sysu.edu.c n Journal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2015 Volume: 8 Running head verso: Wang et al Running head recto: Spontaneous regression of hepatocarcinoma DOI: http://dx.doi.org/10.2147/OTT.S79102",Non-OADS,/arxiv_data1/oa_pdf/c6/ba/ott-8-395.PMC4332258.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c6/ba/ott-8-395.PMC4332258.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/ba/ott-8-395.PMC4332258.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/81/a2/tcrm-11-189.PMC4332259.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 189–200Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  189ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S6875 2echocardiographic assessment of left ventricular  function in thyrotoxicosis and implications for the  therapeutics of thyrotoxic cardiac disease Correspondence: RC anakwue Department of Pharmacology and  Therapeutics, College of Medicine,  University of nigeria, enugu Campus,  ituku Ozalla, PMB 01129, enugu state,  nigeria Tel +234 803 334 3044 email dranakwue@yahoo.co m Raphael C anakwue1,2 Basden J Onwubere2 Vincent ikeh2 Benedict anisiuba2 samuel ike2 angel-Mary C anakwue3 1Department of Pharmacology  and Therapeutics, 2Department  of Medicine, 3Department of  Radiography and Radiological  sciences, imaging Unit, College of  Medicine, University of nigeria,   nsukka, enugu state, nigeriaIntroduction:  Thyrotoxicosis is an endocrine disorder with prominent cardiovascular  manifestations.",Non-OADS,/arxiv_data1/oa_pdf/81/a2/tcrm-11-189.PMC4332259.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/81/a2/tcrm-11-189.PMC4332259.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/81/a2/tcrm-11-189.PMC4332259.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/55/4a/opth-9-245.PMC4332260.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 245–252Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  245Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S6837 1Color light-emitting diode reflection topography:  validation of keratometric repeatability in a large  sample of wide cylindrical-range corneas anastasios John  Kanellopoulos1,2 george asimellis1 1laserVision.gr Clinical and research  eye institute, athens, greece;   2new Y ork University Medical school,   new Y ork, nY, UsaPurpose:  To investigate repeatability of steep and flat keratometry measurements, as well as  astigmatism axis in cohorts with normal range and regular astigmatic such as: eyes following  laser-assisted in situ keratomileusis (LASIK) and normal population, as well as cohorts of high  and irregular astigmatism such as keratoconic eyes, and keratoconic eyes following corneal  collagen cross-linking, employing a novel corneal reflection topography device.",Non-OADS,/arxiv_data1/oa_pdf/55/4a/opth-9-245.PMC4332260.pdf
"Keywords:  LED topography, point-source topography, VU topographer, axis of astigmatism, Cassini  topographer, steep meridian, surface regularity index, surface asymmetry index, form factor Introduction Corneal topographers provide qualitative characteristics and quantitative metrics of the  anterior corneal surface,1 transforming raw data into color-coded dioptric power-scale Correspondence: anastasios John  Kanellopoulos laserVision.gr Clinical and research  eye institute, 17 Tsocha street,  athens, greece 11521 Tel +30 210 7472777 Fax +30 210 7472789 email ajk@brilliantvision.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Kanellopoulos and Asimellis Running head recto: Color light-emitting diode reflection topography DOI: http://dx.doi.org/10.2147/OPTH.S68371",Non-OADS,/arxiv_data1/oa_pdf/55/4a/opth-9-245.PMC4332260.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/55/4a/opth-9-245.PMC4332260.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/55/4a/opth-9-245.PMC4332260.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/56/72/ott-8-385.PMC4332261.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 385–394OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  385Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7576 7XPa a23g polymorphism and risk of digestive  system cancers: a meta-analysis lei he Tao Deng hesheng luo Department of gastroenterology,   renmin hospital of Wuhan University,   Wuhan, People’s republic of chinaBackground:  Several studies have reported  an association between the A23G polymorphism  (rs 1800975) in the xeroderma pigmentosum group A (XPA) gene and risk of digestive system  cancers.",Non-OADS,/arxiv_data1/oa_pdf/56/72/ott-8-385.PMC4332261.pdf
statistical analysis HWE was evaluated for each study using an Internet-based  HWE calculator ( http://ihg.gsf.de/cgi-bin/hw/hwa1.p l).,OADS,/arxiv_data1/oa_pdf/56/72/ott-8-385.PMC4332261.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/56/72/ott-8-385.PMC4332261.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/72/ott-8-385.PMC4332261.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/09/bd/opth-9-253.PMC4332262.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 253–261Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  253Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7138 7Vitreous flow rates through dual pneumatic  cutters: effects of duty cycle and cut rate Dina Joy K abulon  Medical affairs, alcon research, ltd,   lake Forest, C a, UsaPurpose:  We aimed to investigate effects of instrument settings on porcine vitreous flow rates  through dual pneumatic high-speed vitrectomy probes.",Non-OADS,/arxiv_data1/oa_pdf/09/bd/opth-9-253.PMC4332262.pdf
"Correspondence: Dina Joy K abulon alcon research, ltd, 20511 lake Forest  Drive, lake Forest, Ca 92630, Usa Tel +1 949 505 7586 Fax +1 949 753 6270 email dina.abulon@alcon.co mJournal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Abulon Running head recto: Instrumental effects on vitreous flow DOI: http://dx.doi.org/10.2147/OPTH.S71387",Non-OADS,/arxiv_data1/oa_pdf/09/bd/opth-9-253.PMC4332262.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/09/bd/opth-9-253.PMC4332262.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/09/bd/opth-9-253.PMC4332262.pdf
Available from: http://www.retinalphysician.com/ articleviewer.aspx?articleID =104860.,Non-OADS,/arxiv_data1/oa_pdf/09/bd/opth-9-253.PMC4332262.pdf
"Retrieved from http://ec.europa.eu/education/ languages/euromosaic/doc4658_de.htm#3 Finkel, E. J., Burnette, J. L., & Scissors, L. E. (2007).",Non-OADS,/arxiv_data1/oa_pdf/0b/33/10.1177_1073191113498267.PMC4332286.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d9/8c/copd-10-239.PMC4332287.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 239–259International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  239OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7514 6Tiotropium handihaler® and respimat®  in COPD:  a pooled safety analysis David M g halpin1 ronald Dahl2 Christoph hallmann3 achim Mueller3 Donald Tashkin4 1royal Devon and exeter hospital,   exeter, Devon, england, UK; 2allergy  Centre, Odense University hospital,   Odense, Denmark; 3Boehringer  Ingelheim Pharma gmbh & Co  Kg, Ingelheim am rhein, germany;   4Department of Medicine, David  geffen school of Medicine UCla,   los angeles, C a, UsaIntroduction:  Tiotropium is prescribed for the treatment of chronic obstructive pulmonary  disease (COPD) and delivered via HandiHaler® (18 µg once daily) or Respimat® Soft Mist™  inhaler (5 µg once daily).",Non-OADS,/arxiv_data1/oa_pdf/d9/8c/copd-10-239.PMC4332287.pdf
"In addition, patients are often prescribed a number of medications for  the management of the concomitant diseases, as well as their COPD, and therefore it Correspondence: David Mg halpin respiratory Clinical lead, nhs sW,  royal Devon and exeter hospital,  Barrack road, exeter,   Devon eX2 5DW, england, UK Tel +4413 9240 2133 Fax +4413 9240 2828 email d.halpin@nhs.ne t Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Halpin et al Running head recto: Tiotropium: pooled safety analysis DOI: http://dx.doi.org/10.2147/COPD.S75146 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/d9/8c/copd-10-239.PMC4332287.pdf
Or use: http://dvpr.es/1wXRBO YVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/d9/8c/copd-10-239.PMC4332287.pdf
"COPD: Treatment from Bronchodila - tors to Other Pharmacological Interventions, May 1, 2014,  A5973-A5973; http://www.atsjournals.org/doi/abs/10.1164/ ajrccm-conference.2014.189.1_MeetingAbstracts.A597 3.",Non-OADS,/arxiv_data1/oa_pdf/d9/8c/copd-10-239.PMC4332287.pdf
Available from:  http://www.goldcopd.com/uploads/users/files/GOLD_Report_2014_ Oct30.pdf.,OADS,/arxiv_data1/oa_pdf/d9/8c/copd-10-239.PMC4332287.pdf
Available from: http://www.medicines.org.u k/em c/ medicine/10039/SPC/Spiriva +18+microgram +inhalation +powder   %2c+hard+capsule /.,Non-OADS,/arxiv_data1/oa_pdf/d9/8c/copd-10-239.PMC4332287.pdf
Available from: http://www.medicines.org.,Non-OADS,/arxiv_data1/oa_pdf/d9/8c/copd-10-239.PMC4332287.pdf
Available from: http://www.boehringer-ingelheim.,Non-OADS,/arxiv_data1/oa_pdf/d9/8c/copd-10-239.PMC4332287.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/d9/8c/copd-10-239.PMC4332287.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d9/8c/copd-10-239.PMC4332287.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3f/63/ppa-9-281.PMC4332288.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 281–287Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  281Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S6469 1Clinical utility and patient considerations  in the use of the sitagliptin–metformin  combination in Chinese patients Qiang Du Yan-Jun wang Sheng Yang Ping Han Department of endocrinology,   Shengjing Hospital of China Medical  University, Shenyang, Liaoning,   People’s Republic of ChinaAbstract:  The prevalence of diabetes mellitus (DM) continues to increase each year.",Non-OADS,/arxiv_data1/oa_pdf/3f/63/ppa-9-281.PMC4332288.pdf
"These differences may affect  the efficacy of glucose-lowering therapy.Correspondence: Qiang Du Department of endocrinology, Shengjing  Hospital of China Medical University,  Shenyang 110004, Liaoning, People’s  Republic of China Tel +86 138 4206 0676 email kobe9903@sina.co m Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Du et al Running head recto: Use of sitagliptin–metformin in Chinese patients DOI: http://dx.doi.org/10.2147/PPA.S64691",Non-OADS,/arxiv_data1/oa_pdf/3f/63/ppa-9-281.PMC4332288.pdf
Available from: http://www.accessdata.,OADS,/arxiv_data1/oa_pdf/3f/63/ppa-9-281.PMC4332288.pdf
"Available  from: http://www.accessdata.fda.gov/drugsatfda_docs/lab el/2008/020 357s031,021202s016lbl.pd f. Accessed November 1, 2014.",Non-OADS,/arxiv_data1/oa_pdf/3f/63/ppa-9-281.PMC4332288.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/3f/63/ppa-9-281.PMC4332288.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a0/36/ijwh-7-205.PMC4332289.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 205–211International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  205OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S7528 8cYFra 21-1 in urine: a diagnostic marker  for endometriosis?,Non-OADS,/arxiv_data1/oa_pdf/a0/36/ijwh-7-205.PMC4332289.pdf
"51,  a-6912 Hörbranz, austria Tel +4983822796988 email g javotchanoff@bodenseelabor.co m Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2015 Volume: 7 Running head verso: Gjavotchanoff Running head recto: CYFRA 21-1 level in urine can serve as endometriosis biomarker DOI: http://dx.doi.org/10.2147/IJWH.S75288",Non-OADS,/arxiv_data1/oa_pdf/a0/36/ijwh-7-205.PMC4332289.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/a0/36/ijwh-7-205.PMC4332289.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/36/ijwh-7-205.PMC4332289.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/52/02/ppa-9-249.PMC4332290.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 249–256Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  249OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7869 1Motivation of adult female patients seeking  orthodontic treatment: an application  of Q-methodology Xia Tang1 Jiaxin cai1 Beibei lin1 linjie Yao2 Feiou lin3 1school of stomatology,   2Department of Pedodontics,   3Department of Orthodontics,   school of stomatology, Wenzhou  Medical University, lu cheng District,   People’s republic of chinaBackground:  Motivation is the impetus for patients to seek orthodontic treatment, affecting  adherence, treatment outcomes, and satisfaction.",Non-OADS,/arxiv_data1/oa_pdf/52/02/ppa-9-249.PMC4332290.pdf
"Motivation stems from several  sources, and can be defined as a concept that describes the conscious or unconscious  stimulus for action toward a desired goal.7 Both positive and negative motivations  are correlated with adherence.8 The motivation to seek treatment in this research is correspondence: Feiou lin Department of Orthodontics, school  and hospital of stomatology, Wenzhou  Medical University, 113, Xue Yuan West  road, lu cheng District, Wenzhou,  People’s republic of china Tel +86 577 8806 3012 Fax +86 577 8806 3666 email linfeiousci@163.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Tang et al Running head recto: Q-methodology in orthodontics DOI: http://dx.doi.org/10.2147/PPA.S7869 1",Non-OADS,/arxiv_data1/oa_pdf/52/02/ppa-9-249.PMC4332290.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/52/02/ppa-9-249.PMC4332290.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ca/ce/ppa-9-257.PMC4332291.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 257–263Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  257OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7623 6Patients’ satisfaction and prevalence of  complications on surgical extraction of third molar correspondence: ch chu 1B30, Prince Philip Dental hospital,  34 hospital road, hong Kong sAr,  People’s republic of china Tel +852 2859 0287 Fax +852 2858 2532 email chchu@.hku.h k crystal TY lee shinan Zhang Yiu Yan leung samantha KY li cissy c Tsang chun-hung chu Faculty of Dentistry, The University  of hong Kong, hong Kong sAr,   People’s republic of chinaObjectives:  To study patients’ satisfaction and prevalence of complications in surgical  extraction of impacted third molar by senior dentists and recently graduated dentists in a uni - versity dental clinic.",Non-OADS,/arxiv_data1/oa_pdf/ca/ce/ppa-9-257.PMC4332291.pdf
The prudent Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Lee et al Running head recto: Patients’ satisfaction with third molar extraction DOI: http://dx.doi.org/10.2147/PPA.S76236,Non-OADS,/arxiv_data1/oa_pdf/ca/ce/ppa-9-257.PMC4332291.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/ca/ce/ppa-9-257.PMC4332291.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d0/ed/ijwh-7-213.PMC4332292.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 213–218International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  213OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S7337 3Health-related quality of life in southern Iranian  rural women: a multivariate multilevel study seyed Mohammad Taghi  ayatollahi najaf Zare Tania Dehesh Department of Biostatistics, school of  Medicine, shiraz University of Medical  sciences, shiraz, IranPurpose:  The evaluation of health-related quality of life (HRQOL) is increasingly growing  to be of much significance.",Non-OADS,/arxiv_data1/oa_pdf/d0/ed/ijwh-7-213.PMC4332292.pdf
"These concepts are relevant to  cultural, political, and economic status of communities.2 The WHO defines HRQOL  as an individual perception of an individual’s position in life in the context of cultural  and value systems in which he/she lives, and in relation to ambitions, expectations,  standards, and concerns.3 HRQOL is an important consideration in choosing an area in which to reside; certainly,  people tend to move to communities of higher HRQOL.4 Education and employment are  the two most important motivational factors in rural migration to cities and urban areas.5 correspondence: Tania Dehesh  Department of Biostatistics, school  of Medicine, shiraz University of Medical  sciences, PO Box 71345-1874,  shiraz, Iran Tel +98 711 625 8645  Fax +98 711 234 9330  email tania_dehesh@yahoo.co m/ dehesht@sums.ac.i r Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2015 Volume: 7 Running head verso: Ayatollahi et al Running head recto: Health-related quality of life in southern Iranian rural women DOI: http://dx.doi.org/10.2147/IJWH.S73373",Non-OADS,/arxiv_data1/oa_pdf/d0/ed/ijwh-7-213.PMC4332292.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/d0/ed/ijwh-7-213.PMC4332292.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/ed/ijwh-7-213.PMC4332292.pdf
Available from: http://www.agriculturejour - nals.cz/publicFiles/07901.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d0/ed/ijwh-7-213.PMC4332292.pdf
Avail - able from: http://www.indexmundi.com/facts/iran/rural-population.,Non-OADS,/arxiv_data1/oa_pdf/d0/ed/ijwh-7-213.PMC4332292.pdf
Available from: http://www.who.int/mental_health/ who_qol_field_trial_1995.pdf.,OADS,/arxiv_data1/oa_pdf/d0/ed/ijwh-7-213.PMC4332292.pdf
Available from: http://faculty.udesa.edu.ar/WalterSosa/ multinivel/Handbook.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d0/ed/ijwh-7-213.PMC4332292.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bb/e5/jpr-8-079.PMC4332293.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2015:8 79–85Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  79ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S5655 8Reanalysis of morphine consumption from two  randomized controlled trials of gabapentin   using longitudinal statistical methods shiyuan Zhang1 James Paul2 Manyat nantha-aree2 norman Buckley2 Uswa shahzad2 Ji cheng2 Justin DeBeer5 Mitchell Winemaker5 David Wismer5 Dinshaw Punthakee5 Victoria avram5 lehana Thabane1–4 1Department of clinical epidemiology  and Biostatistics, McMaster University,  2Department of anesthesia, McMaster  University,  3Biostatistics Unit/ centre  for evaluation of Medicines, st Joseph’s  healthcare-hamilton, 4Population  health Research institute, hamilton  health science/McMaster University,  5Department of surgery, Division of  Orthopaedics, McMaster University,  hamilton, On , canada correspondence: lehana Thabane   Department of clinical epidemiology  and Biostatistics, McMaster University,   1280 Main street West, On l8s  4K1,  hamilton, On, canada   email thabanl@mcmaster.c aBackground:  Postoperative pain management in total joint replacement surgery remains  ineffective in up to  50% of patients and has an overwhelming impact in terms of patient well- being and health care burden.",Non-OADS,/arxiv_data1/oa_pdf/bb/e5/jpr-8-079.PMC4332293.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/bb/e5/jpr-8-079.PMC4332293.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bb/e5/jpr-8-079.PMC4332293.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/42/b3/jpr-8-063.PMC4332294.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 63–77Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  63Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S5536 0Chronic pain management in the obese patient:  a focused review of key challenges and potential  exercise solutions Laura Ann Zdziarski Joseph G wasser Heather K vincent Department of Orthopaedics and  Rehabilitation, Division of Research,   interdisciplinary Center for  Musculoskeletal Training and   Research, University of Florida,   Gainesville, FL, USA Correspondence: Heather K vincent   Department of Orthopaedics and  Rehabilitation, Division of Research,  UF Orthopaedics and Sports Medicine  institute (OSMi), PO Box  112727,  Gainesville, FL  32611, USA   Tel +1 352 273 7459  Fax +1 352 273 7388  email vincehk@ortho.ufl.ed uAbstract:  In obese persons, general and specific musculoskeletal pain is common.",Non-OADS,/arxiv_data1/oa_pdf/42/b3/jpr-8-063.PMC4332294.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/42/b3/jpr-8-063.PMC4332294.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/42/b3/jpr-8-063.PMC4332294.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7b/91/ott-8-401.PMC4332310.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 401–404OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  401Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6846 9Use of allogeneic platelet gel in the management  of chemotherapy extravasation injuries: a case  report Gaetano Di Costanzo1 Giovanna Loquercio1 Gianpaolo Marcacci2 Vincenzo Iervolino1 stefano Mori3 arnolfo p etruzziello1 pasquale Barra1 Carmela Cacciapuoti1 1Transfusion service, Department of  Haematology, National Cancer Institute  “G pascale” Foundation, IrCCs,  Naples, Italy; 2Hematology-Oncology  and stem Cell Transplantation  Unit, National Cancer Institute  “G pascale” Foundation, IrCCs,  Naples, Italy; 3Department of surgery,  Melanoma – soft Tissues – Head  and Neck – skin Cancers, National  Cancer Institute “G pascale”  Foundation, IrCCs, Naples, ItalyAbstract:  The allogeneic platelet (PLT) gel offers to be a valid supportive measure in the  management of chemotherapy extravasation injuries.",Non-OADS,/arxiv_data1/oa_pdf/7b/91/ott-8-401.PMC4332310.pdf
"Skin ulcer was debrided, and the wound was reconstructed with local Correspondence: Giovanna Loquercio Department of Haematology, National  Cancer Institute “G pascale” Foundation,  IrCCs, via Mariano semmola, 80131,  Napoli, Italy Tel +39 81 590 3433 Fax +39 81 545 3560 email giovyloquercio@libero.i t Journal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2015 Volume: 8 Running head verso: Di Costanzo et al Running head recto: Allogeneic PLT in the management of chemotherapy extravasation DOI: http://dx.doi.org/10.2147/OTT.S68469",Non-OADS,/arxiv_data1/oa_pdf/7b/91/ott-8-401.PMC4332310.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7b/91/ott-8-401.PMC4332310.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/91/ott-8-401.PMC4332310.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b1/01/tcrm-11-201.PMC4332311.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 201–207Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  201ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S7663 6Current status of parenteral nutrition and enteral  nutrition application: an assessment of nutritional  prescriptions from 59 hospitals in the People’s  Republic of China gang han Zhenwei Yu Ke Ma sir Run Run shaw hospital, College  of Medicine, Zhejiang University,   hangzhou, People’s Republic of ChinaPurpose:  The aim of the study reported here was to assess the use of parenteral nutrition  (PN) and enteral nutrition (EN), and the prevalence of PN and EN formulas, in the People’s  Republic of China.",Non-OADS,/arxiv_data1/oa_pdf/b1/01/tcrm-11-201.PMC4332311.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/b1/01/tcrm-11-201.PMC4332311.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/01/tcrm-11-201.PMC4332311.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e9/eb/jir-8-049.PMC4332312.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Inflammation Research 2015:8 49–57Journal of Inflammation Research Dove press submit your manuscript | www.dovepress.co m Dove press  49ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JIR.S7811 8eggshell membrane hydrolyzates activate nF- κB  in vitro: possible implications for in vivo efficacy Kevin J Ruff1 Paul l Durham2 austin O’Reilly2 F Daniel long1 1esM Technologies, llc, carthage,  MO, Usa; 2center for Biomedical  and life sciences, Missouri state  University, springfield, MO, Usa correspondence: Kevin J Ruff   esM Technologies, llc, 2213 Missouri  avenue, carthage, MO 64836, Usa   Tel +1 417 310 6059   Fax +1 417 358 4944   email kruff@esmingredients.co mPurpose:  Eggshell membrane (ESM) has been shown to contain naturally occurring bioactive  components, and biological activities such as reducing proinflammatory cytokines, liver fibrosis,  and joint pain in osteoarthritis sufferers have also been reported for ESM matrix as a whole.",Non-OADS,/arxiv_data1/oa_pdf/e9/eb/jir-8-049.PMC4332312.pdf
"Journal of Inflammation Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-inflammation-research-journa lThe Journal of Inflammation Research is an international, peer-reviewed  open-access journal that welcomes laboratory and clinical findings on the  molecular basis, cell biology and pharmacology of inflammation including  original research, reviews, symposium reports, hypothesis formation and  commentaries on: acute/chronic inflammation; mediators of inflamma -tion; cellular processes; molecular mechanisms; pharmacology and novel  anti-inflammatory drugs; clinical conditions involving inflammation.",Non-OADS,/arxiv_data1/oa_pdf/e9/eb/jir-8-049.PMC4332312.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e9/eb/jir-8-049.PMC4332312.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d3/13/ppa-9-275.PMC4332313.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 275–279Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  275OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7687 7Patronage of traditional bonesetters in Makurdi,  north-central nigeria ndubuisi Oc Onyemaechi1 Omolade A lasebikan2 itodo c elachi3 sunday O Popoola4 Kehinde s Oluwadiya4 1Department of surgery, University  of nigeria T eaching hospital,   ituku-Ozalla, enugu, 2Department  of Orthopaedic surgery, national  Orthopaedic hospital, enugu,   3Department of surgery, Benue state  University T eaching hospital, Makurdi,   4Department of surgery, ekiti  state University T eaching hospital,   Ado-ekiti, nigeriaBackground:  Despite the numerous complications associated with traditional bonesetters’  (TBS) practices, their patronage has remained high in developing countries.",Non-OADS,/arxiv_data1/oa_pdf/d3/13/ppa-9-275.PMC4332313.pdf
"Ogunlusi et al8 and Oyebola9 (southwestern Nigeria) reported cultural beliefs, quicker  and cheaper services, and fear of amputation at an orthodox hospital as the reasons  for TBS patronage in their studies.correspondence: ndubuisi Oc  Onyemaechi Department of surgery, University  of nigeria Teaching hospital,   ituku-Ozalla enugu, nigeria Tel +234 803 550 4767 email bisionyemaechi@yahoo.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Onyemaechi et al Running head recto: Patronage of traditional bonesetters in Nigeria DOI: http://dx.doi.org/10.2147/PPA.S76877",Non-OADS,/arxiv_data1/oa_pdf/d3/13/ppa-9-275.PMC4332313.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/d3/13/ppa-9-275.PMC4332313.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/80/a8/opth-9-271.PMC4332314.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 271–275Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  271Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7580 4Correlation between optic nerve involvement  and chronic obstructive pulmonary disease haleh Mikaeili1 Mohammad Yazdchi2 shiva solahaye Kahnamouii2 elyar sadeghi-hokmabadi2 reshad Mirnour2 1Tuberculosis and lung Diseases  research Center, Tabriz University  of Medical science, Tabriz, iran;   2neuroscience research Center,   Tabriz University of Medical science,   Tabriz, iranBackground:  Chronic obstructive pulmonary disease (COPD) is a major public health  problem worldwide.",Non-OADS,/arxiv_data1/oa_pdf/80/a8/opth-9-271.PMC4332314.pdf
"Correspondence: Mohammad Yazdchi neuroscience research Center,  imam reza hospital, Tabriz University  of Medical science, gholghasht street,  Tabriz, 5166614756, iran Tel +98 91 4116 5992 Fax +98 41 3334 0730 email yazdchim@yahoo.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Mikaeili et al Running head recto: COPD and optic nerve involvement DOI: http://dx.doi.org/10.2147/OPTH.S75804",Non-OADS,/arxiv_data1/oa_pdf/80/a8/opth-9-271.PMC4332314.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/80/a8/opth-9-271.PMC4332314.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/a8/opth-9-271.PMC4332314.pdf
Available from: http://www.acns.org/pdf/ guidelines/Guideline-9B.pdf.,Non-OADS,/arxiv_data1/oa_pdf/80/a8/opth-9-271.PMC4332314.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9c/c0/ijwh-7-219.PMC4332315.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2015:7 219–225International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  219ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S6674 3Random-start GnRH antagonist for emergency  fertility preservation: a self-controlled trial Miguel A Checa1,2 Mario Brassesco2 Margalida Sastre1 Manuel Gómez2 Julio Herrero3 Laura Marque3 Arturo Brassesco2 Juan José Espinós3 1Department of Obstetrics  and Gynecology, Parc de Salut  Mar, Universitat Autònoma de  Barcelona,  2Centro de Infertilidad  y Reproducción Humana (CIRH),   3Centro de Reproducción Asistida  Sagrada Familia, Clínica Sagrada  Familia, Barcelona, Spain Correspondence: Miguel A Checa   Department of Obstetrics and  Gynecology, Parc de Salut Mar, Passeig  Marítim  25-29, E-08003 Barcelona, Spain   Fax +34 932 483 254  Email macheca@hospitaldelmar.ca tAbstract:  The aim of this study is to evaluate the feasibility and safety of random-start  controlled ovarian hyperstimulation (COH) for emergency fertility preservation, regardless of  the phase of the menstrual cycle.",Non-OADS,/arxiv_data1/oa_pdf/9c/c0/ijwh-7-219.PMC4332315.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/9c/c0/ijwh-7-219.PMC4332315.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/c0/ijwh-7-219.PMC4332315.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ae/0a/ndt-11-333.PMC4332316.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 333–337Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  333Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S7852 2Common psychocutaneous disorders in children Anca Chiriac1–3 Piotr Brzezinski4 T udor Pinteala5 Anca e Chiriac5 Liliana Foia5 1Apollonia University, Department of  Dermato-Physiology, 2Nicolina Medical  Center, Department of Dermatology,  3“P .",Non-OADS,/arxiv_data1/oa_pdf/ae/0a/ndt-11-333.PMC4332316.pdf
"Psychosomatic diseases These are secondary psychiatric disorders due to disfiguring dermatoses and are asso - ciated with depression, anxiety, and delusional symptoms.Correspondence: Anca Chiriac Apollonia University, Nicolina Medical  Center, Department of Dermatology,  “P Poni” institute of Macromolecular  Chemistry, Strada Muzicii nr2, ia și,  Romania Tel +40 721 234 999 email ancachiriac@yahoo.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Chiriac et al Running head recto: Common psychocutaneous disorders in children DOI: http://dx.doi.org/10.2147/NDT.S78522",Non-OADS,/arxiv_data1/oa_pdf/ae/0a/ndt-11-333.PMC4332316.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/ae/0a/ndt-11-333.PMC4332316.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/0a/ndt-11-333.PMC4332316.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e6/6d/ppa-9-265.PMC4332317.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 265–274Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  265Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S6165 1T eriflunomide for the treatment of relapsing– remitting multiple sclerosis: patient preference  and adherence Antonios Bayas1 Mathias Mäurer2 1Department of Neurology, Klinikum  Augsburg, Augsburg, Germany;   2Department of Neurology, Caritas  Krankenhaus Bad Mergentheim,   Bad Mergentheim, GermanyAbstract:  Multiple sclerosis (MS), a chronic demyelinating neuroinflammatory disease of  the central nervous system, is the most common neurological disorder leading to disability in  young adulthood.",Non-OADS,/arxiv_data1/oa_pdf/e6/6d/ppa-9-265.PMC4332317.pdf
"For many years, interferon beta preparations and glatiramer acetate (Table 1) have  belonged to the well-established group of injectable immunoprophylactic therapeutics, Correspondence: Antonios Bayas Department of Neurology, Klinikum  Augsburg, Stenglinstr 2, 86156  Augsburg, Germany Tel +49 821 400 3892 Fax +49 821 400 2691 email antonios.bayas@klinikum-augsburg.d e Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Bayas and Mäurer Running head recto: Teriflunomide in multiple sclerosis: patient preference and adherence DOI: http://dx.doi.org/10.2147/PPA.S61651",Non-OADS,/arxiv_data1/oa_pdf/e6/6d/ppa-9-265.PMC4332317.pdf
21. https://http://www.copaxone.com/Resources/pdfs/PrescribingInformation.,Non-OADS,/arxiv_data1/oa_pdf/e6/6d/ppa-9-265.PMC4332317.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/e6/6d/ppa-9-265.PMC4332317.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d1/42/main.PMC4332399.pdf
http://dx.doi.org/10.1016/j.ejro.2014.12.003 2352-0477/©  2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/42/main.PMC4332399.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d1/42/main.PMC4332399.pdf
"Developmental Cognitive Neuroscience 10 (2014) 34–43 Contents lists available at ScienceDirect Developmental Cognitive Neuroscience journal homepage: http://www.elsevier.com/locate/dcn Developmental continuity in reward-related enhancement of cognitive control Nicole M. Stranga,∗, Seth D. Pollakb aCenter for Addictions and Mental Health Addictions Research, 100 Stokes St., Rum 3165, Toronto, Ontario M6J 1H4, Canada bUniversity of Wisconsin - Madison, United States article info Article history: Received 30 August 2013Received in revised form 11 July 2014Accepted 25 July 2014Available online 2 August 2014 Keywords:DevelopmentCognitiveAffectivefMRIAdolescentabstract Adolescents engage in more risky behavior than children or adults.",Non-OADS,/arxiv_data1/oa_pdf/b2/fe/main.PMC4332542.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/b2/fe/main.PMC4332542.pdf
"In contrast, less http://dx.doi.org/10.1016/j.dcn.2014.07.005 1878-9293/© 2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b2/fe/main.PMC4332542.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/b2/fe/main.PMC4332542.pdf
"Random durations of ﬁxation, andorder of events were created using Make Random Timing (http://afni.nimh.nih.gov/pub/dist/doc/program help/make random timing.py.html) and the efﬁciency of the design was assessed using 3dDeconvolve.",OADS,/arxiv_data1/oa_pdf/b2/fe/main.PMC4332542.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/ j.dcn.2014.07.005.",OADS,/arxiv_data1/oa_pdf/b2/fe/main.PMC4332542.pdf
"Bactobolin A Binds to a Site on the 70S Ribosome Distinct from Previously Seen Antibiotics Alexey Amunts1,†, Karol Fiedorczuk1,†, Thao T. Truong2, Josephine Chandler2, E. Peter Greenberg2and V. Ramakrishnan1 1 - MRC Laboratory of Molecular Biology, Cambridge CB20QH, UK 2 - Department of Microbiology, School of Medicine, University of Washington, Seattle, WA 98195, USA Correspondence to V. Ramakrishnan: ramak@mrc-lmb.cam.ac.uk http://dx.doi.org/10.1016/j.jmb.2014.12.018 Edited by J. H. Naismith Abstract The ribosome is the target of a large number of antibiotics.",Non-OADS,/arxiv_data1/oa_pdf/36/f6/main.PMC4332689.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/f6/main.PMC4332689.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/f6/main.PMC4332689.pdf
Supplementary data Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.jmb.2014.12.,OADS,/arxiv_data1/oa_pdf/36/f6/main.PMC4332689.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use, distributio n, and reproduction in any medium, provided the original work is properly cited.1 Citation: Libyan J Med 2015, 10: 26680 - http://dx.doi.org/10.3402/ljm.v10.26680 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/2e/cf/LJM-10-26680.PMC4332739.pdf
"2 (page number not for citation purpose)Citation: Libyan J Med 2015, 10: 26680 - http://dx.doi.org/10.3402/ljm.v10.26680",Non-OADS,/arxiv_data1/oa_pdf/2e/cf/LJM-10-26680.PMC4332739.pdf
"$,$$: significant difference Pre- vs. Post program at pB0.05, pB0.01, respectively.Training effects on lung function and aerobic capacity of smokers Citation: Libyan J Med 2015, 10: 26680 - http://dx.doi.org/10.3402/ljm.v10.26680 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/2e/cf/LJM-10-26680.PMC4332739.pdf
"4 (page number not for citation purpose)Citation: Libyan J Med 2015, 10: 26680 - http://dx.doi.org/10.3402/ljm.v10.26680",Non-OADS,/arxiv_data1/oa_pdf/2e/cf/LJM-10-26680.PMC4332739.pdf
"Intra-group changes in percentage ( D%) of spirometric values of the three groups.Training effects on lung function and aerobic capacity of smokers Citation: Libyan J Med 2015, 10: 26680 - http://dx.doi.org/10.3402/ljm.v10.26680 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/2e/cf/LJM-10-26680.PMC4332739.pdf
"6 (page number not for citation purpose)Citation: Libyan J Med 2015, 10: 26680 - http://dx.doi.org/10.3402/ljm.v10.26680",Non-OADS,/arxiv_data1/oa_pdf/2e/cf/LJM-10-26680.PMC4332739.pdf
"Association between self-reported leisure-time physical activity and measures ofTraining effects on lung function and aerobic capacity of smokers Citation: Libyan J Med 2015, 10: 26680 - http://dx.doi.org/10.3402/ljm.v10.26680 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/2e/cf/LJM-10-26680.PMC4332739.pdf
"8 (page number not for citation purpose)Citation: Libyan J Med 2015, 10: 26680 - http://dx.doi.org/10.3402/ljm.v10.26680",Non-OADS,/arxiv_data1/oa_pdf/2e/cf/LJM-10-26680.PMC4332739.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2014, 1–9 doi:10.1093/ijnp/pyu035 Research Article 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/b7/pyu035.PMC4332795.pdf
"To view a copy of this license,  visit http://creativecommons.org/licenses/by-nc-nd/3.0/ *Author for correspondence: Tel.",Non-OADS,/arxiv_data1/oa_pdf/52/07/nihms658761.PMC4332836.pdf
"For reprint orders, please contact: reprints@futuremedicine.com Information resources See also the online supplement, available at http://oernst.f5lvg.free.fr/liver/iron.html Ethical conduct of research The authors state that they have obtained appropriate institutional review board approval or have followed the principles outlined in  the Declaration of Helsinki for all human or animal experimental investigations.",Non-OADS,/arxiv_data1/oa_pdf/52/07/nihms658761.PMC4332836.pdf
"    Journal of Epidemiology and  Global Health    ISSN (Online): 2210 -6014  ISSN (Print): 2210 -6006   Journal Home Page:  https://www.atlantis -press.com/journals/jegh      HIV status, knowledge of mother -to-child transmission of HIV and  antenatal care use among Ethiopian women   Ida Sahlu, Chanelle J. Howe, Melissa A. Clark, Brando n D.L.",Non-OADS,/arxiv_data1/oa_pdf/da/3f/JEGH-4-3-177.PMC4332875.pdf
"Marshall   (2014 ) HIV status, knowledge of mother -to-child transmission of HIV and antenatal care  use among Ethiopian women , Journal of Epidemiology and Global Health  4:3, 177–184,  DOI: https://doi.org/10.1016/j.jegh.2014.01.001  To link to this article : https://doi.org/ 10.1016/j.jegh.2014.01.001    Published online: 23  April 2019",Non-OADS,/arxiv_data1/oa_pdf/da/3f/JEGH-4-3-177.PMC4332875.pdf
"2210-6006/$ - see front matter ª2014http://dx.doi.org/10.1016/j.jegh.2014.01.001*Corresponding author at: Department of Epidemiology, Brown University School of Public Health, 121 South Main Street, Providence, RI 02912, USA.",Non-OADS,/arxiv_data1/oa_pdf/da/3f/JEGH-4-3-177.PMC4332875.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/da/3f/JEGH-4-3-177.PMC4332875.pdf
This is an open accessarticleundertheCCBY-NC-NDlicense( http://creativecommons.org/licenses/ by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/da/3f/JEGH-4-3-177.PMC4332875.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7e/49/sbu099.PMC4332942.pdf
http://www.real-   statistics.com/ .,Non-OADS,/arxiv_data1/oa_pdf/7e/49/sbu099.PMC4332942.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/bc/sbu219.PMC4332962.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ce/8f/nms-03-14022.PMC4332990.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/97/bd/nms-03-19948.PMC4332991.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/fb/12/nms-03-20213.PMC4332992.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/2a/bf/nms-03-20249.PMC4332993.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ab/63/nms-03-21136.PMC4332994.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e9/cf/nms-03-21764.PMC4332995.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/f5/ca/nms-03-22063.PMC4332996.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/92/nms-03-22261.PMC4332997.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.Dear editor, Nurses continue to report high levels of job-related in - jury and illness.",Non-OADS,/arxiv_data1/oa_pdf/86/75/nms-03-22357.PMC4332998.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.Cesarean delivery (CD) is a life-saving procedure with  specific medical indications.",Non-OADS,/arxiv_data1/oa_pdf/d6/81/nms-03-22502.PMC4332999.pdf
"This Open Access article is distributed under the terms of the Creative Commons License Attribution-Non-Commercial Share Alike ( <http://creativecommons.org/licenses/by-nc-sa/4.0/ >).STEM CELLS AND DEVELOPMENT Volume 24, Number 5, 2015 Mary Ann Liebert, Inc. DOI: 10.1089/scd.2014.0314 597",Non-OADS,/arxiv_data1/oa_pdf/ae/fe/scd.2014.0314.PMC4333258.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and  redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/a5/40/aapm-04-05-19862.PMC4333302.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and  redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/9c/99/aapm-04-05-20326.PMC4333304.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and  redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/cf/6e/aapm-04-05-21649.PMC4333305.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/69/11/aapm-04-05-23149.PMC4333306.pdf
Software implementation Epidaurus was implemented in Python and C: the source codeanddocumentationarefreelyavailablefromourweb- site (http://epidaurus.sourceforge.net/ ).,OADS,/arxiv_data1/oa_pdf/45/93/gku1079.PMC4333365.pdf
Epidaurus can be invoked from the command line as well as from our on- line web server ( http://bioinformaticstools.mayo.edu:8080/ Epidaurus/ ).,OADS,/arxiv_data1/oa_pdf/45/93/gku1079.PMC4333365.pdf
